<!-- image -->

## NATIONAL ACTION PLAN ON COMBATING ANTIMICROBIAL RESISTANCE

This document was prepared by Dr. Rima Moghnieh, MD (WHO consultant, private sector), under the overall guidance of WHO Country Office Representative in Lebanon Dr. Iman Shankiti, in close coordination with the Director General of MOPH Professor Walid Ammar.

With the support of the members of the national AMR committee, with special acknowledgement of the efforts of Ms. Loubna al Batlouni and Ms. Hajar Samaha for their inputs in coordinating the process of development of this plan, and editing and finalizing the plan document.

## National AMR Committee Members

-  President : Dr. Atika Berry (Ministry of Public Health, Head of Preventive Medicine
- Department)
-  Vice President :
- Dr. Jacques Mokhbat (Lebanese American University, Microbiologist and Infectious Diseases Specialist)
-  Members ( by alphabetical order of family names ):
- Dr. Georges Araj (American University of Beirut Medical Center, Head of Laboratory Medicine)
- Dr. Ghada Asmar (Lebanese University, School of Dentistry)
- Dr. Bassel Bazzal (Ministry of Agriculture, Head of Animal Health Services) Dr. Nada Ghosn (Ministry of Public Health, Head of Epidemiology Surveillance Unit)
- Dr. Rasha Hamra (Ministry of Public Health, Director of Public Relations and Health Education Departments)

Dr. Rola Husni Samaha (Lebanese American University Medical Center- Rizk Hospital, Head of Infectious Diseases Division and Infection Control Program) Dr. Rima Moghnieh (Makassed General Hospital, Head of Antimicrobial Stewardship Program)

- Dr. Alissar Rady (World Health Organization-National Professional Officer) Dr. Georges Salem (Lebanese Pediatric Society)
- Dr. Dolla Sarkis (Saint Joseph University, Vice President for Research)
- Eng. Abir Sirawan (Ministry of Agriculture, Head of Poultry Husbandry Department)
- Dr. Rony Zeinni (Lebanese Order of Pharmacists)

## Table of Content

| Abbreviations and acronyms                   | p.4   |
|----------------------------------------------|-------|
| Foreword                                     | p.5   |
| Executive summary                            | p.6   |
| Introduction                                 | p.10  |
| Situation analyses and Assessment            | p.12  |
| Country Response                             | p.14  |
| Axis A (Awareness)                           |       |
| Strategic plan                               | p.15  |
| Operational and budget plan                  | p.20  |
| Monitoring and Evaluation plan               | p.34  |
| Axis B (Surveillance)                        |       |
| Strategic plan                               | p.45  |
| Operational and budget plan                  | p.50  |
| Monitoring and Evaluation plan               | p.62  |
| Axis C (Infection prevention and Control)    |       |
| Strategic plan                               | p.72  |
| Operational and budget plan                  | p.77  |
| Monitoring and Evaluation plan               | p.88  |
| Axis D (Antibiotic Use)                      |       |
| Strategic plan                               | p.97  |
| Operational and budget plan                  | p.102 |
| Monitoring and Evaluation plan               | p.116 |
| Axis E (Budget Planning and Fund Attraction) |       |
| Strategic plan                               | p.126 |
| Operational and budget plan                  | p.130 |
| Monitoring and Evaluation plan               | p.139 |
| References                                   | p.145 |
| Acknowledgement                              | p.147 |
| Appendix                                     | p.148 |

## Abbreviations and acronyms

- ABX: Antibiotics

| AMR: Antimicrobial resistance  AMS: Antimicrobial Stewardship   AUB: American University of Beirut  BAU: Beirut Arab University  CERD: Center for Educational Research and Development  CIAM: Critically Important Antimicrobials  CME: Continuous Medical Education   DDD: Defined Daily Dose  Dpt: Department  EMRO: Eastern Mediterranean Region Office  ESCMID: European Society of Clinical Microbiology and Infectious Diseases  ESU: Epidemiological Surveillance Unit  FAO: Food and Agriculture Organization  GAP: Global Action Plan  GLASS: Global Antimicrobial Resistance Surveillance System  ID: Infectious Diseases   IDSA: Infectious Diseases Society of America  IHR: International Health Regulation  IPC: Infection Prevention and Control   |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IT: Information Technology                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| LARI: Lebanese Agricultural Research Institute                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| LSIDCM: Lebanese Society of Infectious Diseases and Clinical Microbiology                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| LTCF: Long-Term Care Facilities                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| MOA: Ministry of Agriculture                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| MOH: Ministry of Health                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| NA: Not Available                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| NAP: National Action Plan                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| NGO: Non-governmental Organization                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| PHC: Primary Health Care                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| PHCC: Primary Health Care Center                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| QC: Quality Control  TOR: Terms of Reference                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| TV: Television                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| UN: United Nations                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| USD: United States Dollars                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| WHO: World Health Organization                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |

## Foreword

Antimicrobial resistance (AMR) has become a global public health concern and Lebanon is of no exception to this issue. The spread of antimicrobial-resistant bacteria is considered an alarming public health threat, with a potential extent similar to global warming and other social and environmental threats.

In the 2014 World Economic Forum's Global Risks report, 50 external global risks were analyzed in terms of their economic, environmental, geopolitical, social, and technological consequences, and classified according to their impact, probability, and interconnections. The impact and the probability of AMR were deemed as high as terrorism or climate change.

In Lebanon, statistics regarding morbidity or mortality related to AMR-related infections, are incomplete; however, there is rising evidence that AMR is a real and imminent public health threat. The fight against AMR has become a national duty and priority not only for professionals working in the One Health field, but also for every responsible individual in the Lebanese community.

The MOPH acknowledges the efforts of all MOPH team, WHO team, scientific societies, experts and researchers who worked together on this plan, for their effort and commitment to partner for AMR mitigation and containment.  This AMR national plan is dedicated to the coming generations of Lebanon and an expression of the MOPH and all stakeholders in health to the fight against AMR.

<!-- image -->

Professor Walid Ammar Director General, MOPH Lebanon

## Executive Summary

In Lebanon, AMR has been detected and reported in multiple scientific publications. (310) Researchers and public officers who work in the field of health mainly infectious diseases and clinical microbiology have already started their fight against the propagation and emergence of AMR (4,8-13). However, this work needs to be channeled into a structured plan whereby gaps are identified and tasks are dedicated to specific people who should execute them during a specific period of time. In addition, a tricyclic approach to the problem is needed to ensure a plan with the 'One Health Approach'. Last but not least, a budget needs to be dedicated for the execution of this plan. In 2015, the World Health Assembly adopted a Global Action Plan (GAP) on AMR, which outlines five objectives (14). This commitment on the behalf of the World Health Organization (WHO) has been an opportunity for Lebanon to organize its fight against AMR into a National Action Plan (NAP). A National multi-sectorial committee was created for the governance of the plan.

The core objectives and activities to be executed in the NAP are as follows:

-For each axis, the first activity is the assignment of a focal person and a technical working group (plus TOR), which aims at organizing the responsibilities and executing tasks in a timely manner.

## Axis A: Awareness of AMR

- 1. Improving AMR awareness among professionals in different fields (e.g. physicians, pharmacists, dentists, healthcare workers, veterinarians, farmers, ecologists, and media specialists) through CME, AMR periodic informational SMS, lectures, etc. offered by Orders/Syndicates, addition to creating an AMR webpage as part of the official websites of MOH and MOA;
- 2. Preparation of broadcasting AMR awareness material to be diffused through the traditional media (radio and television) and social media (Facebook, Twitter, Instagram);
- 3. Raising and improving public awareness on AMR through periodic year-long advertisement and concentrated advertisement in and around the Global AMR Week in November using traditional media (radio, TV spots, interviews, talk shows), advertisement on social media networks and sending SMS periodically through national telecommunication companies;
- 4. Including AMR awareness in education curricula nationwide:
- a. Sensitization in school programs about AMR and Hygiene.
- b. Inclusion of AMR awareness in different levels in higher education programs depending on the major/specialty (medicine, dentistry, pharmacy, nursing, veterinary medicine, food chemistry/safety, agriculture, etc.)

## Axis B: Surveillance of AMR

- 1. Pursing reporting AMR data to the Global Antimicrobial Resistance Surveillance System (GLASS) thus optimizing AMR surveillance in humans through:
- a. Mapping laboratories that can potentially provide microbiologically reliable and epidemiologically representative data.
- b. These labs start reporting their data to GLASS.
- c. Put a plan for capacity building for the labs that are chosen to be included in GLASS report in order to be epidemiologically representative.
- 2. Building the capacity of labs that are not ready yet to report to GLASS in an incremental plan through
- a. Enhancing the quality of used equipment
- b. Workshops
- c. Standardizing laboratory work guidelines
- d. External quality proficiency testing
- e. WHONET Training
- 3. Periodic issuing of an epidemiologically representative national AMR surveillance report with stratification of data according to local needs of scientists, physicians, pharmacists, and researchers (e.g. blood stream infections data, community-acquired resistance, hospital-acquired AMR, healthcare-associated AMR, etc.), in addition to posting this report on AMR webpages (MOH and MOA websites).
- Improving AMR awareness in the veterinary, agriculture and environment fields
- 4. a. Research project about AMR surveillance in these fields.
- b. To design an epidemiologically representative sample for AMR surveillance (cattle, poultry, companion animals, plants, crops, etc).
- c. Conduct AMR surveillance in these fields.
- 5. Creating/Assigning AMR reference lab(s) through
- a. Define TOR of AMR Reference Lab.
- b. Map potential lab(s).
- c. Task force to visits the potential lab(s).
- d. Nominate the reference lab(s)
- e. MOH signs a contract with the lab(s).
- 6. Enhance AMR-related research agenda
- a. Put and broadcast an AMR research agenda including research for alternative agents to antimicrobials.
- b. Build a platform for researchers to communicate expertise and subjects.
- c. A yearly or twice yearly meeting of AMR local researchers.
- d. Organize fund raising for AMR research.
- e. Provide help for writing proposals to bring national research funds for AMR.

## Axis C: Infection Prevention and Control (IPC)

- 1. Optimize IPC practices in hospitals through:
- a. Finalizing national IPC guidelines in hospitals,

- b. Inclusion of IPC checklist into MOH Accreditation Standards for health institutions.
- c. Syndicate of hospitals recommends that each institution provides basic periodic IPC training to its employees.
- 2. Optimize IPC practices in long-term care facilities (LTCF) and in primary health care centers (PHCC) through:
- a. Establishing IPC Guidelines.
- b. Inclusion of IPC checklist into MOH licensing criteria.
- c. Syndicates of these facilities recommend that each provides basic periodic IPC training to its employees.
- 3. Providing basic IPC education and training of professionals
- a. Basic IPC practices, including standard isolation precautions, hand hygiene, etc.
- b. Make it mandatory and uniform in hospitals, LTCF, PHCC, (at differential level among employees).
- c. Make IPC training available in healthcare facilities, scientific societies, universities, etc.
- 4. Including basic IPC educational modules in school curricula of different majors (Medicine, Nursing, Pharmacy, Dentistry, Veterinary medicine, Agriculture, Food Safety)
- 5. Providing advanced IPC for professionals:
- a. Put TOR for IPC professionals in different healthcare facilities.
- b. Put prerequisite training/experience of IPC physicians, officers, and nurses.
- c. Make training available and affordable in universities and professional societies;
- 6. Establishing national key performance indicators (process indicators) in IPC through:
- a. Baseline evaluation of current situation at a national level (research project).
- b. National indicators to be incrementally applied with time (e.g. hand hygiene, standard isolation precautions, etc.)
- 7. Evaluation/Surveillance of nosocomial infection rates:
- a. Conduct a point prevalence study in Lebanese hospitals for the surveillance of nosocomial infections, based on the WHO project of global point prevalence surveys.
- 8. IPC in the veterinary world:
- a. To review the inclusion of OIE Biosafety recommendations and their availability in veterinary laws and monitor their application.

## Axis D: Antibiotics (ABX) Use

- 1. Improve quality control (QC) of ABX through:
- a. Supporting and including ABX as priority drugs in the pharmacovigilance project of the Lebanese University,
- b. Post marketing reporting of safety and efficacy issues of ABX.

- c. Workshops for training personnel on reporting into the pharmacovigilance network.
- d. Organization of a national task force that is responsible for analyzing complaints regarding ABX.
- 2. Putting a list of Clinically Important Antimicrobial Molecules (CIAM).
- 3. Undergoing sentinel surveillance of ABX consumption in a network of hospitals and benchmark it with international data:
- a. Workshops for ABX consumption metrics.
- b. Compilation of data from hospitals.
- 4. Establishing Antimicrobial Stewardship (AMS) Programs in hospitals through
- a.
- Basic AMS training workshops.
- b. Establishment and dissemination of national treatment guidelines of infectious diseases.
- c. Inclusion of AMS programs as an accreditation standard.
- d. Audit of AMS during Accreditation with feedback to hospitals.
- e. Development of AMS website
- 5. Regulating ABX use in veterinary and agriculture fields through:
- a. Banning importation and use of CIAM in Lebanon.
- b. Surveillance of importation of regularly used ABX to Lebanon.
- c. Research study about ABX consumption.
- d. Research study about unofficial importation of ABX to Lebanon.
- 6. Restricting ABX dispensing in community pharmacies
- a. Meeting between a high-authority-level task force and the President of the Order of Pharmacists to agree over a plan on this issue.

## Axis E: Budget planning and fund attraction

The plan for economic sustainability was replaced mainly by a plan for budget preparation and preparation of the ground for fund raising for the execution of the NAP.

- 1. Budget Allocation:
- a. Calculation of the budget for the whole plan.
- b. Identify funding gaps.
- c. Put a strategic plan to attract funds into the NAP

The activities of different axes should be executed within the coming 5 years. One cannot deny the influence of the political instability in the country that might hinder the execution of the plan. The determination of many Lebanese scientists and professionals concerning the necessity to turn the tide in AMR, supported by the WHO, Ministry of Public Health (MOH), and the Ministry of Agriculture (MOA) are major contributors to the hoped success of this NAP.

## Introduction

The discovery of penicillin by Alexander Fleming in the middle of the 20 th century has been one of the most important milestones in the history of evolution of mankind. Since then, antimicrobials have saved lives of millions and have had a direct impact on the longevity of the species.

Like everything in nature, the use of antimicrobials has more than one dimension. On one hand, antimicrobials eradicate offensive organisms and help cure patients from infectious diseases. Meanwhile, other microorganisms were finding their way to escape the effect of these agents, and started building up AMR. In fact, the consumption of antimicrobials is closely correlated to the development of AMR (3-10,13,15).

Antimicrobials are not only used in human medicine, but are also used in veterinary medicine (16), in agriculture (17) and in the environment (18).

In order to turn the tide of AMR, a multifaceted approach is needed. IPC in healthcare facilities, in the community, and in the veterinary world are mandatory. The proper application of IPC practices in these settings will lead to an important decrease in antimicrobial utilization. In addition, the use of antimicrobials is a human behavior that needs to be put under control, whereby, awareness of the consequences of the excessive use or misuse is a major determinant in the tricyclic professional world and in the community.

Subsequently, the use of antimicrobials in humans and animals cannot be left to chance. It should be structured and governed by laws and policies, and should be managed by stewards that are well versed in the fields of infectious diseases and clinical microbiology.

All these efforts against AMR should be monitored by surveillance of the quantity and quality of resistance. Continuous research should be carried on to discover new modalities of resistance and alternative ways to fight offensive organisms.

In 2015, the World Health Assembly adopted a global action plan to combat AMR, based on the 'One Health' concept outlining five objectives. The goal of the WHO GAP is to ensure, if possible the continuity of successful treatment and prevention of infectious diseases with effective and safe medicines that are quality-assured, used in a responsible way, and accessible to all who need them. (14)

The GAP is a general plan that should be adapted to each country and modified according to each country's situation based on its strengths, weaknesses, opportunities and barriers (NAP template). The national plan should be in line with the global plan and should have 5 major objectives:

- 1. To improve awareness and understanding of the professionals and the public on AMR through effective communication, education, and training.

- 1. To strengthen the knowledge and evidence base through surveillance and research
- 2. To reduce the incidence of infection through effective sanitation, hygiene and transmission prevention measures
- 3. To optimize the use of antimicrobials in human and animal health.
- 4. To develop the economic case for sustainable investment that takes account of the needs of all countries and to increase investment in new drugs, diagnostic tools, vaccines and other interventions.

In Lebanon, AMR has been well documented by the scientific societies (10) and attempts at improving the situation are going on. A NAP that is in line with the GAP and that is owned by the official authorities of the country like the MOH and executed through cooperation between the private and the public sectors will definitely curb AMR.

## Situation analyses and Assessment

Lebanon is a relatively small country in the Eastern Mediterranean region with a known surface area of 10,452 km . The population of Lebanon was estimated to be around 6 2 million inhabitants in 2016 (19) with additional 1.6 million refugees and asylum seekers from neighboring countries (Syria, Palestine and Iraq) due to wars and political conflicts, as of 2012. (20) Lebanon adult literacy rate (+15 years) was 94.1 % in 2015. (21) According to the MOH, Lebanon has 152 hospitals, 120 public and 32 private, including 6 major hospitals that have medical schools. Medical tourism is quite active in the country mainly from Iraq and other neighboring countries.

## Strengths

A national official AMR committee appointed by the MOH exists. Substantial work on AMR has been done mainly on awareness and surveillance and has been achieved by scientists and academicians. Local expertise is available. What was achieved is the following:

- 1-Lab training for staff capacity building (covering 160 labs from governmental and private hospitals),
- 2-Proficiency testing (two cycles including unknowns of 5 pathogens each conducted for 33 labs, covering governmental and private labs), and
- 3-Producing a booklet about standardized methodology for antimicrobial susceptibility testing by disk diffusion.

## Weaknesses

The AMR-NAP is not officially integrated into the national health plan, and there is no national progress report on implementation of the NAP that is published regularly with open access. There is an absence of a long-term technical and financial investment for implementation. The core components of the existing NAP include 2 to 3 major goals. The operational plan does not include milestones for the coming 1 to 2 years; it rather includes separate activities, where the available specific interventions are fragmented. Specific monitoring and budget plans referring to each operational activity is not available.

## Threats

The political and economic situation of the country can be a major threat to the realization of the NAP to combat AMR, especially with the lack of funds in the MOH, MOA, and the Ministry of Finance. The deficiencies in the basic needs like electricity and waste management on the national level would make it difficult for AMR to become a priority at the high level especially for budget allocation in the cabinet of ministers.

## Opportunities

Several opportunities can be explored like the global interest in AMR, the affiliation of many members of the scientific societies to international organizations that can provide support to the NAP, like The European Society of Clinical Microbiology and Infectious Diseases (ESCMID), The Infectious Diseases Society of America (IDSA), The Food and Agriculture Organization (FAO) of the United Nations (UN), or Mérieux Foundation. The WHO GAP that supports national plans in the region is also a great opportunity for helping and supporting our plan in Lebanon.

## Country Response

The country response to the spread of AMR has started before the preparation of the current NAP, where members of the 'Technical Committee on IHR' and 'National AMR committee' have already been appointed (Appendix). The 'Technical Committee on IHR' is the highest-level authority in charge of supporting legislations and policies requested by the 'National AMR committee'. Currently, a NAP is being developed according to the WHO templates to be in line with WHO GAP.

## Governance Organogram

The below diagram illustrates the suggested governance flow of the NAP in Lebanon as a beginning of execution of this plan.

<!-- image -->

## Axis A: Awareness

## Strategic plan

| Objective                                                                 | Activity                                                                                                                                                                                                                         | Sub-activity                                                                                                                                                              | Date                                   | Milestone                        |
|---------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------|----------------------------------|
| A.1 Organization of the  responsibilities for the  execution of the tasks | A.1.1 Nominate a focal  person in charge of  following up the activities of  the objectives of this axis                                                                                                                         |                                                                                                                                                                           | A.1.1  time 'zero'                     | A.1 three months from time  zero |
|                                                                           | A.1.2 Choose the members  of the Awareness technical  working group (Radio/TV  Media, Social media expert,  Technical, Pharmacist, ID,  Microbiologist, Veterinarian,  Agriculture, MOH  representative, WHO) and  nominate them |                                                                                                                                                                           | A.1.2 time 'zero'                      | A.1 three months from time  zero |
|                                                                           | A.1.3 Put the terms of  reference of this technical  group according to NAP                                                                                                                                                      |                                                                                                                                                                           | A.1.3 two months from time  'zero'     | A.1 three months from time  zero |
|                                                                           | A.1.4 Slogan for AMR                                                                                                                                                                                                             |                                                                                                                                                                           | A.1.4 three months from  time 'zero'   | A.1 three months from time  zero |
| A.2 Improving AMR  awareness among  professionals from different  sectors | A.2.1 Raising AMR  awareness through  syndicates, orders and  scientific societies  (CME, AMR periodic  informational SMS, etc.)                                                                                                 | A.2.1.1 LSIDCM scheduled  lectures in national  conferences of the medical,  pharmaceutical, nursing,  veterinary, agricultural and  environmental fields across  Lebanon | A.2.1.1   two months from time  'zero' | A.2   5 years                    |

|                                               | A.2.1.2 Ask  syndicates/orders (human  and animal health and  agriculture) that for CME  credits to be given for any  lecture involving ABX use,  at least 2-3 slides should be  put to increase awareness  about AMR and the ways to  prevent it including  antimicrobial use.   | A.2.1.2   Six months from time 'zero'                  |
|-----------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------|
|                                               | A.2.1.3 Ask orders of  pharmacists, veterinarians,  physicians, and dentists to  send monthly SMS as  reminders to health  professionals about the  dangers of AMR and/or  AMR News.                                                                                              | A.2.1.3   36 months from time zero                     |
|                                               | A.2.1.4  Workshops on AMR  awareness to media  professionals                                                                                                                                                                                                                      | A.2.1.4  Beginning of November  each year over 5 years |
|                                               | A.2.1.5  Do one workshop per  governorate per year to  veterinarians and agriculture  specialists  (Train the trainer)                                                                                                                                                            | A.2.1.5  Six months from time zero                     |
| A.2.2 Raising AMR  awareness through Internet | A.2.2.1 Create a webpage  for AMR on the official  websites of MOH and MOA                                                                                                                                                                                                        | A.2.2.1 Three months from  time 'zero'                 |

|                                                                                                                       |                                                                                                                               | A.2.2.2  Use existing webpages of  MOH and WHO and  relevant societies on  different social networks  (Facebook, YouTube,  Twitter, Instagram)   | A.2.2.2  One year from time zero                   |                                |
|-----------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------|--------------------------------|
| A.3 Involving traditional  (TV, radio) media and social  media (Facebook,  Instagram) in raising AMR  awareness       | A.3.1 Prepare broadcasting  material that includes all  sectors of the One health  approach for  Radio/TV/Social media  spots |                                                                                                                                                  | A.3.1   Six months from time zero                  | A.3  Six months from time zero |
| A.4 Raising and improving  public awareness using  traditional media, social  media and  telecommunication  companies | A.4.1 Prepare a yearlong  schedule for TV, Radio and  social media advertisement.                                             |                                                                                                                                                  | A.4.1  Six months from time zero                   | A.4  Two years from time zero  |
|                                                                                                                       | A.4.2 AMR to be  periodically discussed in  highly watched talk shows                                                         |                                                                                                                                                  | A.4.2  One year from time zero                     |                                |
|                                                                                                                       | A.4.3 Public figure(s)  associated with AMR                                                                                   |                                                                                                                                                  | A.4.3  One year from time zero                     |                                |
|                                                                                                                       | A.4.4 Politician(s) involved  in AMR                                                                                          |                                                                                                                                                  | A.4.4  Two years from time zero                    |                                |
|                                                                                                                       | A.4.5 SMS through national  telecommunication  companies sent four times  per year and during the                             |                                                                                                                                                  | A.4.5   Starting end of first year  from time zero |                                |

|                                                                                     | global AMR awareness  week                                                                                                                 |                                                                                                                                       |                                                                                     |                              |
|-------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------|------------------------------|
| A.5 Raising/Improving  AMR awareness in  education curricula on the  national level | A.5.1 Sensitization about  AMR and hygiene in school  curricula                                                                            | A.5.1.1 Prepare a checklist  including basic information  about AMR that should be  included in school curricula                      | A.5.1.1 Start 3 months from  time zero,  Ready at end of first year  from time zero | A.5  9 months from time zero |
|                                                                                     |                                                                                                                                            | A.5.1.2 Check available  school curricula and ask to  fill in the gaps when AMR  information according to  checklist is not available | A.5.1.2 Start three months  from time zero  Ready at 6 months from time  zero       |                              |
|                                                                                     | A.5.2 Inclusion of AMR  awareness modules in in  curricula of human health- related specialties (medicine,  dentistry, pharmacy,  nursing) | A.5.2.1 Prepare checklists  for university curricula of  these specialties each one  separately                                       | A.5.2.1 Start 3 months from  time zero  Finalized 9 months from  time zero          |                              |
|                                                                                     |                                                                                                                                            | A.5.2.2 Check curricula of  health specialties to include  information on AMR   Include AMR tricyclic  education                      | A.5.2.2 Start 3 months from  time zero   Finalized 9 months from  time zero         |                              |
|                                                                                     | A.5.3 Inclusion of AMR  awareness modules in  curricula of veterinary  school                                                              | A.5.3.1 Prepare a checklist  for the needed information  on AMR for veterinary  school curricula                                      | A.5.3.1 Three months from  time zero                                                |                              |
|                                                                                     |                                                                                                                                            | A.5.3.2  Fill the gap in AMR  information in veterinary  school curricula                                                             | A.5.3.2  Six months from time zero                                                  |                              |
|                                                                                     | A.5.4 Inclusion of AMR  awareness modules in                                                                                               | A.5.4.1                                                                                                                               | A.5.4.1   Six months from time zero                                                 |                              |

|                                                                                                                        | curricula of agriculture  school                                                                                                                                                                                                 | Checklist for the needed  information on AMR for  agriculture school curricula                                                                                                                                           |                                                  |              |
|------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------|--------------|
|                                                                                                                        |                                                                                                                                                                                                                                  | A.5.4.2  Fill the gap in AMR  information in agriculture  school curricula                                                                                                                                               | A.5.4.2  Six months from time zero               |              |
| A.6  Involvement of  pharmaceutical companies in  raising AMR awareness and  provide finding for  awareness activities | A.6.1 MOH and MOA  should advise  pharmaceutical companies  (Human and Veterinary) to  include in every presentation  related to antimicrobial use  at least 3 slides (5%)  concerning AMR (Send one  letter from each ministry) |                                                                                                                                                                                                                          | A.6.1 Starting end of first  year from time zero | A.6   1 year |
|                                                                                                                        | A.6.2  Seek private funding from  Pharmaceutical companies  for awareness activities  targeting public and  professionals                                                                                                        | A.6.2.1  Meeting with CEO s of main  Pharmaceutical companies  and working group and  present the highlights of the  AMR plan in general,  awareness specifically and  put plan of contribution to  awareness activities | A.6.2  6 months                                  |              |

## Operational plan and budget

| Objective                                                                     | Activity                                                                                                                                     | Sub- activity   | Unit                                                                                             | Quantity                                           | Date               | Location        | Responsibl e entity                                                                                    | Cost                                                 | Source   Of funding   | Indicator                                                      |
|-------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------|-----------------|--------------------------------------------------------------------------------------------------|----------------------------------------------------|--------------------|-----------------|--------------------------------------------------------------------------------------------------------|------------------------------------------------------|-----------------------|----------------------------------------------------------------|
| A.1  Organizatio n of the  responsibili ties for the  execution  of the tasks | A.1.1  Nominate a  focal  person in  charge of  following  up the  activities of  the  objectives  of this axis                              |                 | A.1.1  Letter of  appointmen t                                                                   | A.1.1 One                                          | A.1.1  time 'zero' | A.1.1  MOH      | A.1.1  -WHO- National  Professiona l Officer  (Dr. A  Rady)  -MOH-  General  Director  (Dr. W  Ammar)  | A.1.1  0.25 time  employee  (Secretarial  functions) | A.1.1  MOH            | A.1.1  Focal  person  nominated                                |
| A.1  Organizatio n of the  responsibili ties for the  execution  of the tasks | A.1.2  Choose the  members of  the  Awareness  technical  working  group  (Radio/TV  Media,  Social  media  expert,  Technical,  Pharmacist, |                 | A.1.2   -One focal  person  -One  technical  group  Suggestion s:  -Focal  person:  Dr. R  Hamra | A.1.2   -One focal  person  -One  technical  group | A.1.2 time  'zero' | A.1.2  MOH  WHO | A.1.2   -WHO- National  Professiona l Officer  (Dr. A  Rady)  -MOH-  General  Director  (Dr. W  Ammar) | A.1.2 None                                           | A.1.2 None            | A.1.2   Technical  group  formed and  posted on  AMR  website. |

| ID,  Microbiolo gist,  Veterinaria n,  Agriculture , MOH  representati ve, WHO)  and  nominate  them   | -Technical  group  members:  Dr. A  Rady,  Dr. R  Hamra,  Dr. Z  Helou  Dr .A  Sirawan  Dr. M  Matar  Dr. Z  Daoud,  Dr. B  Bazzal,  WHO  technical  person.   |            |                                      |                         |                                                                              |             |             |                                                    |
|--------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|--------------------------------------|-------------------------|------------------------------------------------------------------------------|-------------|-------------|----------------------------------------------------|
| A.1.3 Put  the terms of  reference  of this  technical  group  according  to NAP                       | A.1.3  Document                                                                                                                                                | A.1.3  One | A.1.3 two  months  from time  'zero' | A.1.3  -MOH  -WHO  -MOA | A.1.3  -Focal  person   -WHO- National  Professiona l Officer  (Dr. A  Rady) | A.1.3  None | A.1.3  None | A.1.3 TOR  of technical  group  posted on  website |

|                                                                                | A.1.4  Slogan for  AMR                                                                                                                    |                                                                                                                                                                                      | A.1.4  Awareness  technical  working  group  (PAC)   | A.1.4  One                                            | A.1.4 three  months  from time  'zero'   | A.1.4  -MOH  -WHO                  | A.1.4  Awareness  technical  working  group                                            | A.1.4 None    | A.1.4 None    | A.1.4  Slogan is  posted on  AMR  website                                                  |
|--------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------|-------------------------------------------------------|------------------------------------------|------------------------------------|----------------------------------------------------------------------------------------|---------------|---------------|--------------------------------------------------------------------------------------------|
| A.2  Improving  AMR  awareness  among  professiona ls from  different  sectors | A.2.1  Raising  AMR  awareness  through  syndicates,  orders and  scientific  societies  (CME,  AMR  periodic  information al SMS,  etc.) | A.2.1.1  LSIDCM  scheduled  lectures in  national  conferences  of the  medical,  pharmaceut ical,  nursing,  veterinary,  agricultural  and  environmen tal fields  across  Lebanon | A.2.1.1  Schedule                                    | A.2.1.1  One                                          | A.2.1.1   two months  from time  'zero'  | A.2.1.1 - LSIDCM  -MOH  -WHO  -MOA | A.2.1.1   -LSIDCM  president  (Dr. Z  Helou)   -  Awareness  technical  working  group | A.2.1.1  None | A.2.1.1  None | A.2.1.1  Official  schedule  from  LSIDCM                                                  |
|                                                                                |                                                                                                                                           | A.2.1.2  Ask  syndicates/ orders  (human and  animal  health and  agriculture)                                                                                                       | A.2.1.2  Letters to  syndicates/ orders              | A.2.1.2  depending  on number  of  syndicates/ orders | A.2.1.2   Six months  from time  'zero'  | A.2.1.2  Order of  physicians      | A.2.1.2 - Focal  person  -LSIDCM  president  (Dr. Z  Helou)                            | A.2.1.2  None | A.2.1.2  None | A.2.1.2  Percentage  of lectures  involving  ABX that  contain the  message in  2-3 slides |

| that for  CME  credits to  be given  for any  lecture  involving  ABX use,  at least 2-3  slides  should be  put to  increase  awareness  about AMR  and the  ways to  prevent it  including  antimicrobi   |                                                                                     |                |                                      |                                        | -President  of the  Order of  physicians  endorsed  by the IHR  technical  committee   |                   |               |                                                                                                           |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------|----------------|--------------------------------------|----------------------------------------|----------------------------------------------------------------------------------------|-------------------|---------------|-----------------------------------------------------------------------------------------------------------|
| A.2.1.3  Ask orders  of  pharmacists ,  veterinarian s,  physicians,  and dentists  to send  monthly                                                                                                        | A.2.1.3  Letters to  orders from  MOH/MO A to send   SMS to  health  professiona ls | A.2.1.3  three | A.2.1.3   36 months  from time  zero | A.2.1.3   -Order of  pharmacists  -MOA | A.2.1.3  Focal  person  endorsed  by a  national  multisectori al group                | A.2.1.3  None/MOH | A.2.1.3  None | A.2.1.3   -Percentage  compliance  to this  request of  sending  monthly  SMS to  health  professiona ls. |

| SMS as  reminders  to health  professiona ls about the  dangers of  AMR  and/or  AMR  News.   |                    |                               |                                                            |                |                                                                                                                                                 |                          |                   | -Number of  months  where SMS  were sent  from each  order/total  number of  months  audited   |
|-----------------------------------------------------------------------------------------------|--------------------|-------------------------------|------------------------------------------------------------|----------------|-------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------|-------------------|------------------------------------------------------------------------------------------------|
| A.2.1.4  Workshops  on AMR  awareness  to media  professiona ls                               | A.2.1.4  Workshops | A.2.1.4  Once/year  5/5 years | A.2.1.4  Beginning  of  November  each year  over 5  years | A.2.1.4  Hotel | -Focal  person  -MOH- Director of  Public  Relations  & Health  Education  Dpts (Dr. R  Hamra)  -MOH-  Public  Health  Officer  (Ms. H  Semaha) | A.2.1.4  2,000  USD/year | A.2.1.4  AMR Fund | A.2.1.4  Percentage  of target  media  personnel  whom  attend these  workshops.               |
| A.2.1.5                                                                                       | A.2.1.5  Workshops | A.2.1.5                       | A.2.1.5                                                    | A.2.1.5  MOA   | A.2.1.5  -MOA-                                                                                                                                  | A.2.1.5                  | A.2.1.5           | A.2.1.5                                                                                        |

|                                                   | Do one  workshop  per  governorate  per year to  veterinarian s and  agriculture  specialists  (Train the  trainer)   |                                                          | Seven per  year   | Six months  from time  zero               |                      | Head of  Animal  Health  Service  (Dr. B  Bazzal) -MOA- Head of  Poultry  Husbandry  Dpt (Eng.  A Sirawan)   | 4000 USD  per year  TOTAL:  4000X7=  28,000 $   | -AMR  Fund  -MOA   | Number of  workshops  per  governorat e per year    |
|---------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------|-------------------|-------------------------------------------|----------------------|--------------------------------------------------------------------------------------------------------------|-------------------------------------------------|--------------------|-----------------------------------------------------|
| A.2.2  Raising  AMR  awareness  through  Internet | A.2.2.1  Create a  webpage  for AMR  on the  official  websites of  MOH and  MOA                                      | A.2.2.1  AMR blog  present on  websites of  MOH and  MOA | A.2.2.1  One      | A.2.2.1  Three  months  from time  'zero' | A.2.2.1   -MOH  -MOA | Director of  Public  Relations  & Health  Education  Dpts (Dr. R  Hamra)  -MOH- Head of                      | A.2.2.1  10,000  USD  -C/O MOH                  | A.2.2.1  AMR fund  | A.2.2.1  AMR  section is  put on  MOH/MO A websites |

|                                                                    |                                                                        |                                                                   |                              |                                     |              | able  Diseases  Dpts (Dr. A  Berry)  -MOH-IT  specialist                                                                                   |                    |                          |                                                                |
|--------------------------------------------------------------------|------------------------------------------------------------------------|-------------------------------------------------------------------|------------------------------|-------------------------------------|--------------|--------------------------------------------------------------------------------------------------------------------------------------------|--------------------|--------------------------|----------------------------------------------------------------|
|                                                                    |                                                                        | A.2.2.2  Webpages  A.2.2.2  Four                                  |                              | A.2.2.2  One year  from time  zero  | A.2.2.2  MOH | A.2.2.2  -Webpage  designer  - Outsourcin g call for  cotations at  WHO  -MOH- National E- Health  Program  Director  (Mrs. L  Abou  Mrad) | A.2.2.2  5,000 USD | A.2.2.2  Within her  job | A.2.2.2  Webpages  available                                   |
| A.3  Involving  traditional  (TV, radio)  media and  social  media | A.3.1  Prepare  broadcastin g material  that  includes all  sectors of | A.3.1  Broadcastin g material  for  Radio/TV/ Social  media spots | A.3.1   One set of  material | A.3.1   Six months  from time  zero | A.3.1  WHO   | A.3.1 All  broadcastin g messages  will be  prepared  and                                                                                  | A.3.1  15,000  USD | A.3.1  WHO               | A.3.1  Broadcasti ng material  available,  they are  tricyclic |

| (Facebook,  Instagram)  in raising  AMR  awareness                                                                           | the One  health  approach  for  Radio/TV/ Social  media spots                            |                   |                    |                                    |                 | supported  by WHO                                                                     |                                                   |             |                                                                |
|------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------|-------------------|--------------------|------------------------------------|-----------------|---------------------------------------------------------------------------------------|---------------------------------------------------|-------------|----------------------------------------------------------------|
| A.4 Raising  and  improving  public  awareness  using  traditional  media,  social  media and  telecommu nication  companies | A.4.1  Prepare a  yearlong  schedule  for TV,  Radio and  social  media  advertisem ent. | A.4.1  Schedule   | A.4.1 One          | A.4.1  Six months  from time  zero | A.4.1  MOH      | A.4.1 - MOH- Director of  Public  Relations  & Health  Education  Dpts (Dr. R  Hamra) | A.4.1  15,000  USD per  year  TOTAL:  60,000  USD | A.4.1  WHO  | A.4.1  Schedules  put and  spots                               |
|                                                                                                                              | A.4.2 AMR  to be  periodically  discussed  in highly  watched  talk shows                | A.4.2 Talk  shows | A.4.2  Multiple    | A.4.2  One year  from time  zero   | A.4.2  MOH      | A.4.2  -Focal  person  -AMR  Committee  members.                                      | A.4.2  None                                       | A.4.2 None  | A.4.2  Number of  talk shows  that discuss  AMR per  trimester |
|                                                                                                                              | A.4.3  Public  figure(s)  associated  with AMR                                           | A.4.3  Person     | A.4.3 One  or more | A.4.3  One year  from time  zero   | A.4.3  MOH  MOA | A.4.3  -LSIDCM  president  (Dr. Z  Helou)                                             | A.4.3 None                                        | A.4.3  None | A.4.3  Number of  appearance s in  media/publ                  |

|                                                                                                                                       |                                                                         |                                                        |                                                      |                                                   | -MOH- Director of  Public  Relations  & Health  Education  Dpts (Dr. R  Hamra)        |             |                                                          | ic to  discuss the  subject                                               |
|---------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------|--------------------------------------------------------|------------------------------------------------------|---------------------------------------------------|---------------------------------------------------------------------------------------|-------------|----------------------------------------------------------|---------------------------------------------------------------------------|
| A.4.4  Politician(s ) involved  in AMR                                                                                                | A.4.4  Politicians  public  statements  on TV,  radio or  social  media | A.4.4   Three from  three  different  political  sides | A.4.4  Two years  from time  zero                    | A.4.4  TV, Radio,  social  media                  | A.4.4  -Focal  person  -MOH  -WHO                                                     | A.4.4  None | A.4.4  None                                              | A.4.4  Number of  appearance s in  media/publ ic to  discuss the  subject |
| A.4.5 SMS  through  national  telecommu nication  companies  sent four  times per  year and  during the  global  AMR  awareness  week | A.4.5 SMS                                                               | A.4.5 four  per year                                   | A.4.5   Starting  end of first  year from  time zero | A.4.5   -National  telecommu nication  -MOH  -MOA | A.4.5   -MOH  -Ministry  of  Communic ation  -MOH-  General  Director  (Dr. W  Ammar) | A.4.5  None | A.4.5   -MOH/  -Ministry  of  Communic ation/  MOA  -WHO | A.4.5 SMS  sent                                                           |

| A.5  Raising/Im proving  AMR  awareness  in  education  curricula  on the  national  level   | A.5.1  Sensitizatio n about  AMR and  hygiene in  school  curricula   | A.5.1.1  Prepare a  checklist  including  basic  information  about AMR  that should  be included  in school  curricula   | A.5.1.1  Documents :  Basic for  schools  (Based on  One Health  /E-health)   | A.5.1.1  One   | A.5.1.1  Start 3  months  from time  zero,  Ready at  end of first  year from  time zero   | A.5.1.1   -Ministry  of  education  -MOA  -MOH   | A.5.1.1   -Focal  person  -WHO- National  Professiona l Officer  (Dr. A  Rady)  -MOA- Head of  Poultry  Husbandry  Dpt (Eng.  A Sirawan)  -Private  sector,  WHO  consultant  (Dr. P Abi  Hanna)   | A.5.1.1  None   | A.5.1.1  None   | A.5.1  Percentage  of school  curricula  that include  the  message   |
|----------------------------------------------------------------------------------------------|-----------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------|----------------|--------------------------------------------------------------------------------------------|--------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------|-----------------|-----------------------------------------------------------------------|
|                                                                                              |                                                                       | A.5.1.2  Check  available  school  curricula  and ask to  fill in the  gaps when  AMR                                     | A.5.1.2  Report and  letter                                                   | A.5.1.2  Two   | A.5.1.2  Start three  months  from time  zero  Ready at 6  months  from time  zero         | A.5.1.2   -Ministry  of  education  -MOA  -MOH   | A.5.1.2   -WHO- National  Professiona l Officer  (Dr. A  Rady)                                                                                                                                     | A.5.1.2  None   | A.5.1.2  None   |                                                                       |

|                                                                                                                                                    | information  according  to checklist  is not  available                                                                 |                                                                                                                            |                                                       |                                                                                  |                             | -Ms S  Najem  (private  sector)  -CERD                                                    |                    |                   |                                                                                                                          |
|----------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------|----------------------------------------------------------------------------------|-----------------------------|-------------------------------------------------------------------------------------------|--------------------|-------------------|--------------------------------------------------------------------------------------------------------------------------|
| A.5.2  Inclusion  of AMR  awareness  modules in  in curricula  of human  health- related  specialties  (medicine,  dentistry,  pharmacy,  nursing) | A.5.2.1  Prepare  checklists  for  university  curricula of  these  specialties  each one  separately                   | A.5.2.1  Checklists  for  different  curricula of  health  specialties                                                     | A.5.2.1  Number of  curricula of  health  specialties | A.5.2.1  Start 3  months  from time  zero  Finalized 9  months  from time  zero  | A.5.2.1  Universitie s  WHO | A.5.2.1  Private  sector,  WHO  consultant,  former  LSIDCM  president  (Dr. R  Moghnieh) | A.5.2.1  2,000 USD | A.5.2.1  AMR fund | A.5.2  Percentage  of curricula  of health  specialties  that include  chapters  about  AMR/IPC  according  to checklist |
|                                                                                                                                                    | A.5.2.2  Check  curricula of  health  specialties  to include  information  on AMR   Include  AMR  tricyclic  education | A.5.2.2  Report and  detailed list  of  objectives  that are to  be included  and are  missing in  each health  curriculum | A.5.2.2  One                                          | A.5.2.2  Start 3  months  from time  zero   Finalized 9  months  from time  zero | A.5.2.2  Universitie s      | A.5.2.2  Private  sector,  WHO  consultant,  former  LSIDCM  president  (Dr. R  Moghnieh) | A.5.2.2  2,000 USD | A.5.2.2  AMR fund |                                                                                                                          |

| A.5.3  Inclusion  of AMR  awareness  modules in  curricula of  veterinary  school   | A.5.3.1  Prepare a  checklist  for the  needed  information  on AMR  for  veterinary  school  curricula   | A.5.3.1  Checklist                                           | A.5.3.1  One   | A.5.3.1  Three  months  from time  zero   | A.5.3.1  MOA                                       | A.8.1  -MOA- Head of  Animal  Health  Service  (Dr. B  Bazzal)   | A.5.3.1   500 USD   | A.5.3.1  AMR fund   | A.5.3  Veterinary  school  curricula  include  chapters  about  AMR/IPC    |
|-------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------|--------------------------------------------------------------|----------------|-------------------------------------------|----------------------------------------------------|------------------------------------------------------------------|---------------------|---------------------|----------------------------------------------------------------------------|
|                                                                                     | A.5.3.2  Fill the gap  in AMR  information  in  veterinary  school  curricula                             | A.5.3.2  Report to  Lebanese  University  veterinary  school | A.5.3.2  One   | A.5.3.2  Six months  from time  zero      | A.5.3.2  Veterinary   School- Lebanese  University | A.5.3.2  -MOA- Head of  Animal  Health  Service  (Dr. B  Bazzal) | A.5.3.2  1,000 USD  | A.5.3.2  AMR fund   |                                                                            |
| A.5.4  Inclusion  of AMR  awareness  modules in  curricula of  agriculture  school  | A.5.4.1  Checklist  for the  needed  information  on AMR  for  agriculture  school  curricula             | A.5.4.1  Checklist                                           | A.5.4.1  One   | A.5.4.1   Six months  from time  zero     | A.5.4.1   -MOA  - Universitie s                    | A.5.4.1  MOA-Head  of Poultry  Husbandry  Dpt (Eng.  A Sirawan)  | A.5.4.1   500 USD   | A.5.4.1  AMR fund   | A.5.4.1  Agriculture  school  curricula  include  chapters  about  AMR/IPC |
|                                                                                     | A.5.4.2                                                                                                   | A.5.4.2                                                      | A.5.4.2  One   | A.5.4.2                                   | A.5.4.2  -MOA                                      | A.5.4.2                                                          | A.5.4.2  1,000 USD  | A.5.4.2  AMR fund   |                                                                            |

|                                                                                                                               |                                                                                                                                                                                                                    | Fill the gap  in AMR  information  in  agriculture  school  curricula   | Letter from  the  Ministries  of Health,  Education  and  Agriculture  to  agriculture  schools   |           | Six months  from time  zero                         | - Universitie s   | MOA-Head  of Poultry  Husbandry  Dpt (Eng.  A Sirawan)                                                                                                                             |            |            |                                                                                                         |
|-------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------|-----------|-----------------------------------------------------|-------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|---------------------------------------------------------------------------------------------------------|
| A.6  Involvemen t of  pharmaceut ical  companies  in raising  AMR  awareness  and provide  finding for  awareness  activities | A.6.1  MOH and  MOA  should  advice  pharmaceut ical  companies  (Human  and  Veterinary)  to include  in every  presentatio n related to  antimicrobi al use at  least 3  slides (5%)  concerning  AMR  (Send one |                                                                         | A.6.1  Letters to  Ministries  of Health  and  Agriculture                                        | A.6.1 Two | A.6.1  Starting  end of first  year from  time zero | A.6.1   MOH  MOA  | A.6.1   -MOH-  Director of  Public  Relations  & Health  Education  Dpts (Dr. R  Hamra)  -MOA- Head of  Animal  Health  Service  (Dr. B  Bazzal) -MOA- Head of  Poultry  Husbandry | A.6.1 None | A.6.1  MOH | A.6.1  Percentage  of  pharmaceut ical  companies  presentatio ns that  include the  message  about AMR |

| letter from  each  ministry)                                                                                                       |                                                                                                                                                                                                                                        |                  |                    |                   |              | Dpt (Eng.  A Sirawan)              |                    |                   |                                                                                                                                                           |
|------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------|--------------------|-------------------|--------------|------------------------------------|--------------------|-------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------|
| A.6.2  Seek  private  funding  from  Pharmaceut ical  companies  for  awareness  activities  targeting  public and  professiona ls | A.6.2.1  Meeting  with CEO s  of main  Pharmaceut ical  companies  and  working  group and  present the  highlights  of the  AMR plan  in general,  awareness  specifically  and put  plan of  contributio n to  awareness  activities | A.6.2.1  Meeting | A.6.2.1  1 or more | A.6.2.1  6 months | A.6.2.1  MOH | A.6.2.1  Technical  working  group | A.6.2.1  1,000 USD | A.6.2.1  AMR Fund | A.6.2.1  Percentage  of  pharmaceut ical  companies  that  promote  antimicrobi als that are  contributin g into the  budget of  the  awareness  campaign |

## Monitoring and evaluation plan

| Objective                                                                     | Activity                                                                                                                                                                                                            | Sub-activity   | Indicator                                                                          | Purpose                                                       | Calculation          | Frequency                  | Data source            | Method                    | Baseline          |
|-------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------|------------------------------------------------------------------------------------|---------------------------------------------------------------|----------------------|----------------------------|------------------------|---------------------------|-------------------|
| A.1  Organization  of the  responsibiliti es for the  execution of  the tasks | A.1.1  Nominate a  focal person  in charge of  following up  the activities  of the  objectives of  this axis                                                                                                       |                | A.1.1  Focal person  nominated                                                     | A.1.1, A.1.2  Organize and  follow up the  tasks in the  plan | A.1.1, A.1.2  Yes/No | A.1.1, A.1.2  Once/5 years | A.1.1, A.1.2  MOH  WHO | A.1.1, A.1.2  Appointment | A.1.1, A.1.2   NA |
|                                                                               | A.1.2  Choose the  members of  the technical  working  group  (Radio/TV  Media,  Social media  expert,  Technical,  Pharmacist,  ID,  Microbiologi st,  Veterinarian,  Agriculture,  MOH  representativ e, WHO) and |                | A.1.2   Awareness  technical  working  group  formed and  posted on  AMR  website. |                                                               |                      |                            |                        |                           |                   |

|                                                                                | nominate  them                                                                                                                          |                                                                                                                                                                    |                                                            |                                                                           |                                                                |                          |                  |                   |                                                                                                    |
|--------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------|---------------------------------------------------------------------------|----------------------------------------------------------------|--------------------------|------------------|-------------------|----------------------------------------------------------------------------------------------------|
|                                                                                | A.1.3 Put the  terms of  reference of  Awareness  technical  working  group  according to  NAP                                          |                                                                                                                                                                    | A.1.3 TOR  of technical  working  group posted  on website | A.1.3  Specify its  activities                                            | A.1.3  Yes/No                                                  | A.1.3  Once/5 years      | A.1.3   MOH  WHO | A.1.3  Document   | A.1.3 NA                                                                                           |
|                                                                                | A.1.4 Slogan  for AMR                                                                                                                   |                                                                                                                                                                    | A.1.4  Slogan is  posted on  AMR  website                  | A.1.4 not  applicable                                                     | A.1.4  Yes/No                                                  | A.1.4  Once/5 years      | A.1.4 MOH  WHO   | A.1.4 Slogan      | A.1.4 NA                                                                                           |
| A.2  Improving  AMR  awareness  among  professionals  from  different  sectors | A.2.1  Raising  AMR  awareness  through  syndicates,  orders and  scientific  societies  (CME, AMR  periodic  informationa l SMS, etc.) | A.2.1.1  LSIDCM  scheduled  lectures in  national  conferences  of the  medical,  pharmaceuti cal, nursing,  veterinary,  agricultural  and  environment al fields | A.2.1.1  Official  schedule  from  LSIDCM                  | A.2.1.1  Having the  commitment  from  LSIDCM in  giving these  lectures. | A.2.1.1  Number of  lectures  given per  governorate  per year | A.2.1.1  every 6  months | A.2.1.1  LSIDCM  | A.2.1.1  Document | A.2.1.1 No  schedule  available,  talks  concentrated  in Beirut  area, not to  all  professionals |

| across  Lebanon                                                                                                                                                                                                                                                                             |                                                                                            |                                                  |                                                                                   |                             |                                        |                               |              |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------|--------------------------------------------------|-----------------------------------------------------------------------------------|-----------------------------|----------------------------------------|-------------------------------|--------------|
| A.2.1.2 Ask  syndicates/or ders (human  and animal  health and  agriculture)  that for CME  credits to be  given for any  lecture  involving  ABX use, at  least 2-3  slides should  be put to  increase  awareness  about AMR  and the ways  to prevent it  including  antimicrobial  use. | A.2.1.2  Percentage  of lectures  involving  ABX that  contain the  message in  2-3 slides | A.2.1.2  Reminder of  AMR in all  ABX  lectures. | A.2.1.2  Number of  lectures with  the  message/nu mber of  lectures  audited*100 | A.2.1.2  every year         | A.2.1.2 NAP  audit of  lectures  given | A.2.1.2  Audit                | A.2.1.2 NA   |
| A.2.1.3 Ask  Orders of  pharmacists,  veterinarians , physicians,  and dentists  to send                                                                                                                                                                                                    | A.2.1.3   -Percentage  compliance  to this  request of  sending  monthly                   | A.2.1.3   Permanent  reminding                   | A.2.1.3   Number of  months  where SMS  were sent  from each  Order/total         | A.2.1.3   every six  months | A.2.1.3   Orders                       | A.2.1.3   Report from  Orders | A.2.1.3   NA |

| monthly  SMS as  reminders to  health  professionals  about the  dangers of  AMR and/or  AMR News.   | SMS to  health  professionals .  -Number of  months  where SMS  were sent  from each  Order/total  number of  months  audited   |                                                                                                                                                    | number of  months  audited                                        |                         |                                               |                           |             |
|------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------|-------------------------|-----------------------------------------------|---------------------------|-------------|
| A.2.1.4  Workshops  on AMR  awareness to  media  professionals                                       | A.2.1.4   Percentage  of target  media  personnel  whom attend  these  workshops.                                               | A.2.1.4  Sensitize the  media to  propagate  the message  and gain  their interest  in bringing it  up in their  programs,  sites, and  newspapers | A.2.1.4  Number of  attendees/nu mber of  target media  personnel | A.2.1.4  Once per  year | A.2.1.4  Awareness  technical  working  group | A.2.1.4  Data  collection | A.2.1.4  NA |
| A.2.1.5  Do one  workshop  per  governorate  per year to  veterinarians                              | A.2.1.5  Number of  workshops  per  governorate  per year                                                                       | A.2.1.5  Raise post- graduate  AMR  awareness  among  professionals                                                                                | A.2.1.5  Number of  workshops  per  governorate  per year         | A.2.1.5  Once/year      | A.2.1.5  MOA  WHO                             | A.2.1.5  Workshop         | A.2.1.5  NA |

|                                                     |                                                           | and  agriculture  specialists  (Train the  trainer)                                                                                                   |                                                     |                                                                                                     |                                         |                              |                                               |                              |                                            |
|-----------------------------------------------------|-----------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------|-----------------------------------------------------------------------------------------------------|-----------------------------------------|------------------------------|-----------------------------------------------|------------------------------|--------------------------------------------|
|                                                     | A.2.2  Raising  AMR  awareness  through  Internet         | A.2.2.1  Create a  webpage for  AMR on the  official  websites of  MOH and  MOA                                                                       | A.2.2.1  AMR  section is put  on  MOH/MOA  websites | A.2.2.1  Increase  visibility                                                                       | A.2.2.1  Yes/No                         | A.2.2.1  Once/5 years        | A.2.2.1  MOH  MOA                             | A.2.2.1  Section on  website | A.2.2.1 NA                                 |
|                                                     |                                                           | A.2.2.2  Use existing  webpages of  MOH and  WHO and  relevant  societies on  different  social  networks  (Facebook,  YouTube,  Twitter,  Instagram) | A.2.2.2  Webpages  available                        | A.2.2.2  Reach the  young  population  and broaden  the spectrum  of people  receiving the  message | A.2.2.2  Yes/No  Presence of  webpages  | A.2.2.2  Every three  months | A.2.2.2  Awareness  technical  working  group | A.2.2.2  Webpage             | A.2.2.2  NA                                |
| A.3  Involving  traditional  (TV, radio)  media and | A.3.1  Prepare  broadcasting  material that  includes all |                                                                                                                                                       | A.3.1  Broadcasting  material  available,           | A.3.1  Percentage  of media  type for  which                                                        | A.3.1  Yes/No  For each  type of  media | A.3.1   every three  months  | A.3.1  Awareness  technical  working  group   | A.3.1  Counting              | A.3.1  Few TV  spots  available  regarding |

| social media  (Facebook,  Instagram)  in raising  AMR  awareness                                                            | sectors of the  One health  approach for  Radio/TV/So cial media  spots                 | they are  tricyclic                                                      | broadcasting  messages  have been  prepared        |                                                               |                                         |                                             |                  | human  health, not  tricyclic.         |
|-----------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------|--------------------------------------------------------------------------|----------------------------------------------------|---------------------------------------------------------------|-----------------------------------------|---------------------------------------------|------------------|----------------------------------------|
| A.4 Raising  and  improving  public  awareness  using  traditional  media, social  media and  telecommuni cation  companies | A.4.1  Prepare a  yearlong  schedule for  TV, Radio  and social  media  advertisemen t. | A.4.1  Schedules  put and spots                                          | A.4.1  Emphasize  the  importance  of the  subject | A.4.1  Number of  talk shows  per 3 months  that discuss  AMR | A.4.1 every  three months               | A.4.1  Awareness  technical  working  group | A.4.1  Schedule  | A.4.1  Erratic, in  few morning  shows |
|                                                                                                                             | A.4.2 AMR  to be  periodically  discussed in  highly  watched talk  shows               | A.4.2  Number of  talk shows  that discuss  AMR per  trimester           | A.4.2 Reach  more people                           | A.4.2  Number of  activities per  trimester per  governorate  | A.4.2 every  three months  over 5 years | A.4.2  Awareness  technical  working  group | A.4.2 Talk  show | A.4.2 NA                               |
|                                                                                                                             | A.4.3 Public  figure(s)  associated  with AMR                                           | A.4.3  Number of  appearances  in  media/public  to discuss  the subject | A.4.3 Reach  more people                           | A.4.3  Number of  appearances                                 | A.4.3 every  three months  over 5 years | A.4.3  Awareness  technical  working  group | A.4.3  Statement | A.4.3 NA                               |

|                                                                                         | A.4.4  Politician(s)  involved in  AMR                                                                                               |                                                                                                                         | A.4.4  Number of  appearances  in  media/public  to discuss  the subject   | A.4.4 Reach  more people                                       | A.4.4  Number of  appearances                                                               | A.4.4 every  three months  over 5 years   | A.4.4  Awareness  technical  working  group   | A.4.4  Statement                       | A.4.4 NA   |
|-----------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------|----------------------------------------------------------------|---------------------------------------------------------------------------------------------|-------------------------------------------|-----------------------------------------------|----------------------------------------|------------|
|                                                                                         | A.4.5 SMS  through  national  telecommuni cation  companies  sent four  times per  year and  during the  global AMR  awareness  week |                                                                                                                         | A.4.5 SMS  sent                                                            | A.4.5 Reach  more people                                       | A.4.5  Number of  messages  sent                                                            | A.4.5 every  three months  over 5 years   | A.4.5  Awareness  technical  working  group   | A.4.5  Message                         | A.4.5 NA   |
| A.5  Raising/Impr oving AMR  awareness in  education  curricula on  the national  level | A.5.1  Sensitization  about AMR  and hygiene  in school  curricula                                                                   | A.5.1.1  Prepare a  checklist  including  basic  information  about AMR  that should  be included  in school  curricula | A.5.1  Percentage  of school  curricula that  include the  message         | A.5.1  Include  AMR-related  information  in school  curricula | A.5.1  number of  curricula that  included the  message/  total number  of curricula  * 100 | A.5.1  Once/5 years                       | A.5.1  -Ministry of  education  -WHO          | A.5.1  Checking  and filling  the gaps | A.5.1  NA  |

|                                                                                                                                                    | A.5.1.2  Check  available  school  curricula and  ask to fill in  the gaps  when AMR  information  according to  checklist is  not available   |                                                                                                                     |                                                                              |                                                                                             |                     |                                                           |                                        |                             |
|----------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------|---------------------|-----------------------------------------------------------|----------------------------------------|-----------------------------|
| A.5.2  Inclusion of  AMR  awareness  modules in  in curricula  of human  health- related  specialties  (medicine,  dentistry,  pharmacy,  nursing) | A.5.2.1  Prepare  checklists  for  university  curricula of  these  specialties  each one  separately                                          | A.5.2  Percentage  of curricula  of health  specialties  that include  chapters  about AMR  according to  checklist | A.5.2  Include  AMR  modules in  curricula of  health  sciences  specialties | A.5.2  number of  curricula that  included the  message/  total number  of curricula  * 100 | A.5.2  Once/5 years | A.5.2 - Ministry of  education  -Universities  -MOH  -WHO | A.5.2  Checking  and filling  the gaps | A.5.2  Partially  available |
|                                                                                                                                                    | A.5.2.2  Check  curricula of  health  specialties to  include                                                                                  |                                                                                                                     |                                                                              |                                                                                             |                     |                                                           |                                        |                             |

|                                                                                    | information  on AMR   Include  AMR  tricyclic  education                                              |                                                                            |                                                                        |                                                         |                     |                                                            |                                        |           |
|------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------|------------------------------------------------------------------------|---------------------------------------------------------|---------------------|------------------------------------------------------------|----------------------------------------|-----------|
| A.5.3  Inclusion of  AMR  awareness  modules in  curricula of  veterinary  school  | A.5.3.1  Prepare a  checklist for  the needed  information  on AMR for  veterinary  school  curricula | A.5.3  Veterinary  school  curricula  include  chapters  about AMR         | A.5.3  Include  AMR  modules in  curricula of  veterinary  school      | A.5.3  number of  curricula that  included the  message | A.5.3  Once/5 years | A.5.3  -Ministry of  education  -Universities  -WHO        | A.5.3  Checking  and filling  the gaps | A.5.3  NA |
|                                                                                    | A.5.3.2  Fill the gap  in AMR  information  in veterinary  school  curricula                          |                                                                            |                                                                        |                                                         |                     |                                                            |                                        |           |
| A.5.4  Inclusion of  AMR  awareness  modules in  curricula of  agriculture  school | A.5.4.1  Checklist for  the needed  information  on AMR for  agriculture  school  curricula           | A.5.4.1  Agriculture  school  curricula  include  chapters  about  AMR/IPC | A.5.4  Include  AMR/IPC  modules in  curricula of  agriculture  school | A.5.4  number of  curricula that  included the  message | A.5.4  Once/5 years | A.5.4   -Ministry of  education  -Universities  -MOA  -WHO | A.5.4  Checking  and filling  the gaps | A.5.4 NA  |
|                                                                                    | A.5.4.2                                                                                               |                                                                            |                                                                        |                                                         |                     |                                                            |                                        |           |

|                                                                                                                              |                                                                                                                                                                                                                                              | Fill the gap  in AMR  information  in agriculture  school  curricula   |                                                                                                        |                                                                                                                      |                                                                                             |                                |                   |                     |                 |
|------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------|--------------------------------|-------------------|---------------------|-----------------|
| A.6  Involvement  of  pharmaceuti cal  companies in  raising AMR  awareness  and provide  finding for  awareness  activities | A.6.1 MOH  and MOA  should  advice  pharmaceuti cal  companies  (Human and  Veterinary)  to include in  every  presentation  related to  antimicrobial  use at least 3  slides (5%)  concerning  AMR (Send  one letter  from each  ministry) |                                                                        | A.6.1  Percentage  of  pharmaceuti cal  companies  presentations  that include  the message  about AMR | A.6.1  involving  pharmaceuti cal  companies in  raising AMR  awareness  among  professionals  in all health  fields | A.6.1  number of  presentations  including  message/  total number  of  presentations  *100 | A.6.1   Once/5 years           | A.6.1   MOH  MOA  | A.6.1 Letter        | A.6.1  Sporadic |
|                                                                                                                              | A.6.2  Seek private  funding from  Pharmaceuti cal                                                                                                                                                                                           | A.6.2.1  Meeting  with CEO s  of main                                  | A.6.2.1  Percentage  of  pharmaceuti cal                                                               | A.6.2.1  Involving  pharmaceuti cal  companies in                                                                    | A.6.2.1  Number of  companies  contributing  to the                                         | A.6.2.1 Once  or more/5  years | A.6.2.1  MOH  MOA | A.6.2.1  Meeting(s) | A.6.2.1  NA     |

## Axis B: Surveillance

## Strategic Plan

| Objective                                                                 | Activity                                                                                                                                                                               | Sub-activity                                                                                                                                                                                 | Date from operational plan            | Milestone                        |
|---------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------|----------------------------------|
| B.1 Organization of the  responsibilities for the  execution of the tasks | B.1.1 Appointment of focal  person n charge of following  up the activities of the  objectives of this axis                                                                            | B.1.1.1  Empower   ESU director as focal person                                                                                                                                              | B.1.1.1  three months from time zero  | B.1  three months from time zero |
|                                                                           | B.1.2 Appointment of the  members of the technical  working group along with its  TOR                                                                                                  |                                                                                                                                                                                              | B.1.2  three months from time zero    |                                  |
| B.2  Reporting of AMR data to  GLASS                                      | B.2.1  Mapping of labs that can  potentially provide  microbiologically reliable  and epidemiologically  representative data.  These labs start reporting  their data to the (GLASS).  | B.2.1.1  Make a list of laboratories  that will ultimately form an  epidemiologic representation  of the country and that will  be sequentially entered into  GLASS after capacity  building | B.2.1.1  Three months from time  zero | B.2  5 years                     |
|                                                                           | B.2.2  Put a plan for capacity  building for the labs that are  chosen to be included in  GLASS report in order to be  epidemiologically  representative based on an  incremental plan | B.2.2.1  Organize a nationwide  workshop about GLASS and  the plan of inclusion in  GLASS and introduction to  WHONET                                                                        | B.2.2.1  Three months from time  zero |                                  |
|                                                                           |                                                                                                                                                                                        | B.2.2.2                                                                                                                                                                                      | B.2.2.2                               |                                  |

| -Evaluate the quality of  work in the selected  laboratories (visit),  -Check 8 laboratories per  year,  -Select the ones that can  immediately report to  GLASS,  -Put a plan for 4 laboratories  that will undergo  improvement in their  capacity during coming year,  then repeat the same the  following year, then the  following years   | End of first year from time  zero: 4 laboratories  Second year from time zero:  4 laboratories   Each year 4 laboratories   |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------|
| B.2.2.3  Do a start up WHONET  training for the 8  laboratories that were chosen  for the coming 2 years every  2 years                                                                                                                                                                                                                         | B.2.2.3  Three months from time  zero                                                                                       |
| B.2.2.4  Do 3 laboratory visits for  capacity building/year for 4  laboratories in different  areas for building capacity  and WHONET training                                                                                                                                                                                                  | B.2.2.4  Three visits per lab each  year for 4 laboratories  starting year 1                                                |
| B.2.2.5  External quality control  twice per year for the 8  laboratories chosen for the 2  years, then to add the ones of                                                                                                                                                                                                                      | B.2.2.5  Six months from time zero                                                                                          |

|                                                                                                             |                                                                                                                                                                                                                                                                                                          | the following 2 years, after  the 2 nd  year.      |                                                  |              |
|-------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------|--------------------------------------------------|--------------|
|                                                                                                             | B.2.3  Data Entry in GLASS                                                                                                                                                                                                                                                                               | B.2.3.1  Data collection from mature  laboratories | B.2.3.1  Start end of 1 st  year from  time zero |              |
|                                                                                                             |                                                                                                                                                                                                                                                                                                          | B.2.3.2  Data cleaning and entry into  GLASS       | B.2.3.2  Start end of 1 st  year from  time zero |              |
| B.3  Periodic issuing of an  epidemiologically  representative national AMR  surveillance report in  humans | B.3.1  -This report is based on  WHONET data, according  to local needs of physicians,  pharmacists and researchers  (stratification of data based  on the type of priority  organisms, site/region of  infection or acquisition, etc.)  -This report is posted on  AMR webpages (MOH and  MOA websites) |                                                    | B.3.1  Once/year starting end of 1 st year       | B.3  1 year  |
| B.4  Optimize AMR surveillance  in the agricultural, food,  veterinary, and  environmental fields           | B.4.1  Research project about AMR  surveillance in the veterinary  field.                                                                                                                                                                                                                                |                                                    | B.4.1  6 months from time zero                   | B.4  2 years |
|                                                                                                             | B.4.2 Design an  epidemiologically  representative sample for  AMR surveillance (cattle,  poultry, companion  animals).                                                                                                                                                                                  |                                                    | B.4.2 9 months from time  zero                   |              |

|                                           | B.4.3 Put a list of AMR  priority organisms and  related resistance genes for  surveillance in these fields                                                                                                                                                                                         | B.4.3 6 months from time  zero                                              |                               |
|-------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------|-------------------------------|
|                                           | B.4.4  -Assessment of LARI,  agriculture laboratory, and  the chamber of  manufacturing and  commerce in Tripoli for the  analysis of surveillance  specimens in agricultural,  food, veterinary, and  environmental fields   -Suggestion of a plan of the  microbiology work in this  surveillance | B.4.4  Six months from time zero  and completed nine months  from time zero |                               |
|                                           | B.4.5   -Report results of ABX use  and resistance surveillance  in agriculture and veterinary  world   -Send a yearly report with  recommendations to the  animal drug registry about  ABX purchasing in the  country during the coming 2  years                                                   | B.4.5   First report should be ready  at end of year 2 from time  zero      |                               |
| B.5  Create/Appoint AMR  reference lab(s) | B.5.1  Define TOR of AMR  reference lab                                                                                                                                                                                                                                                             | B.5.1  3 months from time zero                                              | B.5   9 months from time zero |
|                                           | B.5.2                                                                                                                                                                                                                                                                                               | B.5.2                                                                       |                               |

|                                                       | Map potential lab(s) across  Lebanon                                                                            | Start at time zero  Mapping finalized 3 months  from time zero   |                               |
|-------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------|-------------------------------|
|                                                       | B.5.3  Task force to visits the  potential lab(s) (WHO  EMRO) to be discussed with  Dr A. Rady                  | B.5.3  5 months from time zero                                   |                               |
|                                                       | B.5.4  Nominate the reference  lab(s)                                                                           | B.5.4  6 months from time zero                                   |                               |
|                                                       | B.5.5 MOH to sign a  contract with the lab(s)                                                                   | B.5.5 9 months from time  zero                                   |                               |
| B.6 Enhance research  activities in AMR  surveillance | B.6.1  Put and broadcast an AMR  Research Agenda including  research for alternative  agents to antimicrobials. | B.6.1  1 st  agenda sent   1.5s year from time zero              | B.6  1.5 years from time zero |

## Operational Plan

| Objective                                                                     | Activity                                                                                                           | Sub- activity                                       | Unit                  | Quantity     | Date                                    | Location            | Responsibl e  Entity                                                                                  | Cost                                      | Source  Of  Funding   | Indicator                                  |
|-------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------|-----------------------|--------------|-----------------------------------------|---------------------|-------------------------------------------------------------------------------------------------------|-------------------------------------------|-----------------------|--------------------------------------------|
| B.1  Organizatio n of the  responsibili ties for the  execution  of the tasks | B.1.1  Appointme nt of focal  person n  charge of  following  up the  activities of  the  objectives  of this axis | B.1.1.1  Empower   ESU  director as  focal  person. | B.1.1.1  Appointme nt | B.1.1.1  One | B.1.1.1  three  months  from time  zero | B.1.1.1  MOH    ESU | B.1.1.1  -WHO- National  Professiona l Officer  (Dr. A  Rady)  -MOH-  General  Director  (Dr. W       | B.1.1.1  ½ time  extra  employee  for ESU | B.1.1.1  MOH          | B.1.1.1  Focal  person  nominated          |
|                                                                               | B.1.2  Appointme nt of the  members of  the  technical  working  group  along with  its TOR                        |                                                     | B.1.2  Appointme nt   | B.1.2  One   | B.1.2  three  months  from time  zero   | B.1.2  MOH   ESU    | B.1.2  -WHO- National  Professiona l Officer  (Dr. A  Rady)  -MOH-  General  Director  (Dr. W  Ammar) | B.1.2  ½ time  extra  employee  for ESU   | B.1.2  MOH            | B.1.2  Technical  working  group  assigned |
| B.2                                                                           | B.2.1                                                                                                              | B.2.1.1                                             | B.2.1.1               | B.2.1.1      | B.2.1.1                                 | B.2.1.1             | B.2.1.1                                                                                               | B.2.1.1                                   | B.2.1.1               | B.2.1.1                                    |

| Reporting  of AMR  data to  GLASS   | Mapping of  labs that  can  potentially  provide  microbiolo gically  reliable and  epidemiolo gically  representati ve data.  These labs  start  reporting  their data to  the  (GLASS).   | Make a list  of  laboratories  that will  ultimately  form an  epidemiolo gic  representati on of the  country and  that will be  sequentiall y entered  into  GLASS  after  capacity  building   | List              | One                         | Three  months  from time  zero          | MOH    ESU   | -Focal  person   -                                  | None                              | None              | List  available to  technical  working  group   |
|-------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------|-----------------------------|-----------------------------------------|--------------|-----------------------------------------------------|-----------------------------------|-------------------|-------------------------------------------------|
|                                     | B.2.2  Put a plan  for capacity  building for  the labs  that are  chosen to  be included  in GLASS  report in  order to be  epidemiolo gically                                             | B.2.2.1  Organize a  nationwide  workshop  about  GLASS  and the  plan of  inclusion in  GLASS  and  introductio                                                                                  | B.2.2.1  Workshop | B.2.2.1  one every 5  years | B.2.2.1  Three  months  from time  zero | B.2.2.1  WHO | B.2.2.1  -Technical  working  group  -Focal  Person | B.2.2.1  1,800 USD  per  workshop | B.2.2.1  AMR Fund | B.2.2.1  Workshop  given                        |

| representati ve based on  an  incremental  plan   | n to  WHONET                                                                                                                                                                                                                                                                                         |                             |                                                                                                             |                                                                                                                                         |                                   |                                                                        |                                                                                             |                   |                                                                                                                                    |
|---------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------|-------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------|------------------------------------------------------------------------|---------------------------------------------------------------------------------------------|-------------------|------------------------------------------------------------------------------------------------------------------------------------|
|                                                   | B.2.2.2  -Evaluate  the quality  of work in  the selected  laboratories  (visit),  -Check 8  laboratories  per year,  -Select the  ones that  can  immediatel y report to  GLASS,  -Put a plan  for 4  laboratories  that will  undergo  improveme nt in their  capacity  during  coming  year, then | B.2.2.2  Laboratory  visits | B.2.2.2  8  laboratories  per 2 years  Total=  20  laboratories  in 5 years  from  different  governorate s | B.2.2.2  End of first  year from  time zero: 4  laboratories  Second  year from  time zero: 4  laboratories   Each year 4  laboratories | B.2.2.2  The chosen  laboratories | B.2.2.2  Technical  working  group  helped by  laboratory  technicians | B.2.2.2  500 USD  per visit  Total:  500*8=  4,000 USD  per 2 years  In 5 years:  8,000 USD | B.2.2.2  AMR Fund | B.2.2.2  -List of  laboratories  that will  immediatel y report is  listed on  website  -Schedule  for other  laboratories  is put |

| repeat the  same the  following  year, then  the  following  years                                                             |                             |                                                                |                                                                                  |                                   |                                                                                                              |                                                                                           |                     |                                                                                                             |
|--------------------------------------------------------------------------------------------------------------------------------|-----------------------------|----------------------------------------------------------------|----------------------------------------------------------------------------------|-----------------------------------|--------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------|---------------------|-------------------------------------------------------------------------------------------------------------|
| B.2.2.3  Do a start  up  WHONET  training for  the 8  laboratories  that were  chosen for  the coming  2 years  every 2  years | B.2.2.3  Workshop           | B.2.2.3  One every  two years                                  | B.2.2.3  Three  months  from time  zero                                          | B.2.2.3  WHO                      | B.2.2.3  -Private  sector,  WHO  consultant  (Dr. Z  Daoud)  -Private  sector (Dr.  G Matar)  - Technician s | B.2.2.3  2,000 USD                                                                        | B.2.2.3  AMR   Fund | B.2.2.3  Workshop  is done                                                                                  |
| B.2.2.4  Do 3  laboratory  visits for  capacity  building/ye ar for 4  laboratories  in different  areas for                   | B.2.2.4  Laboratory  visits | B.2.2.4  Three visits  per lab  each year  for 4  laboratories | B.2.2.4  Three visits  per lab  each year  for 4  laboratories  starting  year 1 | B.2.2.4  The chosen  laboratories | B.2.2.4  Technical  working  group                                                                           | B.2.2.4  3 capacity  building  workshops  per year  5 years:   15  workshop  800 USD  per | B.2.2.4  AMR   Fund | B.2.2.4  Number of  laboratories  that are  passing the  external  QC / Total  external  QC tests  sent*100 |

|                             | building  capacity  and  WHONET  training                                                                                                                                         |                                                                   |                                                              |                                                    |                                       |                                    | workshop =  12,000  USD                                       |                     |                                                        |
|-----------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------|--------------------------------------------------------------|----------------------------------------------------|---------------------------------------|------------------------------------|---------------------------------------------------------------|---------------------|--------------------------------------------------------|
|                             | B.2.2.5  External  quality  control  twice per  year for the  8  laboratories  chosen for  the 2 years,  then to add  the ones of  the  following 2  years, after  the 2 nd year. | B.2.2.5  Send the  quality  control  specimens  and collect  them | B.2.2.5  Years 1 &2  year: 8  Years 3 &  4:16   Year: 5   24 | B.2.2.5  Six months  from time  zero               | B.2.2.5  Reference  laboratory  (ies) | B.2.2.5  Technical  working  group | B.2.2.5  100 USD  /specimen  (8+8+4)*2 =  4,000  USD/5  years | B.2.2.5  AMR   Fund | B.2.2.5  Number of  laboratories  having  external  QC |
| B.2.3  Data Entry  in GLASS | B.2.3.1  Data  collection  from  mature  laboratories                                                                                                                             | B.2.3.1  Data  collection                                         | B.2.3.1  Once/year                                           | B.2.3.1  Start end of  1 st  year  from time  zero | B.2.3.1  ESU                          | B.2.3.1  ESU                       | B.2.3.1  None                                                 | B.2.3.1  None       | B.2.3  Number of  laboratories  reporting to  GLASS    |
|                             | B.2.3.2  Data  cleaning  and entry                                                                                                                                                | B.2.3.2  Data  cleaning  and entry                                | B.2.3.2  Once/year                                           | B.2.3.2  Start end of  1 st  year                  | B.2.3.2  ESU                          | B.2.3.2  -ESU                      | B.2.3.2  ½ time   Extra  employee                             | B.2.3.2  MOH        |                                                        |

|                                                                                                                   |                                                                                                                                                                                                                              | into  GLASS   |               |                                               | from time  zero                               |                                      | -MOH- Head of  Epidemiolo gical  Surveillanc e Program  (Dr. N  Ghosn)                               |             |             |                                                               |
|-------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------|---------------|-----------------------------------------------|-----------------------------------------------|--------------------------------------|------------------------------------------------------------------------------------------------------|-------------|-------------|---------------------------------------------------------------|
| B.3  Periodic  issuing of  an  epidemiolo gically  representati ve national  AMR  surveillanc e report in  humans | B.3.1  -This report  is based on  WHONET  data,  according  to local  needs of  physicians,  pharmacists  and  researchers  (stratificati on of data  based on  the type of  priority  organisms,  site/region  of infection |               | B.3.1  Report | B.3.1  Once/year  starting end  of 1 st  year | B.3.1  Once/year  starting end  of 1 st  year | B.3.1  University  hospitals  LSIDCM | B.3.1  Technical  working  group or  interested  researchers  assigned by  technical  working  group | B.3.1  None | B.3.1  None | B.3.1  Epidemiolo gic report  posted on  AMR  website  yearly |

|                                                                                                         | -This report  is posted on  AMR  webpages  (MOH and  MOA  websites)           |                |            |                                  |                                                  |                                                                                            |             |             |                                             |
|---------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------|----------------|------------|----------------------------------|--------------------------------------------------|--------------------------------------------------------------------------------------------|-------------|-------------|---------------------------------------------|
| B.4  Optimize  AMR  surveillanc e in the  agricultural , food,  veterinary,  and  environmen tal fields | B.4.1  Research  project  about AMR  surveillanc e in the  veterinary  field. | B.4.1  Project | B.4.1  One | B.4.1  6 months  from time  zero | B.4.1  MOA  Department  of    agriculture  (AUB) | -MOA- Head of  Animal  Health  Service  (Dr. B  Bazzal)  -MOA- Head of  Poultry  Husbandry | B.4.1  None | B.4.1  None | B.4.1  Surveillanc e report  every 2  years |

|                                                                                                                               |                              |              |                                  |                         | gical  Surveillanc e Program  (Dr. N  Ghosn)                                                                |                       |                  |            |
|-------------------------------------------------------------------------------------------------------------------------------|------------------------------|--------------|----------------------------------|-------------------------|-------------------------------------------------------------------------------------------------------------|-----------------------|------------------|------------|
| B.4.2  Design an  epidemiolo gically  representati ve sample  for AMR  surveillanc e (cattle,  poultry,  companion  animals). | B.4.2  Organizatio n project | B.4.2 one    | B.4.2 9  months  from time  zero | B.4.2 MOA               | B.4.2 - MOA-Head  of Animal  Health  Service  (Dr. B  Bazzal)  -MOA- Head of  Poultry  Husbandry  Dpt (Eng. | B.4.2 1,000  USD/year | B.4.2 AMR  fund  | B.4.2 None |
| B.4.3 Put a  list of  AMR  priority  organisms  and related  resistance  genes for  surveillanc e in these  fields            | B.4.3 List                   | B.4.3 One    | B.4.3 6  months  from time  zero | B.4.3 - MOA  -MOH  -WHO | B.4.3 - MOA-Head  of Animal  Health  Service  (Dr. B  Bazzal)  -Technical  working  group                   | B.4.3   1,000 USD     | B.4.3   AMR fund | B.4.3 None |
| B.4.4                                                                                                                         | B.4.4                        | B.4.4  three | B.4.4                            | B.4.4  -LARI            | B.4.4                                                                                                       | B.4.4                 | B.4.4  AMR       | B.4.4      |

| - Assessment  of LARI,  agriculture  laboratory,  and the  chamber of  manufactur ing and  commerce  in Tripoli  for the  analysis of  surveillanc e  specimens  in  agricultural , food,  veterinary,  and   | Visits to  three  laboratories  with audit  result   |       | Six months  from time  zero and  completed  nine  months  from time  zero   | -Tripoli  chamber of  manufactur ing and  commerce  -Bekaa  AUB  laboratory   | -Technical  working  group  -LARI  -Tripoli  chamber of  manufactur ing and  commerce  -Bekaa  AUB  laboratory   | 500 USD  per visit  Total: 3  visits  1,500 USD   | Fund   | Report  about the  capacity of  these  laboratories  to do AMR  surveillanc e in the  veterinary  world   |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------|-------|-----------------------------------------------------------------------------|-------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------|---------------------------------------------------|--------|-----------------------------------------------------------------------------------------------------------|
| B.4.5                                                                                                                                                                                                         | B.4.5                                                | B.4.5 | B.4.5                                                                       | B.4.5                                                                         | B.4.5                                                                                                            | B.4.5                                             | B.4.5  | B.4.5                                                                                                     |

|                                             | -Report  results of  ABX use  and  resistance  surveillanc e in  agriculture  and  veterinary  world   -Send a  yearly  report with  recommend ations to  the animal  drug  registry  about ABX  purchasing  in the  country  during the  coming 2  years   | Report          | Once every  2 years   | First report  should be  ready at  end of year  2 from time  zero   | MOA             | -MOA- Head of  Animal  Health  Service  (Dr. B  Bazzal)  -Technical  working  group   | 3,000  USD/report  (Every 2  years)  Total  7,000  USD/5  years   | AMR Fund    | Quantity of  purchased  ABX that  are listed in  the  'restricted  use list' in  the  veterinary  world   |
|---------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------|-----------------------|---------------------------------------------------------------------|-----------------|---------------------------------------------------------------------------------------|-------------------------------------------------------------------|-------------|-----------------------------------------------------------------------------------------------------------|
| B.5  Create/App oint AMR  reference  lab(s) | B.5.1  Define  TOR of  AMR  reference  lab                                                                                                                                                                                                                  | B.5.1  Document | B.5.1  1              | B.5.1  3 months  from time  zero                                    | B.5.1  ESU  MOH | B.5.1  Technical  working  group                                                      | B.5.1  None                                                       | B.5.1  None | B.5  Reference  laboratory/l aboratories  appointed  and                                                  |

|                                                                                                      |                                        |                                                       |                                                                           |                                          |                                  |                  |             | contracts  done   |
|------------------------------------------------------------------------------------------------------|----------------------------------------|-------------------------------------------------------|---------------------------------------------------------------------------|------------------------------------------|----------------------------------|------------------|-------------|-------------------|
| B.5.2  Map  potential  lab(s)  across  Lebanon                                                       | B.5.2  List                            | B.5.2  One                                            | B.5.2  Start at  time zero  Mapping  finalized 3  months  from time  zero | B.5.2  ESU  MOH  Potential  laboratories | B.5.2  Technical  working  group | B.5.2  None      | B.5.2  None |                   |
| B.5.3  Task force  to visits the  potential  lab(s)  (WHO  EMRO) to  be  discussed  with Dr A.  Rady | B.5.3  Visit done  by EMRO  consultant | B.5.3  one to each  potential  reference  laboratory  | B.5.3  5 months  from time  zero                                          | B.5.3  Potential  laboratories           | B.5.3  EMRO                      | B.5.3  3,000 USD | B.5.3  EMRO |                   |
| B.5.4  Nominate  the  reference  lab(s)                                                              | B.5.4  Nominatio n                     | B.5.4  One  nomination  of one or  more  laboratories | B.5.4  6 months  from time  zero                                          | B.5.4  EMRO  WHO  MOH                    | B.5.4  EMRO  WHO   MOH           | B.5.4  None      | B.5.4  None |                   |
| B.5.5 MOH  to sign a  contract  with the  lab(s)                                                     | B.5.5  Contract                        | B.5.5  one or  more  depending  on  number            | B.5.5 9  months  from time  zero                                          | B.5.5 MOH                                | B.5.5 - MOH-  General  Director  | B.5.5 None       | B.5.5 None  |                   |

|                                                           |                                                                                                                        |               | of chosen  reference  laboratories   |                                                        |                                     | (Dr. W  Ammar)                         |             |             |                                                  |
|-----------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------|---------------|--------------------------------------|--------------------------------------------------------|-------------------------------------|----------------------------------------|-------------|-------------|--------------------------------------------------|
| B.6  Enhance  research  activities in  AMR  surveillanc e | B.6.1  Put and  broadcast  an AMR  Research  Agenda  including  research for  alternative  agents to  antimicrobi als. | B.6.1  Agenda | B.6.1  One/2  years                  | B.6.1  1 st  agenda  sent   1.5 years  from time  zero | B.6.1  MOH  WHO  ESU  Universitie s | B.6.1  Technical  working  group   ESU | B.6.1  None | B.6.1  None | B.6.1  Research  agenda  listed on  AMR  website |

## Monitoring and evaluation plan

| Objective                                                                     | Activity                                                                                                          | Sub-activity                                                                                                   | Indicator                                              | Purpose                                                                                                            | Calculation     | Frequency             | Data source       | Method           | Baseline                          |
|-------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------|--------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------|-----------------|-----------------------|-------------------|------------------|-----------------------------------|
| B.1  Organization  of the  responsibiliti es for the  execution of  the tasks | B.1.1  Appointment  of focal  person n  charge of  following up  the activities  of the  objectives of  this axis | B.1.1.1  Empower   ESU director  as focal  person                                                              | B.1.1.1  Focal person  nominated                       | B.1.1.1  Follow up on  the activities  of this axis                                                                | B.1.1.1  Yes/No | B.1.1.1  Once/5 years | B.1.1.1  MOH  WHO | B.1.1.1  Letter  | B.1.1.1  Partially,  unofficially |
|                                                                               | B.1.2  Appointment  of the  members of  the technical  working  group along  with its TOR                         |                                                                                                                | B.1.2  Technical  working  group  assigned             | B.1.2  Execution of  most of the  activities of  the axis                                                          | B.1.2  Yes/No   | B.1.2  Once/5 years   | B.1.2  MOH  WHO   | B.1.2  Letter    | B.1.2  NA                         |
| B.2  Reporting of  AMR data to  GLASS                                         | B.2.1  Mapping of  labs that can  potentially  provide  microbiologi cally reliable  and  epidemiologi cally      | B.2.1.1  Make a list  of  laboratories  that will  ultimately  form an  epidemiologi c  representatio n of the | B.2.1.1  List  available to  technical  working  group | B.2.1.1  Mapping of  potential  laboratories  and in order  to have an  epidemiologi cally  representativ e sample | B.2.1.1  Yes/No | B.2.1.1  Once/4 years | B.2.1.1  ESU  MOH | B.2.1.1  Listing | B.2.1.1  NA                       |

| representativ e data.  These labs  start  reporting  their data to  the  (GLASS).                                                                                                               | country and  that will be  sequentially  entered into  GLASS after  capacity  building                                      |                                                                    |                                                                                                                                                           |                                    |                       |                                      |                             |                          |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------|-----------------------|--------------------------------------|-----------------------------|--------------------------|
| B.2.2  Put a plan  for capacity  building for  the labs that  are chosen to  be included  in GLASS  report in  order to be  epidemiologi cally  representativ e based on  an  incremental  plan | B.2.2.1  Organize a  nationwide  workshop  about  GLASS and  the plan of  inclusion in  GLASS and  introduction  to  WHONET | B.2.2.1  Workshop  given                                           | B.2.2.1  Introduction  to GLASS  and the plan,  mainly  because  recruitment  of the  laboratories  is based on  voluntary  enrollment  into the  project | B.2.2.1  Yes/No                    | B.2.2.1  Once/5 years | B.2.2.1  WHO  MOH                    | B.2.2.1  workshop           | B.2.2.1  Done  partially |
|                                                                                                                                                                                                 | B.2.2.2  -Evaluate the  quality of  work in the  selected  laboratories  (visit),                                           | B.2.2.2  -List of  laboratories  that will  immediately  report is | B.2.2.2  Organization  of the work  and a 4 year  schedule                                                                                                | B.2.2.2  Schedule is  put.  Yes/No | B.2.2.2  Once/year    | B.2.2.2  -WHO  -Chosen  laboratories | B.2.2.2  Laboratory  visits | B.2.2.2  NA              |

| -Check 8  laboratories  per year,  -Select the  ones that can  immediately  report to  GLASS,  -Put a plan  for 4  laboratories  that will  undergo  improvement  in their  capacity  during  coming year,  then repeat  the same the  following  year, then  the  following  years   | listed on  website  -Schedule  for other  laboratories  is put   |                                                                          |                 |                                |                   |                   |                                                              |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------|--------------------------------------------------------------------------|-----------------|--------------------------------|-------------------|-------------------|--------------------------------------------------------------|
| B.2.2.3  Do a start up  WHONET  training for  the 8  laboratories  that were                                                                                                                                                                                                          | B.2.2.3  Workshop is  done                                       | B.1.1.4  WHONET  training for  laboratories  that will  report to  GLASS | B.2.2.3  Yes/No | B.2.2.3  Once every  two years | B.2.2.3  WHO  MOH | B.2.2.3  Workshop | B.2.2.3  Once done  not focused  to  laboratories  that will |

| chosen for  the coming 2  years every 2  years                                                                                                         |                                                                                                             |                                                            |                                                                                                             |                    |                                       |                                                                   | enter  GLASS                               |
|--------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------|------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------|--------------------|---------------------------------------|-------------------------------------------------------------------|--------------------------------------------|
| B.2.2.4  Do 3  laboratory  visits for  capacity  building/year  for 4  laboratories  in different  areas for  building  capacity and  WHONET  training | B.2.2.4  Number of  laboratories  that are  passing the  external QC  / Total  external QC  tests  sent*100 | B.2.2.4  Recommend ation for  GLASS  entry                 | B.2.2.4  Number of  laboratories  that are  passing the  external QC  / Total  external QC  tests  sent*100 | B.2.2.4  Once/Year | B.2.2.4  -Chosen  laboratories        | B.2.2.4  Laboratory  visits                                       | B.2.2.4  NA                                |
| B.2.2.5  External  quality  control twice  per year for  the 8  laboratories  chosen for  the 2 years,  then to add  the ones of  the  following 2     | B.2.2.5  Number of  laboratories  having  external QC                                                       | B.2.2.5  Measure the  progress of  the capacity  building. | B.2.2.5  Number of  quality  control  specimen  sent /year                                                  | B.2.2.5  Once/year | B.2.2.5  Reference  laboratory  (ies) | B.2.2.5  Send the  quality  control  specimens  and collect  them | B.2.2.5  Few labs in  the country  have it |

|                                                                                                                  |                                                                                                                                            | years, after  the 2 nd  year.                        |                                                               |                                                   |                                                     |                     |                                |                                    |                                                                                                              |
|------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------|---------------------------------------------------------------|---------------------------------------------------|-----------------------------------------------------|---------------------|--------------------------------|------------------------------------|--------------------------------------------------------------------------------------------------------------|
|                                                                                                                  | B.2.3  Data Entry  in GLASS                                                                                                                | B.2.3.1  Data  collection  from mature  laboratories | B.2.3  Number of  laboratories  reporting to  GLASS           | B.2.3  Reach  epidemiologi c  representativ eness | B.2.3  Number of  laboratories  reporting to  GLASS | B.2.3  Once/Year    | B.2.3  WHO  MOH                | B.2.3  Data  collection  and entry | B.2.3  Two  laboratories  have already  submitted  data to  GLASS.  Not  epidemiologi cally  representativ e |
|                                                                                                                  |                                                                                                                                            | B.2.3.2  Data  cleaning and  entry into  GLASS       |                                                               |                                                   |                                                     |                     |                                |                                    |                                                                                                              |
| B.3  Periodic  issuing of an  epidemiologi cally  representativ e national  AMR  surveillance  report in  humans | B.3.1  -This report  is based on  WHONET  data,  according to  local needs  of  physicians,  pharmacists  and  researchers  (stratificatio |                                                      | B.3.1  Epidemiolog ic report  posted on  AMR  website  yearly | B.3.1  Improve  awareness in  scientific  society | B.3.1  Compilation  of  WHONET  data                | B.3.1  Once/5 years | B.3.1  University  hospital(s) | B.3.1  Project                     | B.3.1  NA                                                                                                    |

|                                                                                                         | n of data  based on the  type of  priority  organisms,  site/region of  infection or  acquisition,  etc.)  -This report  is posted on  AMR  webpages  (MOH and  MOA  websites)   |                                            |                                                                |               |                        |                                 |               |          |
|---------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------|----------------------------------------------------------------|---------------|------------------------|---------------------------------|---------------|----------|
| B.4  Optimize  AMR  surveillance  in the  agricultural,  food,  veterinary,  and  environment al fields | B.4.1  Research  project about  AMR  surveillance  in the  veterinary  field.                                                                                                    | B.4.1  Surveillance  report every  2 years | B.4.1  Standardized  AMR  surveillance  in cattle and  poultry | B.4.1  Yes/No | B.4.1 every  two years | B.4.1  Agriculture  school  MOA | B.4.1 Project | B.4.1 NA |
|                                                                                                         | B.4.2 Design  an  epidemiologi cally  representativ                                                                                                                              | B.4.2 None                                 |                                                                |               |                        |                                 |               |          |

| e sample for  AMR  surveillance  (cattle,  poultry,  companion  animals).                                                                                               |                                                                                                               |                                                                   |               |                     |                                                                                           |              |          |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------|---------------|---------------------|-------------------------------------------------------------------------------------------|--------------|----------|
| B.4.3 Put a  list of AMR  priority  organisms  and related  resistance  genes for  surveillance  in these  fields                                                       | B.4.3 None                                                                                                    |                                                                   |               |                     |                                                                                           |              |          |
| B.4.4  -Assessment  of LARI,  agriculture  laboratory,  and the  chamber of  manufacturin g and  commerce in  Tripoli for  the analysis  of  surveillance  specimens in | B.4.4  Report about  the capacity  of these  laboratories  to do AMR  surveillance  in the  veterinary  world | B.4.4  Standardized  AMR  surveillance  in the  veterinary  world | B.4.4  Yes/No | B.4.4 once/5  years | B.4.4   -LARI  -Tripoli  chamber of  manufacturin g and  commerce  -Bekaa AUB  laboratory | B.4.4 Report | B.4.4 NA |

| agricultural,  food,  veterinary,  and  environment al fields   -Suggestion  of a plan of  the  microbiolog y work in  this  surveillance                                                   |                                                                                                                |                                                    |                                    |                           |           |              |          |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------|----------------------------------------------------|------------------------------------|---------------------------|-----------|--------------|----------|
| B.4.5   -Report  results of  ABX use  and  resistance  surveillance  in  agriculture  and  veterinary  world   -Send a  yearly report  with  recommenda tions to the  animal drug  registry | B.4.5   Quantity of  purchased  ABX that are  listed in the  'restricted  use list' in  the  veterinary  world | B.4.5  Control  ABX use in  the  veterinary  world | B.4.5  Quantity of  purchased  ABX | B.4.5 Once  every 2 years | B.4.5 MOA | B.4.5 Report | B.4.5 NA |

|                                             | about ABX  purchasing  in the  country  during the  coming 2  years                                |                                                                          |                                                                                                         |                                                             |                |                |                  |        |
|---------------------------------------------|----------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------|-------------------------------------------------------------|----------------|----------------|------------------|--------|
| B.5  Create/Appo int AMR  reference  lab(s) | B.5.1  Define TOR  of AMR  reference lab                                                           | B.5  Reference  laboratory/la boratories  appointed  and contracts  done | B.5 Have a  reference for  difficult  situations  and catch  alarming and  emerging  resistance  trends | B.5  No of  specimens/ac tivities of  reference  Lab in AMR | B.5  Once/Year | B.5  -WHO  MOH | B.5  Appointment | B.5 NA |
|                                             | B.5.2  Map  potential  lab(s) across  Lebanon                                                      |                                                                          |                                                                                                         |                                                             |                |                |                  |        |
|                                             | B.5.3  Task force to  visits the  potential  lab(s) (WHO  EMRO) to  be discussed  with Dr A.  Rady |                                                                          |                                                                                                         |                                                             |                |                |                  |        |
|                                             | B.5.4                                                                                              |                                                                          |                                                                                                         |                                                             |                |                |                  |        |

|                                                         | Nominate  the reference  lab(s)                                                                                        |                                                 |                                                                                             |                            |                     |                     |               |          |
|---------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------|---------------------------------------------------------------------------------------------|----------------------------|---------------------|---------------------|---------------|----------|
|                                                         | B.5.5 MOH  to sign a  contract with  the lab(s)                                                                        |                                                 |                                                                                             |                            |                     |                     |               |          |
| B.6 Enhance  research  activities in  AMR  surveillance | B.6.1  Put and  broadcast an  AMR  Research  Agenda  including  research for  alternative  agents to  antimicrobial s. | B.6.1  Research  agenda listed  on AMR  website | B.6.1  Involve and  update  concerned  facilities in  research  activities in  surveillance | B.6.1  number of  projects | B.6.1 Once/2  years | B.6.1 MOH  WHO  ESU | B.6.1  Agenda | B.6.1 NA |

## Axis C: Infection prevention and control (IPC)

## Strategic plan

| Objective                                                                     | Activity                                                                                                    | Sub-activity                                                                                                                                                          | Date (operational plan)                | Milestone                          |
|-------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------|------------------------------------|
| C.1 Organization of the  responsibilities for the  execution of the tasks     | C.1.1 Appointment of focal  person n charge of following  up the activities of the  objectives of this axis |                                                                                                                                                                       | C.1 three months from 'time  zero'     | C.1 three months from 'time  zero' |
|                                                                               | C.1.2 Appointment of the  members of the technical  group along with its TOR                                |                                                                                                                                                                       |                                        |                                    |
| C.2 Optimize IPC practices  in Hospitals, long term care  facilities and PHCC | C.2.1 Improve IPC practices  in Hospitals                                                                   | C.2.1.1 To finalize national  IPC guidelines; guidelines to  be all-inclusive including  requirements and  qualifications of IPC officer  and physician and checklist | C.2.1.1 three months from  'time zero' | C.2  3 years                       |
|                                                                               |                                                                                                             | C.2.1.2 Inclusion of the  checklist of the guidelines in  accreditation standards                                                                                     | C.2.1.2 six months from  'time zero'   |                                    |
|                                                                               |                                                                                                             | C.2.1.3 Follow up and  feedback on IPC practices in  hospitals after each  accreditation                                                                              | C.2.1.3 three years from  'time zero'  |                                    |
|                                                                               |                                                                                                             | C.2.1.4 Syndicate of  hospitals recommends  periodic IPC training and  workshops to employees  hosted by scientific  societies, universities, etc.                    | C.2.1.4  1,5 years from 'time zero'    |                                    |

|                                              | C.2.2 Improve IPC practices  in long-term care facilities                                                                                                                                                                                | C.2.2.1  To review and update  guidelines of IPC in long- term care facilities that are  available in Ministry of  Social Affairs   | C.2.2.1  three months from 'time  zero'   |                               |
|----------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------|-------------------------------|
|                                              |                                                                                                                                                                                                                                          | C.2.2.2 Inclusion of IPC  checklist in the MOH  licensing criteria of these  facilities                                             | C.2.2.2 six months from  'time zero'      |                               |
|                                              | C.2.3 Improve IPC practices  in PHCC                                                                                                                                                                                                     | C.2.3.1 Establish guidelines  on IPC in the PHCC                                                                                    | C.2.3.1 six months from  'time zero'      |                               |
|                                              |                                                                                                                                                                                                                                          | C.2.3.2 Inclusion of IPC  checklist in the MOH  licensing criteria of these  facilities                                             | C.2.3.2 nine months from  'time zero'     |                               |
| C.3  Enhance IPC education  different majors | C.3.1  Include IPC-related  educational modules in  human-health related majors  (physicians, nurses,  midwives, physiotherapists,  pharmacists, dentists, lab  technicians, radiologists,  nutrition, medical and  paramedical schools) |                                                                                                                                     | C.3.1  one year from 'time zero'          | C.3  2 years from 'time zero' |
|                                              | C.3.2 Include IPC-related  educational modules in  veterinary schools curricula                                                                                                                                                          | C.3.2.1 Check the current  situation of IPC in the  ongoing veterinary  curriculum                                                  | C.3.2.1 three months from  'time zero'    |                               |

|                                                   |                                                                                                                                                               | C.3.2.2 Review of IPC in  regional and global  veterinary curricula                                                                                                   | C.3.2.2 three months from  'time zero'   |               |
|---------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------|---------------|
|                                                   |                                                                                                                                                               | C.3.2.3 Prepare a proposal  for veterinary school for  deficit in curricula  improvement, if need be.                                                                 | C.3.2.3 six months from  'time zero'     |               |
|                                                   | C.3.3 IPC-related  educational modules in  curricula of three schools  (Agriculture, Nutrition,  Environment)                                                 | C.3.3.1  Mapping of IPC in three  university curricula  (Agriculture, Nutrition,  Environment)                                                                        | C.3.3.1  six months from 'time zero'     |               |
|                                                   |                                                                                                                                                               | C.3.3.2  Review global and regional  recommendations on IPC in  curricula of agriculture,  nutrition and environment,  and formulate what should  be included in them | C.3.3.2  six months from 'time zero'     |               |
|                                                   |                                                                                                                                                               | C.3.3.3  Include the recommended  tricyclic AMR and IPC in  curricula when not available                                                                              | C.3.3.3  2 years from 'time zero'        |               |
| C.4  Advanced IPC training for  IPC professionals | C.4.1  -Put TOR for IPC  professionals in different  healthcare facilities.  -Put prerequisite  training/experience of IPC  physicians, officers, and  nurses | C.4.1.1  Include in the national IPC  Guidelines the TOR of the  professionals                                                                                        | C.4.1.1  3 months                        | C.4  3 months |

|                                                    | C.4.2  Make training available and  affordable in universities and  professional societies                                          | C.4.2.1  MOH Sends letters to  Ministry of Higher  Education and to Order of  physicians explaining the  need and recommending  training specialization  opportunities and courses  related to IPC   | C.4.2.1  3 months                   |                                  |
|----------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|----------------------------------|
| C.5  National Process Indicators  in IPC           | C.5.1  Baseline evaluation of  current situation at a national  level (research project) and  make it a continuous process          |                                                                                                                                                                                                      | C.5.1  One year from 'time zero'    | C.5  Four years from 'time zero' |
|                                                    | C.5.2 National indicators to  be incrementally applied  with time (hand hygiene,  PPE, isolation, other  standard precautions, etc) |                                                                                                                                                                                                      | C.5.2   Four years from 'time zero' |                                  |
| C.6  Survey of Nosocomial  Infections in hospitals | C.6.1  Conduct a point prevalence  study on nosocomial  infections in Lebanese  hospitals                                           |                                                                                                                                                                                                      | C.6.1  2 years                      | C.6  2 years                     |
| C.7  IPC in the veterinary world                   | C.7.1  Review the OIE biosafety  recommendations                                                                                    |                                                                                                                                                                                                      | C.7.1  3 months                     | C.7  6 months                    |
|                                                    | C.7.2  Check the availability in of  these recommendations in  local veterinary laws                                                |                                                                                                                                                                                                      | C.7.2  5 months                     |                                  |
|                                                    | C.7.3                                                                                                                               | C.7.3                                                                                                                                                                                                | C.7.3                               |                                  |

## Operational plan and budget

| Objective                                                                     | Activity                                                                                                           | Sub- activity   | Unit              | Quantity                                   | Date                                 | Location   | Responsibl e entity                                                                                                                                          | Cost                         | Source   Of funding   | Indicator                                       |
|-------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------|-----------------|-------------------|--------------------------------------------|--------------------------------------|------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------|-----------------------|-------------------------------------------------|
| C.1  Organizatio n of the  responsibili ties for the  execution  of the tasks | C.1.1  Appointme nt of focal  person n  charge of  following  up the  activities of  the  objectives  of this axis |                 | C.1  Appointme nt | C.1 One  person and  one  technical  group | C.1 three  months  from 'time  zero' | C.1 MOH    | C.1   -MOH-  General  Director  (Dr. W  Ammar)  appoints of  the  technical  working  group  -Focal  person is  appointed  by the  technical  working  group | C.1 One  full time  employee | C.1 AMR  Fund         | C.1  Appointme nt letter  with job  description |
|                                                                               | C.1.2  Appointme nt of the  members of  the IPC  technical  working  group  along with  its TOR                    |                 |                   |                                            |                                      |            |                                                                                                                                                              |                              |                       |                                                 |

| C.2  Optimize  IPC  practices in  Hospitals,  long term  care  facilities  and PHCC   | C.2.1  Improve  IPC  practices in  Hospitals   | C.2.1.1 To  finalize  national  IPC  guidelines;  guidelines  to be all- inclusive  including  requiremen ts and  qualificatio ns of IPC  officer and  physician  and   | C.2.1.1  Document   | C.2.1.1 one                 | C.2.1.1  three  months  from 'time  zero'   | C.2.1.1   -MOH  -LSIDCM  -WHO   | C.2.1.1   IPC expert                                                  | C.2.1.1  2,000 USD   | C.2.1.1  AMR  Fund               | C.2.1.1  Guidelines  on MOH  site                                |
|---------------------------------------------------------------------------------------|------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------|-----------------------------|---------------------------------------------|---------------------------------|-----------------------------------------------------------------------|----------------------|----------------------------------|------------------------------------------------------------------|
|                                                                                       |                                                | checklist  C.2.1.2  Inclusion  of the  checklist of  the  guidelines  in  accreditatio n standards                                                                      | C.2.1.2  Checklist  | C.2.1.2 one                 | C.2.1.2 six  months  from 'time  zero'      | C.2.1.2   -MOH  -LSIDCM  -WHO   | C.2.1.2   -IPC expert   -MOH- Project  Coordinato r  (Eng. S  Akkoum) | C.2.1.2  1,000 USD   | C.2.1.2  AMR  Fund               | C.2.1.2  Letter from  team to  IPC  Officer                      |
|                                                                                       |                                                | C.2.1.3  Follow up  and  feedback  on IPC  practices in                                                                                                                 | C.2.1.3  Report     | C.2.1.3 one  every 5  years | C.2.1.3  three years  from 'time  zero'     | C.2.1.3  MOH                    | C.2.1.3   -IPC  coordinator  or  temporary  consultant                | C.2.1.3  3,000 USD   | C.2.1.3  Syndicate  of hospitals | C.2.1.3  Percentage  of hospitals  with  acceptable  results for |

|                                                                | hospitals  after each  accreditatio n                                                                                                                        |                     |              |                                           |                                   | - Accreditati on team                                                                            |                    |                   | IPC in  accreditatio n                       |
|----------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------|--------------|-------------------------------------------|-----------------------------------|--------------------------------------------------------------------------------------------------|--------------------|-------------------|----------------------------------------------|
|                                                                | C.2.1.4  Syndicate  of hospitals  recommend s periodic  IPC  training  and  workshops  to  employees  hosted by  scientific  societies,  universities , etc. | C.2.1.4  Schedule   | C.2.1.4 one  | C.2.1.4  1,5 years  from 'time  zero'     | C.2.1.4  Hospitals  Universitie s | C.2.1.4   -MOH- Head of  Preventive  Medicine  and  Communic able  Diseases  Dpts (Dr. A  Berry) | C.2.1.4  None      | C.1.1.4  None     | C.2.1.4  Number of  IPC  workshops  per year |
| C.2.2  Improve  IPC  practices in  long-term  care  facilities | C.2.2.1  To review  and update  guidelines  of IPC in  long-term  care  facilities  that are  available in  Ministry of                                      | C.2.2.1  Guidelines | C.2.2.1  One | C.2.2.1  three  months  from 'time  zero' | C.2.2.1  MOH                      | C.2.2.1  -Order of  nurses (Ms  M Said)  -Private  sector (Dr.  M Youssef)                       | C.2.2.1  2,000 USD | C.2.2.1  AMR fund | C.2.2.1  Updated  guidelines  on website     |

|                                         | Social  Affairs                                                                              |                     |              |                                          |                               |                                                                                                     |                    |                   |                                                           |
|-----------------------------------------|----------------------------------------------------------------------------------------------|---------------------|--------------|------------------------------------------|-------------------------------|-----------------------------------------------------------------------------------------------------|--------------------|-------------------|-----------------------------------------------------------|
|                                         | C.2.2.2  Inclusion  of IPC  checklist in  the MOH  licensing  criteria of  these  facilities | C.2.2.2  Checklist  | C.2.2.2  One | C.2.2.2 six  months  from 'time  zero'   | C.2.2.2  MOH                  | C.2.2.2   -MOH- Project  Coordinato r  (Eng. S  Akkoum)                                             | C.2.2.2  None      | C.2.2.2  None     | C.2.2.2  Checklist  of IPC in  accreditatio n standards   |
| C.2.3  Improve  IPC  practices in  PHCC | C.2.3.1  Establish  guidelines  on IPC in  the PHCC                                          | C.2.3.1  Guidelines | C.2.3.1  One | C.2.3.1 six  months  from 'time  zero'   | C.2.3.1   -MOH  -LSIDCM  -WHO | C.2.3.1  Private  Sector  (Dean of  School of  Nursing- Saint  Joseph  University)  (Dr. C  Zablit) | C.2.3.1  3,000 USD | C.2.3.1  AMR fund | C.2.3.1  Guidelines  on website                           |
|                                         | C.2.3.2  Inclusion  of IPC  checklist in  the MOH  licensing  criteria of  these  facilities | C.2.3.2  Checklist  | C.2.3.2  One | C.2.3.2  nine  months  from 'time  zero' | C.2.3.2  MOH                  | C.2.3.2  Private  Sector  (Dean of  School of  Nursing- Saint  Joseph  University)                  | C.2.3.2  1,000 USD | C.2.3.2  AMR fund | C.2.3.2  Checklist  of IPC in  accreditatio n  standards. |

|                                                 |                                                                                                                                                                                                                                                        |                                                                                                                                       |                                                                                                 |                                    |                                    | (Dr. C  Zablit)                                                                                                                                                                                                                     |                    |                  |                                                                      |
|-------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------|------------------------------------|------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------|------------------|----------------------------------------------------------------------|
| C.3  Enhance  IPC  education  different  majors | C.3.1  Include  IPC-related  educational  modules in  human- health  related  majors  (physicians , nurses,  midwives,  physiothera pists,  pharmacist s, dentists,  lab  technicians,  radiologists , nutrition,  medical  and  paramedica l schools) | C.3.1  -Basic  recommend ations to be  included  -IPC  Letters  from  Ministry of  education  to different  teaching  establishme nts | C.3.1  one per  year  2 types:  1.General  2.Specific  to nurses,  midwives  medical  students. | C.3.1  one year  from 'time  zero' | C.3.1  Ministry of  Education  MOH | C.3.1  One  appointed  consultant  helped by:  -Order of  nurses- Director  (Ms. N  Richa)  -Order of  Midwives- member  (Ms. M  Romeh)  -MOH- PHC Dpt-  Dental  Coordinato r (Dr M  Msallem)  -Technical  Schools  (Ms. S  Younes) | C.3.1  15,000  USD | C.3.1  AMR  Fund | C.3.1  Percentage  of health  curricula  that  contain  IPC  modules |

|                                                                                      |                                                                                                              |                   |              |                                           |              | '2h/speciali st'                                                                             |                    |                   |                                                                                   |
|--------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------|-------------------|--------------|-------------------------------------------|--------------|----------------------------------------------------------------------------------------------|--------------------|-------------------|-----------------------------------------------------------------------------------|
| C.3.2  Include  IPC-related  educational  modules in  veterinary  schools  curricula | C.3.2.1  Check the  current  situation of  IPC in the  ongoing  veterinary  curriculum                       | C.3.2.1  Report   | C.3.2.1  One | C.3.2.1  three  months  from 'time  zero' | C.3.2.1  MOA | C.3.2.1   -MOA- Head of  Animal  Health  Service  (Dr. B  Bazzal)                            | C.3.2.1   500 USD  | C.3.2.1  AMR fund | C.3.2.1  None                                                                     |
|                                                                                      | C.3.2.2  Review of  IPC in  regional  and global  veterinary  curricula                                      | C.3.2.2  Report   | C.3.2.2  One | C.3.2.2  three  months  from 'time  zero' | C.3.2.2  MOA | C.3.2.2   -MOA- Head of  Animal  Health  Service  (Dr. B  Bazzal)                            | C.3.2.2  1,000 USD | C.3.2.2  AMR fund | C.3.2.2  None                                                                     |
|                                                                                      | C.3.2.3  Prepare a  proposal  for  veterinary  school for  deficit in  curricula  improveme nt, if need  be. | C.3.2.3  Proposal | C.3.2.3  One | C.3.2.3 six  months  from 'time  zero'    | C.3.2.3  MOA | C.3.2.3   -MOA- Head of  Animal  Health  Service  (Dr. B  Bazzal)  -AUB-Dpt  of  Agriculture | C.3.2.3  3,500 USD | C.3.2.3  AMR fund | C.3.2.3  Proposal is  sent to  veterinary  school, and  IPC  included in  program |

|                                                                                                                      |                                                                                                                                                               |                 |              |                                        |                                               | (Dr. M  Farran)                                                   |                    |                   |                                                                                                                                        |
|----------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------|--------------|----------------------------------------|-----------------------------------------------|-------------------------------------------------------------------|--------------------|-------------------|----------------------------------------------------------------------------------------------------------------------------------------|
| C.3.3 IPC- related  educational  modules in  curricula of  three  schools  (Agricultur e,  Nutrition,  Environme nt) | C.3.3.1  Mapping of  IPC in  three  university  curricula  (Agricultur e,  Nutrition,  Environme nt)                                                          | C.3.3.1  Report | C.3.3.1  One | C.3.3.1  six months  from 'time  zero' | C.3.3.1  MOH  Agriculture  schools  (AUB, LU) | C.3.3.1  -MOA- Head of  Poultry  Husbandry  Dpt (Eng.  A Sirawan) | C.3.3.1  1,000 USD | C.3.3.1  AMR fund | C.3.3  IPC  module to  be included  in the three  curricula of  sent from  respective  ministries  as  recommen dation to  the schools |
|                                                                                                                      | C.3.3.2  Review  global and  regional  recommend ations on  IPC in  curricula of  agriculture,  nutrition  and  environmen t, and  formulate  what  should be | C.3.3.2  Report | C.3.3.2  One | C.3.3.2  six months  from 'time  zero' | C.3.3.2  MOH  Agriculture  schools  (AUB, LU) | C.3.3.2  -AUB-Dpt  of  Agriculture  (Dr. M  Farran)               | C.3.3.2  1,000 USD | C.3.3.2  AMR fund |                                                                                                                                        |

|                                                       |                                                                                                                                                           | included in  them                                                                             |                                          |              |                                     |                                               |                                                                                                    |                                      |                   |                                                                            |
|-------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------|------------------------------------------|--------------|-------------------------------------|-----------------------------------------------|----------------------------------------------------------------------------------------------------|--------------------------------------|-------------------|----------------------------------------------------------------------------|
|                                                       |                                                                                                                                                           | C.3.3.3  Include the  recommend ed tricyclic  AMR and  IPC in  curricula  when not  available | C.3.3.3  Memo to  Ministry of  Education | C.3.3.3  One | C.3.3.3  2 years  from 'time  zero' | C.3.3.3  MOH  Agriculture  schools  (AUB, LU) | C.3.3.3  -MOA- Head of  Poultry  Husbandry  Dpt (Eng.  A Sirawan)  -Private  sector (Ms.  S Najem) | C.3.3.3  2,000 USD                   | C.3.3.3  AMR fund |                                                                            |
| C.4  Advanced  IPC  training for  IPC  professiona ls | C.4.1  -Put TOR  for IPC  professiona ls in  different  healthcare  facilities.  -Put  prerequisite  training/ex perience of  IPC  physicians,  officers, | C.4.1.1  Include in  the national  IPC  Guidelines  the TOR of  the  professiona ls           | C.4.1.1  Part of IPC  guidelines         | C.4.1.1  1   | C.4.1.1  3 months                   | C.4.1.1  MOH  WHO                             | C.4.1.1  Same as  guidelines                                                                       | C.4.1.1  Within cost  of  guidelines | C.4.1.1  AMR Fund | C.4.1.1  TOR of  IPC  professiona ls are  included in  the IPC  guidelines |
|                                                       | C.4.2  Make  training                                                                                                                                     | C.4.2.1  MOH  Sends                                                                           | C.4.2.1  Letter                          | C.4.2.1  1   | C.4.2.1  3 months                   | C.4.2.1  MOH                                  | C.4.2.1                                                                                            | C.4.2.1  None                        | C.4.2.1  None     | C.4.2.1  None                                                              |

|                                            | available  and  affordable  in  universities  and  professiona l societies                                                         | letters to  Ministry of  Higher  Education  and to  Order of  physicians  explaining  the need  and  recommend ing training  specializati on  opportuniti es and  courses  related to  IPC   |                          |            |                                    |                               | Technical  working  group  NMCG                                                                             |                  |                      |                                             |
|--------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------|------------|------------------------------------|-------------------------------|-------------------------------------------------------------------------------------------------------------|------------------|----------------------|---------------------------------------------|
| C.5  National  Process  Indicators  in IPC | C.5.1  Baseline  evaluation  of current  situation at  a national  level  (research  project)  and make it  a  continuous  process |                                                                                                                                                                                              | C.5.1  Research  project | C.5.1  One | C.5.1  One year  from 'time  zero' | C.5.1  MOH  LSIDCM  Hospitals | C.5.1  -Private  sector,  WHO  consultant,  former  LSIDCM  president  (Dr. R  Moghnieh)  -Private  sector, | C.5.1  2,000 USD | C.5.1  Fund  raising | C.5.1  Results are  posted on  AMR  website |

|                                                      |                                                                                                                                               |                          |           |                                     |                              | former  LSIDCM  president  (Dr. R  Husni)  -Private  sector (Dr.  M Youssef)  -ESU   |                    |                       |                                                                               |
|------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------|--------------------------|-----------|-------------------------------------|------------------------------|--------------------------------------------------------------------------------------|--------------------|-----------------------|-------------------------------------------------------------------------------|
|                                                      | C.5.2  National  indicators  to be  incremental ly applied  with time  (hand  hygiene,  PPE,  isolation,  other  standard  precautions , etc) | C.5.2  Research  project | C.5.2 One | C.5.2 Four  years from  'time zero' | C.5.2 MOH  LSIDCM  Hospitals | C.5.2   -LSIDCM  -ESU                                                                | C.5.2  20,000  USD | C.5.2   Fund  raising | C.5.2  Percentage  of hospitals  that report  results of  process  indicators |
| C.6  Survey of  Nosocomia l Infections  in hospitals | C.6.1  Conduct a  point  prevalence  study on  nosocomial                                                                                     | C.6.1  Survey            | C.6.1  1  | C.6.1  2 years                      | C.6.1  Lebanese  Hospitals   | C.6.1  Technical  working  group                                                     | C.6.1  3,000 USD   | C.6.1  AMR Fund       | C.6.1  Results of  study  published                                           |

|                                    | infections  in  Lebanese  hospitals                                                       |                                                                                                         |               |          |                 |            |                                                                                             |                  |                 |             |
|------------------------------------|-------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------|---------------|----------|-----------------|------------|---------------------------------------------------------------------------------------------|------------------|-----------------|-------------|
| C.7  IPC in the  veterinary  world | C.7.1  Review the  OIE  biosafety  recommend ations                                       |                                                                                                         | C.7.1  Report | C.7.1  1 | C.7.1  3 months | C.7.1  MOA | C.7.1  Technical  working  group                                                            | C.7.1  None      | C.7.1  None     | C.7.1  None |
|                                    | C.7.2  Check the  availability  in of these  recommend ations in  local  veterinary  laws |                                                                                                         | C.7.2  Report | C.7.2  1 | C.7.2  5 months | C.7.2  MOA | C.7.2  -Technical  working  group   -MOA- Head of  Animal  Health  Service  (Dr. B  Bazzal) | C.7.2  1,000 USD | C.7.2  AMR Fund | C.7.2  None |
|                                    | C.7.3  Monitor the  application  of these  laws                                           | C.7.3  MOH  recommend s to MOA  to follow  up on the  related  activities of  IPC in  Veterinary  world | C.7.3  Letter | C.7.3  1 | C.7.3  6 months | C.7.3  MOH | C.7.3  Technical  working  group                                                            | C.7.3  None      | C.7.3  None     | C.7.3  None |

## Monitoring and evaluation plan

| Objective                                                                         | Activity                                                                                                          | Sub-activity                                                                                                    | Indicator                                       | Purpose                                      | Calculation     | Frequency  Of Data  collection   | Data   Source                      | Method                      | Baseline             |
|-----------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------|-------------------------------------------------|----------------------------------------------|-----------------|----------------------------------|------------------------------------|-----------------------------|----------------------|
| C.1  Organization  of the  responsibiliti es for the  execution of  the tasks     | C.1.1  Appointment  of focal  person n  charge of  following up  the activities  of the  objectives of  this axis |                                                                                                                 | C.1  Appointment  letter with  job  description | C.1 Follow  up on  activities                | C.1 Letter      | C.1 NA                           | C.1 NA                             | C.1 NA                      | C.1 Not  appointed   |
|                                                                                   | C.1.2  Appointment  of the  members of  the technical  group along  with its TOR                                  |                                                                                                                 |                                                 |                                              |                 |                                  |                                    |                             |                      |
| C.2  Optimize  IPC practices  in Hospitals,  long term  care facilities  and PHCC | C.2.1  Improve IPC  practices in  Hospitals                                                                       | C.2.1.1 To  finalize  national IPC  guidelines;  guidelines to  be all- inclusive  including  requirements  and | C.2.1.1  Guidelines  on MOH site                | C.2.1.1  Update and  standardizati on of IPC | C.2.1.1  Yes/no | C.2.1.1  Once/5 years            | C.2.1.1  International  guidelines | C.2.1.1  Scientific  review | C.2.1.1 In  progress |

| qualification s of IPC  officer and  physician  and checklist                                                                        |                                                                                         |                                                                                                     |                                                                                                |                       |                                        |                                                     |                                                          |
|--------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------|-----------------------|----------------------------------------|-----------------------------------------------------|----------------------------------------------------------|
| C.2.1.2  Inclusion of  the checklist  of the  guidelines in  accreditation  standards                                                | C.2.1.2  Letter from  team to IPC  Officer                                              | C.2.1.2  Audit IPC  during the  accreditation  audit in  hospitals                                  | C.2.1.2  Yes/No                                                                                | C.2.1.2  Once/5 years | C.2.1.2  Accreditatio n checklists     | C.2.1.2  Letter  Meeting   Accreditatio n committee | C.2.1.2  Partial                                         |
| C.2.1.3  Follow up  and feedback  on IPC  practices in  hospitals  after each  accreditation                                         | C.2.1.3  Percentage  of hospitals  with  acceptable  results for  IPC in  accreditation | C.2.1.3  Increase the  number of  hospitals that  are  compliant  with national  IPC  guidelines.   | C.2.1.3  (Number of  compliant  hospitals/Tot al number of  audited  hospitals)  x100          | C.2.1.3  Once/3 years | C.2.1.3  Accreditatio n audit  results | C.2.1.3  Checklist in  accreditation  audit         | C.2.1.3 Not  started yet                                 |
| C.2.1.4  Syndicate of  hospitals  recommends  periodic IPC  training and  workshops  to employees  hosted by  scientific  societies, | C.2.1.4  Number of  IPC  workshops  per year                                            | C.2.1.4  Have  qualified  HCW in  charge of  IPC, and  have more  efficient  programs in  hospitals | C.2.1.4  Number of  workshops/  Number of  universities  providing  health  sciences  programs | C.2.1.4  Once/5 years | C.2.1.4  International  standards      | C.2.1.4  Scientific  review                         | C.2.1.4  Workshops  are being  done but not  followed up |

|                                                               | universities,  etc.                                                                                                                    |                                                          |                                                              |                  |                            |                                                                           |                                                      |             |
|---------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------|--------------------------------------------------------------|------------------|----------------------------|---------------------------------------------------------------------------|------------------------------------------------------|-------------|
| C.2.2  Improve IPC  practices in  long-term  care  facilities | C.2.2.1  To review  and update  guidelines of  IPC in long- term care  facilities that  are available  in Ministry  of Social  Affairs | C.2.2.1  Updated  guidelines  on website                 | C.2.2.1  Standardize  IPC in long  term                      | C.2.2.1  Yes /no | C.2.2.1  Once              | C.2.2.1  Ministry of  social affairs  Guidelines                          | C.2.2.1  Review and  update                          | C.2.2.1  NA |
|                                                               | C.2.2.2  Inclusion of  IPC  checklist in  the MOH  licensing  criteria of  these  facilities                                           | C.2.2.2  Checklist of  IPC in  accreditation  standards  | C.2.2.2  Improve  application  of   IPC in these  facilities | C.2.2.2 Yes  /no | C.2.2.2 Once               | C.2.2.2   -Long term  care facilities  -MOH  -Ministry of  social affairs | C.1.2.2   Letter  Meeting                            | C.1.2.2 NA  |
| C.2.3  Improve IPC  practices in  PHCC                        | C.2.3.1  Establish  guidelines  on IPC in the  PHCC                                                                                    | C.2.3.1  Guidelines  on website                          | C.2.3.1  Standardize  IPC in  PHCC                           | C.2.3.1  Yes/No  | C.2.3.1 Once  per 6 months | C.2.3.1  Guidelines   AMS/AMR  website                                    | C.2.3.1  Checking                                    | C.2.3.1 NA  |
|                                                               | C.2.3.2  Inclusion of  IPC  checklist in  the MOH                                                                                      | C.2.3.2  Checklist of  IPC in  accreditation  standards. | C.2.3.2  Improve  application  of                            | C.2.3.2  Yes/No  | C.2.3.2 Once  per 6 months | C.2.3.2  Accreditatio n guidelines                                        | C.2.3.2  Letter   Meeting   Accreditatio n committee | C.2.3.2 NA  |

|                                                |                                                                                                                                                                                                                                                      | licensing  criteria of  these  facilities                      |                                                                    | IPC in these  facilities                                          |                                                                                                           |                     |                                    |                                 |                                                              |
|------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------|--------------------------------------------------------------------|-------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------|---------------------|------------------------------------|---------------------------------|--------------------------------------------------------------|
| C.3  Enhance IPC  education  different  majors | C.3.1  Include IPC- related  educational  modules in  human- health  related  majors  (physicians,  nurses,  midwives,  physiotherap ists,  pharmacists,  dentists, lab  technicians,  radiologists,  nutrition,  medical and  paramedical  schools) |                                                                | C.3.1  Percentage  of health  curricula that  contain IPC  modules | C.3.1  Include IPC  in basic  education of  health  professionals | C.3.1   (Number of  curricula that  have IPC  module/Tota l number of  health  sciences  curricula)  *100 | C.3.1  Once/5 years | C.3.1  Curricula   IPC  guidelines | C.3.1  Letters to  universities | C.3.1  IPC included  but non- standardized  and  unorganized |
|                                                | C.3.2  Include IPC- related  educational  modules in  veterinary                                                                                                                                                                                     | C.3.2.1  Check the  current  situation of  IPC in the  ongoing | C.3.2.1 None                                                       |                                                                   |                                                                                                           |                     |                                    |                                 |                                                              |

| schools  curricula                                                                                                 | veterinary  curriculum                                                                                     |                                                                                                                                       |                                                                                  |                                                                                                                               |                  |                                   |                                  |                               |
|--------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------|------------------|-----------------------------------|----------------------------------|-------------------------------|
|                                                                                                                    | C.3.2.2  Review of  IPC in  regional and  global  veterinary  curricula                                    | C.3.2.2 None                                                                                                                          |                                                                                  |                                                                                                                               |                  |                                   |                                  |                               |
|                                                                                                                    | C.3.2.3  Prepare a  proposal for  veterinary  school for  deficit in  curricula  improvement , if need be. | C.3.2.3  Proposal is  sent to  veterinary  school, and  IPC included  in program                                                      | C.3.2.3  Improve IPC  education in  veterinary  school                           | C.3.2.3  Yes/No                                                                                                               | C.3.2.3 Once     | C.3.2.3  Veterinary  school   MOA | C.3.2.3  Check if  proposal sent | C.3.2.3 NA                    |
| C.3.3 IPC- related  educational  modules in  curricula of  three schools  (Agriculture,  Nutrition,  Environment ) | C.3.3.1  Mapping of  IPC in three  university  curricula  (Agriculture,  Nutrition,  Environment )         | C.3.3  IPC module  to be  included in  the three  curricula of  sent from  respective  ministries as  recommenda tion to the  schools | C.3.3  Improve IPC  education in  Agriculture,  Nutrition,  Environment  Schools | C.3.3  Number of  university  programs  that include   IPC  according to  recommenda tion/Total  number of  audited  programs | C.3.3  Once/year | C.3.3  The 3  schools             | C.3.3  Checking                  | C.3.3  In a  superficial  way |
|                                                                                                                    | C.3.3.2                                                                                                    |                                                                                                                                       |                                                                                  |                                                                                                                               |                  |                                   |                                  |                               |

|                                                     |                                                                                | Review  global and  regional  recommenda tions on IPC  in curricula  of  agriculture,  nutrition and  environment,  and  formulate  what should  be included  in them   |                                                                          |                                                                        |                 |               |                   |                   |             |
|-----------------------------------------------------|--------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------|------------------------------------------------------------------------|-----------------|---------------|-------------------|-------------------|-------------|
|                                                     |                                                                                | C.3.3.3  Include the  recommende d tricyclic  AMR and  IPC in  curricula  when not  available                                                                           |                                                                          |                                                                        |                 |               |                   |                   |             |
| C.4  Advanced  IPC training  for IPC  professionals | C.4.1  -Put TOR for  IPC  professionals  in different  healthcare  facilities. | C.4.1.1  Include in  the national  IPC  Guidelines  the TOR of  the  professionals                                                                                      | C.4.1.1  TOR of IPC  professionals  are included  in the IPC  guidelines | C.4.1.1  To  standardize  the work and  follow-up on  the  performance | C.4.1.1  Yes/No | C.4.1.1  Once | C.4.1.1  MOH  WHO | C.4.1.1  Checking | C.4.1.1  NA |

|                                            | -Put  prerequisite  training/expe rience of IPC  physicians,  officers, and  nurses             |                                                                                                                                                                                                             |                                             |                                     |                                                                   |             |                                                                 |                |           |
|--------------------------------------------|-------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------|-------------------------------------|-------------------------------------------------------------------|-------------|-----------------------------------------------------------------|----------------|-----------|
|                                            | C.4.2  Make  training  available and  affordable in  universities  and  professional  societies | C.4.2.1  MOH Sends  letters to  Ministry of  Higher  Education  and to Order  of physicians  explaining  the need and  recommendi ng training  specializatio n  opportunities  and courses  related to  IPC | C.4.2.1  None                               |                                     |                                                                   |             |                                                                 |                |           |
| C.5  National  Process  Indicators in  IPC | C.5.1  Baseline  evaluation of  current  situation at a  national  level                        |                                                                                                                                                                                                             | C.5.1  Results are  posted on  AMR  website | C.5.1  Have a  baseline  evaluation | C.5.1  Percentage  of hospitals  that do have  milestones of  IPC | C.5.1  Once | C.5.1  Hospitals  that are  epidemiologi cally  representativ e | C.5.1  Project | C.5.1  NA |

|                                                      | (research  project) and  make it a  continuous  process                                                                                       |                                                                               |                                                                                            |                                                                                           |                     |                                                                 |                 |           |
|------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------|---------------------|-----------------------------------------------------------------|-----------------|-----------|
|                                                      | C.5.2  National  indicators to  be  incrementall y applied  with time  (hand  hygiene,  PPE,  isolation,  other  standard  precautions,  etc) | C.5.2  Percentage  of hospitals  that report  results of  process  indicators | C.5.2  improve  application  of IPC  principles                                            | C.5.2 For  each process  indicator  5 hospitals  that have a  follow up of  the indicator | C.5.2 Once/3  years | C.5.2  Hospitals  that are  epidemiologi cally  representativ e | C.5.2   Project | C.5.2 NA  |
| C.6  Survey of  Nosocomial  Infections in  hospitals | C.6.1  Conduct a  point  prevalence  study on  nosocomial  infections in  Lebanese  hospitals                                                 | C.6.1   Results of  study  published                                          | C.6.1   To join the  WHO point  prevalence   HAI study,  and  benchmark  with global  data | C.6.1  NA                                                                                 | C.6.1  Once         | C.6.1  Hospitals  MOH                                           | C.6.1  Study    | C.6.1  NA |
| C.7                                                  | C.7.1  Review the  OIE                                                                                                                        | C.7.1  None                                                                   |                                                                                            |                                                                                           |                     |                                                                 |                 |           |

| IPC in the  veterinary  world   | biosafety  recommenda tions                                                              |                                                                                                        |             |
|---------------------------------|------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------|-------------|
|                                 | C.7.2  Check the  availability  in of these  recommenda tions in local  veterinary  laws |                                                                                                        | C.7.2  None |
|                                 | C.7.3  Monitor the  application  of these laws                                           | C.7.3  MOH  recommends  to MOA to  follow up on  the related  activities of  IPC in  Veterinary  world | C.7.3  None |

## Axis D: Antibiotic use

## Strategic plan

| Major objective                                                                         | Activity                                                                                                                                                                                       | Sub-activity               | Date  (operational plan)                                    | Milestone                        |
|-----------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------|-------------------------------------------------------------|----------------------------------|
| D.1 Organization of the  responsibilities for the  execution of the tasks               | D.1.1 Appointment of focal  person n charge of following  up the activities of the  objectives of this axis                                                                                    |                            | D.1.1 three months from  time zero                          | D.1 three months from time  zero |
| D.1 Organization of the  responsibilities for the  execution of the tasks               | D.1.2 Appointment of the  members of the technical  working group along with its  TOR                                                                                                          |                            | D.1.2 three months from  time zero                          | D.1 three months from time  zero |
| D.2  Improve ABX quality  control                                                       | D.2.1  To support and include ABX  as priority drugs in the  pharmacovigilance project  of the Lebanese University  and the adverse drug event  reporting program of the  Order of Pharmacists |                            | D.2.1  One year from time zero                              | D.2  One year from time zero     |
| D.3 Control the use of  critically important  antimicrobial molecules  (CIAM) in humans | D.3.1 Define CIAM                                                                                                                                                                              | D.3.1.1 Literature search  | D.3.1.1 Three months from  time zero                        | D.3 Six months from time  zero   |
|                                                                                         |                                                                                                                                                                                                | D.3.1.2 Formulate the list | D.3.1.2   Six months from time zero                         |                                  |
| D.4 Sentinel Surveillance of  ABX (CIAM) consumption  from a network of hospitals       | D.4.1  Workshops on metrics for  ABX use measurement                                                                                                                                           |                            | D.4.1  Six months from time zero  and 1 year from time zero | D.4  5 years                     |

| and benchmark with  international data                                                          |                                                                            |                                                                                                                                                                                                                                                                                                 |                                                                                      |              |
|-------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------|--------------|
|                                                                                                 | D.4.2  Compilation of data from  hospitals                                 | D.4.2.1  Determine the  epidemiologically  representative sample of  hospitals for surveillance of  ABX                                                                                                                                                                                         | D.4.2.1  three months from time zero                                                 |              |
|                                                                                                 |                                                                            | D.4.2.2  -Validate the measurement  of hospital consumption by  DDD/1000 patient days in a  batch of 4 hospitals per year  -Include the hospitals with  adequate measurements in a  sequential manner into the  surveillance list and data  -Advice to hospitals that  don't have adequate data | D.4.2.2   One year and three months  from time zero and continue  yearly for 5 years |              |
|                                                                                                 |                                                                            | D.4.2.3  Surveillance of ABX use in  Lebanese hospitals by auto  reporting  DDDs                                                                                                                                                                                                                | D.4.2.3  1.5 years from time zero  then yearly for 5 years                           |              |
| D.5 Prepare hospitals and  build their capacity for  Antimicrobial stewardship   (AMS) programs | D.5.1 Workshops on AMS  twice per year                                     |                                                                                                                                                                                                                                                                                                 | D.5.1  Six months from time zero  then yearly for 5 years                            | D.5  5 years |
|                                                                                                 | D.5.2  Preparation and  dissemination of national  treatment guidelines on | D.5.2.1  Put a list of essential  guidelines                                                                                                                                                                                                                                                    | D.5.2.1  six months from time zero                                                   |              |

| infectious diseases to  standardize the strategies of  ABX use based on local  epidemiology   |                                                                                                                                                                                                               |                                                                                |     |
|-----------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------|-----|
|                                                                                               | D.5.2.2  Prepare the missing  guidelines                                                                                                                                                                      | D.5.2.2  Finalize within 1 year from  time zero                                |     |
|                                                                                               | D.5.2.3  Prepare and follow a  schedule for the presentation  of the guidelines in the  respective scientific societies  meeting and for the  endorsement of these  guidelines with the  respective societies | D.5.2.3  Starting 1 year from time  zero and finalized 3 years  from time zero |     |
|                                                                                               | D.5.2.4  Post these guidelines on the                                                                                                                                                                         | D.5.2.4  1.5 years from time zero                                              |     |
| D.5.3  Inclusion of AMS programs  among hospital accreditation  standards                     | AMR/AMS website                                                                                                                                                                                               | D.5.3.1  Three months from time  zero                                          |     |
| during MOH accreditation  with feedback to hospitals.                                         |                                                                                                                                                                                                               | D.5.4  2021 and after each  accreditation audit for 5                          |     |
| D.5.5  Development of AMS  webpage in the MOH  website                                        |                                                                                                                                                                                                               | D.5.5  six months from time zero                                               |     |
|                                                                                               |                                                                                                                                                                                                               | D.6.1                                                                          |     |
| D.6.1                                                                                         |                                                                                                                                                                                                               |                                                                                |     |
| D.5.4                                                                                         |                                                                                                                                                                                                               |                                                                                |     |
| Auditing the AMS practices                                                                    |                                                                                                                                                                                                               |                                                                                |     |
|                                                                                               |                                                                                                                                                                                                               | years                                                                          |     |
|                                                                                               |                                                                                                                                                                                                               |                                                                                | D.6 |

| Organize the dispensing of  antimicrobials in the  community pharmacies                                             | Nominate a task group for  the meeting between MOH  including Dr. W Ammar and  the Order of pharmacists                                                       |                                                                                                                                      | 3 month                                            | 3 months                      |
|---------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------|-------------------------------|
|                                                                                                                     | D.6.2 Meeting between a  high-authority-level task  force and the President of  the Order of Pharmacists to  agree over a plan to restrict  dispensing of ABX |                                                                                                                                      | D.6.2 To be finalized 3  months from time zero     |                               |
| D.7 Control and regulate the  use of ABX in the  veterinary, agriculture, food  production and environment  sectors | D.7.1 Banning importation  and use of CIAM in the  veterinary field                                                                                           | D.7.1.1 The CIAM list will  be sent to the minister to ban  their importation for  veterinary use                                    | D.7.1.1   Will be sent nine months  from time zero | D.7 Two years from time  zero |
|                                                                                                                     |                                                                                                                                                               | D.7.1.2 The veterinary drug  office will not import these  agents                                                                    | D.7.1.2 one year from time  zero                   |                               |
|                                                                                                                     | D.7.2 Check if CIAM are  used in agriculture and  environment                                                                                                 | D.7.2.1  -Review the list of drugs and  pesticides officially  imported in agriculture.   -Check if CIAM are  included in this list. | D.7.2.1 nine months from  time zero                |                               |
|                                                                                                                     |                                                                                                                                                               | D.7.2.2 Check if any of  these molecules are used in  agriculture or environment  from outside the official  import channel.         | D.7.2.2 two years from time  zero                  |                               |
|                                                                                                                     |                                                                                                                                                               | D.7.2.3 Get results of ABX  residues in food items being  done in Lebanon                                                            | D.7.2.3 three months from  time zero               |                               |

| D.7.3 Surveillance of  importation of regularly used  ABX to Lebanon   | D.7.3.1 Form a registry of  imported ABX in veterinary  world                                            | D.7.3.1 Six months from  time zero           |
|------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------|----------------------------------------------|
| D.7.4  Research study about ABX  consumption                           | D.7 4.1  Research project by one of  Masters Student at Beirut  Arab University (BAU)                    | D.7 4.1  starting at time zero for one  year |
|                                                                        | D.7 4.2  Research project in  Agriculture school (Quantify  the use of ABX in poultry  farms nationally) | D.7 4.2  Two years from time zero            |
| D.7.5 Research study about  unofficial importation of  ABX to Lebanon  | D.7.5 Research project in  Agriculture school                                                            | D.7.5 Two years from time  zero              |

## Operational plan and budget

| Major  objective                                                              | Activity                                                                                                           | Sub- activity   | Unit          | Quantity   | Date                                 | Location   | Responsibl e  Entity                                                                                          | Cost       | Source  Of  Funding   | Indicator                                  |
|-------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------|-----------------|---------------|------------|--------------------------------------|------------|---------------------------------------------------------------------------------------------------------------|------------|-----------------------|--------------------------------------------|
| D.1  Organizatio n of the  responsibili ties for the  execution  of the tasks | D.1.1  Appointme nt of focal  person n  charge of  following  up the  activities of  the  objectives  of this axis |                 | D.1.1  Letter | D.1.1 One  | D.1.1 three  months  from time  zero | D.1.1  MOH | D.1.1  -WHO- National  Professiona l Officer  (Dr. A  Rady)  -MOH-  General  Director  (Dr. W                 | D.1.1 None | D.1.1 None            | D.1.1  Focal  person  nominated            |
|                                                                               | D.1.2  Appointme nt of the  members of  the  technical  working  group  along with  its TOR                        |                 | D.1.2  Letter | D.1.2 One  | D.1.2 three  months  from time  zero | D.1.2  MOH | Ammar)  D.1.2  -WHO- National  Professiona l Officer  (Dr. A  Rady)  -MOH-  General  Director  (Dr. W  Ammar) | D.1.2 None | D.1.2 None            | D.1.2  Technical  working  group  assigned |

| D.2  Improve  ABX  quality  control                                                          | D.2.1  To support  and include  ABX as  priority  drugs in the  pharmacovi gilance  project of  the  Lebanese  University  and the  adverse  drug event  reporting  program of  the Order  of  Pharmacist s   |                             | D.2.1  Network   | D.2.1  One   | D.2.1  One year  from time  zero        | D.2.1  MOH   | D.2.1  -MOH- Head of  Preventive  Medicine  and  Communic able  Diseases  Dpts (Dr. A  Berry)  -MOH- Quality  Assurance  of  Pharmaceut ical  Products  Program  Director  (Dr. R   | D.2.1   None   | D.2.1   None   | D.2.1  Number of  generic  antibiotics  that are  tested by  the  pharmacovi gilance  programs   |
|----------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------|------------------|--------------|-----------------------------------------|--------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------|----------------|--------------------------------------------------------------------------------------------------|
| D.3 Control  the use of  critically  important  antimicrobi al  molecules  (CIAM) in  humans | D.3.1  Define  CIAM                                                                                                                                                                                           | D.3.1.1  Literature  search | D.3.1.1  List    | D.3.1.1  One | D.3.1.1  Three  months  from time  zero | D.3.1.1  MOA | D.3.1.1   -Private  sector,  WHO  consultant,  former  LSIDCM  president                                                                                                            | D.3.1.1  None  | D.3.1.1  None  | D.3.1  List of  CIAM  posted on  AMR/AMS  website                                                |

<!-- image -->

|                                                                  |                                                          |                              |                                  |              |                                                                |                                                                              | (Dr. R  Moghnieh)                                                                                                                                                                                  |                                    |                   |                                                       |
|------------------------------------------------------------------|----------------------------------------------------------|------------------------------|----------------------------------|--------------|----------------------------------------------------------------|------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------|-------------------|-------------------------------------------------------|
|                                                                  |                                                          | D.3.1.2  Formulate  the list | D.3.1.2  National  list of  CIAM | D.3.1.2  One | D.3.1.2   Six months  from time  zero                          | D.3.1.2 - MOH  -MOA                                                          | D.3.1.2   -MOA- Head of  Animal  Health  Service  (Dr. B  Bazzal)  -Private  sector,  WHO  consultant,  former  LSIDCM  president  (Dr. R  Moghnieh)  -Private  sector (Dr  S. Kanj, Dr  G. Matar) | D.3.1.2  2,000 USD                 | D.3.1.2  AMR Fund |                                                       |
| D.4  Sentinel  Surveillanc e of ABX  (CIAM)  consumptio n from a | D.4.1  Workshops  on metrics  for ABX  use  measureme nt |                              | D.4.1  Workshops                 | D.4.1  Six   | D.4.1  Six months  from time  zero and 1  year from  time zero | D.4.1  2 in Beirut,  1 in Bekaa,  1 in the  North, 1 in  the South  and 1 in | D.4.1  Focal  person                                                                                                                                                                               | D.4.1  20,000  USD  (6  workshops) | D.4.1  AMR fund   | D.4.1  Percentage  of hospitals  that sent  attendees |

| network of  hospitals  and  benchmark  with  internationa l data   |                                              |                                                                                                              |                                                                      |                                       |                                                                                           | Mount  Lebanon      |                                                                                                                            |                                                        |                   |                                 |
|--------------------------------------------------------------------|----------------------------------------------|--------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------|---------------------------------------|-------------------------------------------------------------------------------------------|---------------------|----------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------|-------------------|---------------------------------|
|                                                                    | D.4.2  Compilatio n of data  from  hospitals | D.4.2.1  Determine  the  epidemiolo gically  representati ve sample  of hospitals  for  surveillanc e of ABX | D.4.2.1  List                                                        | D.4.2.1  One                          | D.4.2.1  three  months  from time  zero                                                   | D.4.2.1  MOH        | D.4.2.1  -MOH-  Head of  pharmacy  service (Dr.  C Reaydi)  -MOH- Head of  Epidemiolo gical  Surveillanc e Program  (Dr. N | D.4.2.1  None                                          | D.4.2.1  None     | D.4.2.1  The list is  available |
|                                                                    |                                              | D.4.2.2  -Validate  the  measureme nt of  hospital  consumptio n by  DDD/1000  patient                       | D.4.2.2  Hospital  data  assessment  4 times per  year over 5  years | D.4.2.2  Four per  year over 5  years | D.4.2.2   One year  and three  months  from time  zero and  continue  yearly for 5  years | D.4.2.2  -MOH  -WHO | D.4.2.2  AMS  expert                                                                                                       | D.4.2.2  1,000 USD  per year for  5 years =  5,000 USD | D.4.2.2  AMR fund | D.4.2.2  None                   |

| days in a  batch of 4  hospitals  per year  -Include  the  hospitals  with  adequate  measureme nts in a  sequential  manner  into the  surveillanc e list and  data  -Advice to  hospitals  that don't  have  adequate  data   |                 |                         |                                                               |                     |                                                                           |               |               |                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------|-------------------------|---------------------------------------------------------------|---------------------|---------------------------------------------------------------------------|---------------|---------------|-----------------------------------------------------------------|
| D.4.2.3  Surveillanc e of ABX  use in  Lebanese  hospitals  by auto  reporting  DDDs                                                                                                                                            | D.4.2.3  Report | D.4.2.3  Once per  year | D.4.2.3  1.5 years  from time  zero then  yearly for 5  years | D.4.2.3  -MOH  -WHO | D.4.2.3  -MOH-  Head of  pharmacy  service (Dr.  C Reaydi)  -MOH- Head of | D.4.2.3  None | D.4.2.3  None | D.4.2.3  Report on  ABX use  for  2019/2020  posted on  website |

|                                                                                                       |                                                                                                                       |                                               |                   |                                    |                                                              |                            | Epidemiolo gical  Surveillanc e Program  (Dr. N  Ghosn)                                                                    |                                         |                   |                                                                                      |
|-------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------|-----------------------------------------------|-------------------|------------------------------------|--------------------------------------------------------------|----------------------------|----------------------------------------------------------------------------------------------------------------------------|-----------------------------------------|-------------------|--------------------------------------------------------------------------------------|
| D.5 Prepare  hospitals  and build  their  capacity for  Antimicrob ial  stewardship   (AMS)  programs | D.5.1  Workshops  on AMS  twice per  year                                                                             |                                               | D.5.1   Workshops | D.5.1 two  per year  over 5  years | D.5.1  Six months  from time  zero then  yearly for 5  years | D.5.1  -MOH  -WHO  -LSIDCM | D.5.1   -Private  sector, (Dr.  S Kanj)  -Private  sector,  WHO  consultant,  former  LSIDCM  president  (Dr. R  Moghnieh) | D.5.1   4,000 USD   *2= 8,000  USD/year | D.5.1 AMR  fund   | D.5.1  Number of  workshops  on AMS  per year                                        |
|                                                                                                       | D.5.2  Preparation  and  disseminati on of  national  treatment  guidelines  on  infectious  diseases to  standardize | D.5.2.1  Put a list of  essential  guidelines | D.5.2.1  List     | D.5.2.1  One                       | D.5.2.1  six months  from time  zero                         | D.5.2.1  -WHO  -LSIDCM     | D.5.2.1  -Private  sector, (Dr.  S Kanj)  -Private  sector,  WHO  consultant  (Dr. A  Bizri, Dr. J  Mokhbat)               | D.5.2.1  2-3  guidelines  3,500 USD     | D.5.2.1  AMR fund | D.5.2.1  D.5.2.2  Number of  guidelines  published  and posted  on  AMR/AMS  website |

| the  strategies  of ABX use  based on  local  epidemiolo gy   |                                                                                                                                                                                                   |                   |              |                                                                                    |                        |                                                                             |                                                                  |                   |                                                                                      |
|---------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------|--------------|------------------------------------------------------------------------------------|------------------------|-----------------------------------------------------------------------------|------------------------------------------------------------------|-------------------|--------------------------------------------------------------------------------------|
|                                                               | D.5.2.2  Prepare the  missing  guidelines                                                                                                                                                         | D.5.2.2  List     | D.5.2.2  One | D.5.2.2  Finalize  within 1  year from  time zero                                  | D.5.2.2  -WHO  -LSIDCM | D.5.2.2  Focal  person will  distribute  the tasks  according  to the list. | D.5.2.2  Included in  D.5.2.1                                    | D.5.2.2  AMR fund |                                                                                      |
|                                                               | D.5.2.3  Prepare and  follow a  schedule  for the  presentatio n of the  guidelines  in the  respective  scientific  societies  meeting  and for the  endorseme nt of these  guidelines  with the | D.5.2.3  Schedule | D.5.2.3  One | D.5.2.3  Starting 1  year from  time zero  and  finalized 3  years from  time zero | D.5.2.3  MOH           | D.5.2.3  -Focal  person  -LSIDCM  president  (Dr. Z  Helou)                 | D.5.2.3  Workshops  3 times per  year (1,200  USD per  workshop) | D.5.2.3  AMR fund | D.5.2.3  Percentage  of  guidelines  endorsed  by  respective  scientific  societies |

|                                                                               | respective  societies                                     |                                            |                                 |                                                                |              |                                                                                                                                           |               |               |                                                                         |
|-------------------------------------------------------------------------------|-----------------------------------------------------------|--------------------------------------------|---------------------------------|----------------------------------------------------------------|--------------|-------------------------------------------------------------------------------------------------------------------------------------------|---------------|---------------|-------------------------------------------------------------------------|
|                                                                               | D.5.2.4  Post these  guidelines  on the  AMR/AMS  website | D.5.2.4  Guidelines                        | D.5.2.4  to be  assigned  later | D.5.2.4  1.5 years  from time  zero                            | D.5.2.4  MOH | D.5.2.4  -Focal  person  -IT  consultant                                                                                                  | D.5.2.4  None | D.5.2.4  None | D.5.2.4  Number of  guidelines  posted on  AMR/AMS  website.            |
| D.5.3  Inclusion  of AMS  programs  among  hospital  accreditatio n standards |                                                           | D.5.3.1  AMS  checklist in  accreditatio n | D.5.3.1  One                    | D.5.3.1  Three  months  from time  zero                        | D.5.3.1  MOH | D.5.3.1  -Private  sector,  WHO  consultant,  former  LSIDCM  president  (Dr. R  Moghnieh)  -MOH- Project  Coordinato r  (Eng. S  Akkoum) | D.5.3.1  None | D.5.3.1  None | D.5.3.1  AMS and  its checklist  available in  accreditatio n standards |
| D.5.4  Auditing  the AMS  practices  during  MOH  accreditatio                |                                                           | D.5.4  Report                              | D.5.4  One                      | D.5.4  2021 and  after each  accreditatio n audit for  5 years | D.5.4  MOH   | D.5.4  MOH  accreditatio n team                                                                                                           | D.5.4  None   | D.5.4  None   | D.5.4  Number of  feedback  given/num ber of  hospitals                 |

|                                                                                   | n with  feedback to  hospitals.                                                                                        |                        |            |                                                   |                                       |                                                                                     |                  |                 |                                                   |
|-----------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------|------------------------|------------|---------------------------------------------------|---------------------------------------|-------------------------------------------------------------------------------------|------------------|-----------------|---------------------------------------------------|
|                                                                                   | D.5.5  Developme nt of AMS  webpage in  the MOH  website                                                               | D.5.5  AMS on  website | D.5.5  One | D.5.5  six months  from time  zero                | D.5.5  -MOH  -MOA                     | D.5.5  IT  consultant                                                               | D.5.5  5,000 USD | D.5.5  AMR fund | D.5.5  AMS  section  present on  AMR/MO H website |
| D.6  Organize  the  dispensing  of  antimicrobi als in the  community  pharmacies | D.6.1  Nominate a  task group  for the  meeting  between  MOH  including  Dr. W  Ammar and  the Order  of  pharmacists | D.6.1  Group           | D.6.1  1   | D.6.1  3 months                                   | D.6.1  MOH                            | D.6.1  Technical  working  group                                                    | D.6.1  None      | D.6.1  None     | D.6.1  None                                       |
|                                                                                   | D.6.2  Meeting  between a  high- authority- level task  force and  the  President  of the                              | D.6.2  Meeting         | D.6.2 One  | D.6.2 To be  finalized 3  months  from time  zero | D.6.2   -MOH  -Order of  Pharmacist s | D.6.2   -MOH-  Head of  pharmacy  service (Dr.  C Reaydi)  -MOH-  General  Director | D.6.2 None       | D.6.2 None      | D.6.2  Agenda for  collaborati on put             |

|                                                                                                      | Order of  Pharmacist s to agree  over a plan  to restrict  dispensing  of ABX   |                                                                                                         |                 |              |                                                       |              | (Dr. W  Ammar)  -Private  sector,  WHO  consultant,  former  LSIDCM  president  (Dr. R  Moghnieh)  - MOH-  Director of  Public  Relations  & Health  Education  Dpts (Dr. R  Hamra)   |                  |                 |                                                   |
|------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------|-----------------|--------------|-------------------------------------------------------|--------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------|-----------------|---------------------------------------------------|
| D.7 Control  and  regulate the  use of ABX  in the  veterinary,  agriculture,  food  production  and | D.7.1  Banning  importation  and use of  CIAM in  the  veterinary  field        | D.7.1.1 The  CIAM list  will be sent  to the  minister to  ban their  importation  for  veterinary  use | D.7.1.1  Letter | D.7.1.1  One | D.7.1.1   Will be  sent nine  months  from time  zero | D.7.1.1  MOA | D.7.1   -MOA- Head of  Animal  Health  Service  (Dr. B  Bazzal)                                                                                                                       | D.7.1 3,000  USD | D.7.1 AMR  fund | D.7.1 DDD  of CIAM  molecules  imported  per year |

| environmen t sectors   |                                                                    |                                                                                                                                            |               |              |                                        |              | -FAO  representati ve                                           |                  |                 |                                                                                  |
|------------------------|--------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------|---------------|--------------|----------------------------------------|--------------|-----------------------------------------------------------------|------------------|-----------------|----------------------------------------------------------------------------------|
|                        |                                                                    | D.7.1.2 The  veterinary  drug office  will not  import  these  agents                                                                      | D.7.1.2  Memo | D.7.1.2  One | D.7.1.2 one  year from  time zero      | D.7.1.2  MOA |                                                                 |                  |                 |                                                                                  |
|                        | D.7.2  Check if  CIAM are  used in  agriculture  and  environmen t | D.7.2.1  -Review  the list of  drugs and  pesticides  officially  imported in  agriculture.   -Check if  CIAM are  included in  this list. | D.7.2.1  List | D.7.2.1  One | D.7.2.1  nine  months  from time  zero | D.7.2.1  MOA | D.7.2  -MOA- Head of  Poultry  Husbandry  Dpt (Eng.  A Sirawan) | D.7.2 1,000  USD | D.7.2 AMR  fund | D.7.2.1  Report on  antimicrobi als  officially  imported  for  agriculture  use |
|                        |                                                                    | D.7.2.2  Check if  any of  these  molecules  are used in  agriculture  or  environmen t from                                               | D.7.2.2  List | D.7.2.2  One | D.7.2.2 two  years from  time zero     | D.7.2.2  MOA |                                                                 |                  |                 | D.7.2.2  None                                                                    |

|                                                                          | outside the  official  import  channel.                                                    |                   |              |                                                |                      |                                                                                                  |                                             |               |                                                                              |
|--------------------------------------------------------------------------|--------------------------------------------------------------------------------------------|-------------------|--------------|------------------------------------------------|----------------------|--------------------------------------------------------------------------------------------------|---------------------------------------------|---------------|------------------------------------------------------------------------------|
|                                                                          | D.7.2.3 Get  results of  ABX  residues in  food items  being done  in Lebanon              | D.7.2.3  Report   | D.7.2.3  One | D.7.2.3  three  months  from time  zero        | D.7.2.3  MOA         | D.7.2.3   -MOA- Head of  Animal  Health  Service  (Dr. B  Bazzal)                                | D.7.2.3  None                               | D.7.2.3  None | D.7.2.3  None                                                                |
| D.7.3  Surveillanc e of  importation  of regularly  used ABX  to Lebanon | D.7.3.1  Form a  registry of  imported  ABX in  veterinary  world                          | D.7.3.1  Registry | D.7.3.1  One | D.7.3.1 Six  months  from time  zero           | D.7.3.1  MOA         | D.7.3.1   -MOA- Head of  Animal  Health  Service  (Dr. B  Bazzal)                                | D.7.3.1  None                               | D.7.3.1  None | D.7.3.1  Presence of  annual data  of imported  veterinary  ABX on  registry |
| D.7.4  Research  study about  ABX  consumptio n                          | D.7 4.1  Research  project by  one of  Masters  Student at  Beirut Arab  University  (BAU) | D.7 4.1  Project  | D.7 4.1  One | D.7 4.1  starting at  time zero  for one  year | D.7 4.1  -BAU   -MOA | D.7 4.1  -BAU- coordinator  of Masters  degree in  Food  Safety and  Analysis  (Dr .N El  Darra) | D.7 4.1  None  (Human  resources  from BAU) | D.7 4.1  None | D.7 4.1  None                                                                |

|                                                                                                                |                  |              |                                     |                                                      | -Private  sector,  WHO  consultant,  former  LSIDCM  president  (Dr. R  Moghnieh)  -MOA- Head of  Animal  Health  Service  (Dr. B  Bazzal)   |                            |                        |                                                                  |
|----------------------------------------------------------------------------------------------------------------|------------------|--------------|-------------------------------------|------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------|----------------------------|------------------------|------------------------------------------------------------------|
| D.7 4.2  Research  project in  Agriculture  school  (Quantify  the use of  ABX in  poultry  farms  nationally) | D.7 4.2  Project | D.7 4.2  One | D.7 4.2  Two years  from time  zero | D.7 4.2  -MOA  - Agriculture  school  (AUB)  -LSIDCM | D.7 4.2  -LSIDCM  Member  -AUB-Dpt  of  Agriculture  (Dr. M  Farran)  -MOA- Head of  Poultry  Husbandry                                      | D.7 4.2  None (man  power) | D.7 4.2  AUB  Research | D.7 4.2  Report on  the national  use of  ABX in  poultry  farms |

|                                                                           |                                                  |                |           |                                  |                                            | Dpt (Eng.  A Sirawan)                            |                          |                     |                                                                                 |
|---------------------------------------------------------------------------|--------------------------------------------------|----------------|-----------|----------------------------------|--------------------------------------------|--------------------------------------------------|--------------------------|---------------------|---------------------------------------------------------------------------------|
| D.7.5  Research  study about  unofficial  importation  of ABX to  Lebanon | D.7.5  Research  project in  Agriculture  school | D.7.5  Project | D.7.5 One | D.7.5 Two  years from  time zero | D.7.5   -MOA  - Agriculture  school  (AUB) | D.7.5  AUB-Dpt  of  Agriculture  (Dr. M  Farran) | D.7.5 None  (man  power) | D.7.5 AUB  Research | D.7.5  Report on  the  unofficial  ABX  importation  used in  veterinary  world |

## Monitoring and evaluation plan

| Major  objective                                                              | Activity                                                                                                          | Sub-activity   | Indicator                                                                                     | Purpose                                                                                       | Calculation                                            | Frequency  of Data  collection   | Data   Source       | Method         | Baseline   |
|-------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------|----------------|-----------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------|--------------------------------------------------------|----------------------------------|---------------------|----------------|------------|
| D.1  Organization  of the  responsibiliti es for the  execution of  the tasks | D.1.1  Appointment  of focal  person n  charge of  following up  the activities  of the  objectives of  this axis |                | D.1.1  Focal person  nominated                                                                | D.1 Follow  up of  activities and  to be in  charge of  some of  them                         | D.1 Yes/No                                             | D.1 Once/5  years                | D.1   MOH  WHO      | D.1 Letter     | D.1 NA     |
|                                                                               | D.1.2  Appointment  of the  members of  the technical  working  group along  with its TOR                         |                | D.1.2  Technical  working  group  assigned                                                    |                                                                                               |                                                        |                                  |                     |                |            |
| D.2  Improve  ABX quality  control                                            | D.2.1  To support  and include  ABX as  priority  drugs in the  pharmacovig ilance  project of the                |                | D.2.1  Number of  generic  antibiotics  that are  tested by the  pharmacovig ilance  programs | D.2.1  Evaluate  post- marketing  efficacy and  safety of  generic ABX  that are  licensed by | D.2.1  No of reports  /month  (Including  Zero report) | D.2.1  Once/5 years              | D.2.1  AMS  website | D.2.1  Network | D.2.1  NA  |

|                                                                                                                                  | Lebanese  University  and the  adverse drug  event  reporting  program of  the Order of  Pharmacists   |                              |                                                       | MOH and  used in  Lebanon                              |                                                                                        |                     |                           |                 |           |
|----------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------|------------------------------|-------------------------------------------------------|--------------------------------------------------------|----------------------------------------------------------------------------------------|---------------------|---------------------------|-----------------|-----------|
| D.3 Control  the use of  critically  important  antimicrobial  molecules  (CIAM) in  humans                                      | D.3.1 Define  CIAM                                                                                     | D.3.1.1  Literature  search  | D.3.1  List of  CIAM  posted on  AMR/AMS  website     | D.3.1  Make sure it  is prepared  and accessed  by all | D.3.1  Yes/No                                                                          | D.3.1  Once/5 years | D.3.1  Literature  search | D.3.1 Search    | D.3.1 NA  |
|                                                                                                                                  |                                                                                                        | D.3.1.2  Formulate  the list |                                                       |                                                        |                                                                                        |                     |                           |                 |           |
| D.4 Sentinel  Surveillance  of ABX  (CIAM)  consumption  from a  network of  hospitals and  benchmark  with  international  data | D.4.1  Workshops  on metrics  for ABX use  measurement                                                 |                              | D.4.1  Percentage  of hospitals  that sent  attendees | D.4.1  To  standardize  measurement  in Lebanon        | D.4.1  Number of  hospitals that  sent  attendees/  number of  invited  hospitals*10 0 | D.4.1  Once/5 years | D.4.1  Workshop           | D.4.1  Workshop | D.4.1  NA |

| D.4.2  Compilation  of data from  hospitals   | D.4.2.1  Determine  the  epidemiologi cally  representativ e sample of  hospitals for  surveillance  of ABX                                                                                                                                             | D.4.2.1  The list is  available   | D.4.2.1  Establish  epidemiologi cally  representativ e  surveillance  of AMR   | D.4.2.1  Yes/No   | D.4.2.1  Once/5 years   | D.4.2.1  -MOH  -ESU   | D.4.2.1  Epidemiolog ic sampling   | D.4.2.1  NA   |
|-----------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------|---------------------------------------------------------------------------------|-------------------|-------------------------|-----------------------|------------------------------------|---------------|
|                                               | D.4.2.2  -Validate the  measurement  of hospital  consumption  by  DDD/1000  patient days  in a batch of  4 hospitals  per year  -Include the  hospitals  with  adequate  measurement s in a  sequential  manner into  the  surveillance  list and data | D.4.2.2  None                     |                                                                                 |                   |                         |                       |                                    |               |

|                                                                                                     |                                                                                           | -Advice to  hospitals that  don't have  adequate  data                              |                                                                    |                                                                                                          |                                                                    |                                |                                                                             |                                                           |                                                                          |
|-----------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------|--------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------|--------------------------------|-----------------------------------------------------------------------------|-----------------------------------------------------------|--------------------------------------------------------------------------|
|                                                                                                     |                                                                                           | D.4.2.3  Surveillance  of ABX use  in Lebanese  hospitals by  auto  reporting  DDDs | D.4.2.3  Report on  ABX use for  2019/2020  posted on  website     | D.4.2.3  -Baseline  evaluation  and follow  up  -In  preparation  for national  outcome  AMS  indicators | D.4.2.3  Yes /No                                                   | D.4.2.3  June every  year      | D.4.2.3  Lebanese  hospitals                                                | D.4.2.3  Compilation  of results  from  hospital  reports | D.4.2.3  NA                                                              |
| D.5 Prepare  hospitals and  build their  capacity for  Antimicrobia l stewardship   (AMS)  programs | D.5.1  Workshops  on AMS  twice per  year                                                 |                                                                                     | D.5.1  Number of  workshops  on AMS per  year                      | D.5.1  Standardizati on of AMS  and follow  up of  indicators.                                           | D.5.1  Number of  workshops  twice per  year                       | D.5.1 Yearly                   | D.5.1 AMS  focal person                                                     | D.5.1  Workshop                                           | D.5.1  Sporadic  availability                                            |
|                                                                                                     | D.5.2  Preparation  and  disseminatio n of national  treatment  guidelines  on infectious | D.5.2.1  Put a list of  essential  guidelines                                       | D.5.2.1  D.5.2.2  Number of  guidelines  published  and posted  on | D.5.2.1  D.5.2.2  Standardize  ABX  prescription  habits  among  professionals                           | D.5.2.1  D.5.2.2  Number of  guidelines  published  and posted  on | D.5.2.1  D.5.2.2  Once/5 years | D.5.2.1  D.5.2.2  International  guidelines  plus local  epidemiolog y from | D.5.2.1  D.5.2.2  Writing                                 | D.5.2.1  D.5.2.2  The  available  national  guidelines  are in  complete |

| diseases to  standardize  the strategies  of ABX use  based on  local  epidemiolog y   |                                                                                                                                                                                                                          | AMR/AMS  website                                                                   |                                                                        |                       | surveillance  reports          |                                        |             |
|----------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------|------------------------------------------------------------------------|-----------------------|--------------------------------|----------------------------------------|-------------|
|                                                                                        | D.5.2.2  Prepare the  missing  guidelines                                                                                                                                                                                |                                                                                    |                                                                        |                       |                                |                                        |             |
|                                                                                        | D.5.2.3  Prepare and  follow a  schedule for  the  presentation  of the  guidelines in  the  respective  scientific  societies  meeting and  for the  endorsement  of these  guidelines  with the  respective  societies | D.5.2.3  Percentage  of guidelines  endorsed by  respective  scientific  societies | D.5.2.3  Improve  application  of these  guidelines  by  professionals | D.5.2.3  Once/5 years | D.5.2.3  Scientific  societies | D.5.2.3  Meetings  Lectures  Workshops | D.5.2.3  NA |

|                                                                                               | D.5.2.4  Post these  guidelines  on the  AMR/AMS  website   | D.5.2.4  Number of  guidelines  posted on  AMR/AMS  website.            | D.5.2.4  Improve the  visibility of  these  guidelines                                     | D.5.2.4  Yes/No                                                                  | D.5.2.4  Once/5 years  reviewing  and updating  guidelines if  needed          | D.5.2.4  AMS   Website                         | D.5.2.4  Posting on  MOH  website   | D.5.2.4  NA   |
|-----------------------------------------------------------------------------------------------|-------------------------------------------------------------|-------------------------------------------------------------------------|--------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------|--------------------------------------------------------------------------------|------------------------------------------------|-------------------------------------|---------------|
| D.5.3  Inclusion of  AMS  programs  among  hospital  accreditation  standards                 |                                                             | D.5.3.1  AMS and its  checklist  available in  accreditation  standards | D.5.3.1  Standardizati on                                                                  | D.5.3.1  Yes /No                                                                 | D.5.3.1  Once/5 years                                                          | D.5.3.1  Accreditatio n standards              | D.5.3.1  Checking                   | D.5.3.1  NA   |
| D.5.4  Auditing the  AMS  practices  during MOH  accreditation  with  feedback to  hospitals. |                                                             | D.5.4  Number of  feedback  given/numbe r of hospitals                  | D.5.4  Improve  AMS work  in hospitals                                                     | D.5.4  Number of  feedback  given/numbe r of  hospitals*10 0                     | D.5.4  Every 3  years  depending  on the  frequency of  accreditation  renewal | D.5.4  Accreditatio n audit  results  analysis | D.5.4  data analysis  and report    | D.5.4  NA     |
| D.5.5  Developmen t of AMS  webpage in  the MOH  website                                      |                                                             | D.5.5  AMS section  present on  AMR/MOH  website                        | D.5.5  Improve  visibility of  AMS and  make  guidelines  available to  all  professionals | D.5.5  -Yes/No  -Report of  anonymous  hospitals  -National  indicators  results | D.5.5  -Once/5  years  -Yearly  reports                                        | D.5.5  MOH  Website                            | D.5.5  Checking                     | D.5.5  NA     |

| D.6  Organize the  dispensing  of  antimicrobial s in the  community  pharmacies   | D.6.1  Nominate a  task group  for the  meeting  between  MOH  including Dr.  W Ammar  and the  Order of  pharmacists                                                  |                                                           | D.6.1  None                                       |                                                                                                                    |                                                                |                                              |                                |                                      |                                                                                                   |
|------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------|---------------------------------------------------|--------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------|----------------------------------------------|--------------------------------|--------------------------------------|---------------------------------------------------------------------------------------------------|
|                                                                                    | D.6.2  Meeting  between a  high- authority- level task  force and the  President of  the Order of  Pharmacists  to agree over  a plan to  restrict  dispensing  of ABX |                                                           | D.6.2  Agenda for  collaboration  put             | D.6.2  Discuss and  put a plan  that is  acceptable  by  pharmacists  about  dispensing  of ABX  over-the- counter | D.6.2  Minutes of  meeting and  activities  added to the  plan | D.6.2  Once                                  | D.6.2  Meeting                 | D.6.2  Meeting                       | D.6.2  Previous  work with  pharmacists  at lower  levels that  did not lead  to official  action |
| D.7 Control  and regulate  the use of  ABX in the  veterinary,                     | D.7.1  Banning  importation  and use of  CIAM in the                                                                                                                   | D.7.1.1 The  CIAM list  will be sent  to the  minister to | D.7.1 DDD  of CIAM  molecules  imported per  year | D.7.1  Establish  baseline and  follow up of  the quantity                                                         | D.7.1 Report  on 2017 and  2018 data                           | D.7.1 Once  for  2017/2018  then every  year | D.7.1  Veterinary  drug office | D.7.1  Research  project for 1  year | D.7.1 NA                                                                                          |

| agriculture,  food  production  and  environment  sectors   | veterinary  field                                                | ban their  importation  for  veterinary  use                                                                                               |                                                                                | and type of  ABX used in  the country  per year.               | Veterinary  ABX  registry  available and  yearly report  posted on  AMR  website   |                    |              |                                        |            |
|-------------------------------------------------------------|------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------|----------------------------------------------------------------|------------------------------------------------------------------------------------|--------------------|--------------|----------------------------------------|------------|
|                                                             |                                                                  | D.7.1.2 The  veterinary  drug office  will not  import these  agents                                                                       |                                                                                |                                                                |                                                                                    |                    |              |                                        |            |
|                                                             | D.7.2 Check  if CIAM are  used in  agriculture  and  environment | D.7.2.1  -Review the  list of drugs  and  pesticides  officially  imported in  agriculture.   -Check if  CIAM are  included in  this list. | D.7.2.1  Report on  antimicrobial s officially  imported for  agriculture  use | D.7.2.1 To  check the  extent of the  use CIAM in  agriculture | D.7.2.1  Report                                                                    | D.7.2.1  Once/year | D.7.2.1  MOA | D.7.2.1  Research  project for 1  year | D.7.2.1 NA |
|                                                             |                                                                  | D.7.2.2  Check if any  of these  molecules  are used in  agriculture                                                                       | D.7.2.2  None                                                                  |                                                                |                                                                                    |                    |              |                                        |            |

|                                                                          | or  environment  from outside  the official  import  channel.                              |                                                                              |                                                                                 |                 |                          |                                  |                     |            |
|--------------------------------------------------------------------------|--------------------------------------------------------------------------------------------|------------------------------------------------------------------------------|---------------------------------------------------------------------------------|-----------------|--------------------------|----------------------------------|---------------------|------------|
|                                                                          | D.7.2.3 Get  results of  ABX  residues in  food items  being done  in Lebanon              | D.7.2.3  None                                                                |                                                                                 |                 |                          |                                  |                     |            |
| D.7.3  Surveillance  of  importation  of regularly  used ABX to  Lebanon | D.7.3.1  Form a  registry of  imported  ABX in  veterinary  world                          | D.7.3.1  Presence of  annual data  of imported  veterinary  ABX on  registry | D.7.3.1  Yearly report  of imported  ABX in  veterinary  world on  AMR  website | D.7.3.1  Yes/No | D.7.3.1  Yearly  report. | D.7.3.1  Veterinary  drug office | D D.7.3.1  Registry | D.7.3.1 NA |
| D.7.4  Research  study about  ABX  consumption                           | D.7 4.1  Research  project by  one of  Masters  Student at  Beirut Arab  University  (BAU) | D.7 4.1  None                                                                |                                                                                 |                 |                          |                                  |                     |            |
|                                                                          | D.7 4.2                                                                                    | D.7 4.2                                                                      | D.7 4.2                                                                         | D.7 4.2  Yes/No | D.7 4.2  Once            | D.7 4.2                          | D.7 4.2  Project    | D.7 4.2    |

|                                                                           | Research  project in  Agriculture  school  (Quantify  the use of  ABX in  poultry  farms  nationally)   | Report on  the national  use of ABX  in poultry  farms                         | Determine  baseline  ABX use in  poultry in  Lebanon.               |               |            | Poultry  farms                |                         | Partially  available not  standardized  surveillance   |
|---------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------|---------------------------------------------------------------------|---------------|------------|-------------------------------|-------------------------|--------------------------------------------------------|
| D.7.5  Research  study about  unofficial  importation  of ABX to  Lebanon | D.7.5  Research  project in  Agriculture  school                                                        | D.7.5 Report  on the  unofficial  ABX  importation  used in  veterinary  world | D.7.5  Evaluate the  ABX  purchases  outside the  official  routing | D.7.5  Yes/No | D.7.5 Once | D.7.5  Veterinary  pharmacies | D.7.5  Market  research | D.7.5 NA                                               |

## Axis E: Budget Planning and Fund Attraction

The plan for economic sustainability was replaced mainly by a plan for budget preparation and preparation of the ground for fund raising for the execution of the NAP.

## Strategic plan

| Objective                                                                 | Activity                                                                                                 | Sub-activity                                                                  | Date (from operational  plan)        | Mile stone                        |
|---------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------|--------------------------------------|-----------------------------------|
| E.0 Organization of the  responsibilities for the  execution of the tasks | E.0.1 Nominate a focal  person in charge of  following up the activities of  the objectives of this axis |                                                                               | E.0.1 three months from  time zero   | E.0 three months from time  zero  |
| E.0 Organization of the  responsibilities for the  execution of the tasks | E.0.2 Nominate members of  the technical working group                                                   |                                                                               | E.0.2 three months from  time zero   | E.0 three months from time  zero  |
| E.1 AMR budget planning                                                   | E.1.1  Budget for each activity of  the plan has been studied                                            | E.1.1  Budget for every sub- activity is put in the NAP                       | E.1.1  Ready   at 'time zero'        | E.1 Finalized February 2019       |
| E.1 AMR budget planning                                                   | E.1.2  Overall budget of the plan  has been assessed                                                     | E.1.2  Meeting between Dr. A  Rady and Dr. R Moghnieh to  finalize the budget | E.1.2  20 th  December 2018          | E.1 Finalized February 2019       |
| E.2 Looking for sources of  funding for NAP                               | E.2.1  Meeting with WHO, MOH,  MOA, NGOs to check for  investment in NAP                                 | E.2.1.1 Financing from  WHO discussed                                         | E.2.1.1 six months from  'time zero' | E.2 Nine months from 'time  zero' |
| E.2 Looking for sources of  funding for NAP                               | E.2.1  Meeting with WHO, MOH,  MOA, NGOs to check for  investment in NAP                                 | E.2.1.2 Financing from  MOH discussed                                         | E.2.1.2 six months from  'time zero' | E.2 Nine months from 'time  zero' |
| E.2 Looking for sources of  funding for NAP                               | E.2.1  Meeting with WHO, MOH,  MOA, NGOs to check for  investment in NAP                                 | E.2.1.3 Financing from  MOA discussed                                         | E.2.1.3   1 st  Jan 2019             | E.2 Nine months from 'time  zero' |

|                                                                                                                                                                                      |                                                                                                                                                      | E.2.1.4 Financing from  NGO (FAO, Fondation  Merieux) discussed                                                      | E.2.1.4 six months from  'time zero'     |                                   |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------|------------------------------------------|-----------------------------------|
|                                                                                                                                                                                      | E.2.2  Look for other funding  sources (agencies or bodies  or countries)                                                                            | E.2.2.1  Allocate a professional that  will prepare proposals for  funding                                           | E.2.2.1  Three months from 'time  zero'  |                                   |
|                                                                                                                                                                                      | E.2.2  Look for other funding  sources (agencies or bodies  or countries)                                                                            | E.2.2.2 The allocated  professional  prepares the general  proposal                                                  | E.2.2.2 Six months from  'time zero'     |                                   |
|                                                                                                                                                                                      | E.2.2  Look for other funding  sources (agencies or bodies  or countries)                                                                            | E.2.2.3 Allocate a  specialized person to do  mapping of funders                                                     | E.2.2.3 Three months from  'time zero'   |                                   |
|                                                                                                                                                                                      | E.2.2  Look for other funding  sources (agencies or bodies  or countries)                                                                            | E.2.2.4 Send proposals to  agencies or organizations  that are potential funders                                     | E.2.2.4 Nine months from  'time zero'    |                                   |
|                                                                                                                                                                                      | E.2.3  Include private organizations  interested in AMR into the  NAP                                                                                | E.2.3.1  Mapping of private  organizations interested in  AMR                                                        | E.2.3.1  Three months from 'time  zero'  |                                   |
|                                                                                                                                                                                      | E.2.3  Include private organizations  interested in AMR into the  NAP                                                                                | E.2.3.2 Present collaboration  proposals to these  organizations                                                     | E.2.3.2 Six months from  'time zero'     |                                   |
| E.3 Mapping of  organizations for potential  collaboration in the  investigation of natural  sources of biodiversity and  biorepositories as sources of  new antimicrobial molecules | E.3.1 Mapping of  international organizations  /countries for potential  collaboration in the  investigation of natural  sources of biodiversity and | E.3.1.1 Nominate the person  who will be in charge of  doing this mapping and  having a list of these  organizations | E.3.1.1  3 three months from 'time  zero | E.3 Nine months from 'time  zero' |
| E.3 Mapping of  organizations for potential  collaboration in the  investigation of natural  sources of biodiversity and  biorepositories as sources of  new antimicrobial molecules | E.3.1 Mapping of  international organizations  /countries for potential  collaboration in the  investigation of natural  sources of biodiversity and | E.3.1.2 Do the mapping plus  list                                                                                    | E.3.1.2  Six months from 'time zero'     | E.3 Nine months from 'time  zero' |

|                                                                                           | biorepositories as sources of  new antimicrobial molecules                                                                   | E.3.1.3 Approach these  organizations through  showing them the achieved  research in Lebanon as well  as potential for benefit  sharing with these  organizations                             | E.3.1.3  Nine months from 'time  zero'    |                                |
|-------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------|--------------------------------|
|                                                                                           | E.3.2  Mapping of existing or  ongoing local   research that  deals with biodiversity as  source of antimicrobial  molecules | E.3.2.1  Communication with LAS to  organize a yearly meeting  where researchers in  Lebanon expose and discuss  their studies in the field of  biodiversity for alternatives  to ABX  E.3.2.2 | E.3.2.1  3 three months from 'time  zero' |                                |
|                                                                                           | E.3.2  Mapping of existing or  ongoing local   research that  deals with biodiversity as  source of antimicrobial  molecules | Create a section of AMR  Website where local studies,  posters, articles, projects in  biodiversity are posted                                                                                 | E.3.2.2 three months from  'time zero'    |                                |
| E.4 Establishing  communication with public  and private sector for  collaboration to NAP | E.4.1  Establish a network of  researchers in public and  private sectors                                                    | E.4.1.1 LSIDCM to host  yearly workshop for  researchers to discuss AMR  research                                                                                                              | E.4.1.1 three months from  'time zero'    | E.4 One year from 'time  zero' |
| E.4 Establishing  communication with public  and private sector for  collaboration to NAP | E.4.2 Mapping of potential  private partners to encourage  research                                                          | E.4.2.1 Nominate the person  who will do the mapping                                                                                                                                           | E.4.2.1 Three months from  'time zero'    | E.4 One year from 'time  zero' |
| E.4 Establishing  communication with public  and private sector for  collaboration to NAP | E.4.2 Mapping of potential  private partners to encourage  research                                                          | E.4.2.2 Produce a list of  potential partners                                                                                                                                                  | E.4.2.2  Six months from 'time zero'      | E.4 One year from 'time  zero' |
| E.4 Establishing  communication with public  and private sector for  collaboration to NAP | E.4.3 Establish  communication and  collaboration with private  partners                                                     | E.4.3.1  Preparation of specific  proposals for collaboration  with specific partners                                                                                                          | E.4.3.1  Nine months from 'time  zero'    | E.4 One year from 'time  zero' |

## Operational plan and budget

| Objective                                                                     | Activity                                                                                                        | Sub- activity   | Unit         | Quantity   | Date                                 | Location   | Responsibl e entity                                                                                                   | Cost         | Source of  funding   | Indicator                                  |
|-------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------|-----------------|--------------|------------|--------------------------------------|------------|-----------------------------------------------------------------------------------------------------------------------|--------------|----------------------|--------------------------------------------|
| E.0  Organizatio n of the  responsibili ties for the  execution  of the tasks | E.0.1  Nominate a  focal  person in  charge of  following  up the  activities of  the  objectives  of this axis |                 | E.0.1 Letter | E.0.1 One  | E.0.1 three  months  from time  zero | E.0.1 MOH  | E.0.1   -WHO- National  Professiona l Officer  (Dr. A  Rady)  -MOH-  General  Director  (Dr. W  Ammar)  -MOA  general | E.0.1   None | E.0.1   None         | E.0.1   Focal  person  nominated           |
| E.0  Organizatio n of the  responsibili ties for the  execution  of the tasks | E.0.2  Nominate  members of  the  technical  working  group                                                     |                 | E.0.2 Letter | E.0.2 One  | E.0.2 three  months  from time  zero | E.0.2 MOH  | E.0.2   -WHO- National  Professiona l Officer  (Dr. A  Rady)  -MOH-  General  Director                                | E.0.2   None | E.0.2 None           | E.0.2  Technical  working  group  assigned |

|                           |                                                                   |                                                                                   |                                        |            |                                |                    | (Dr. W  Ammar)  -MOA  general  director                                                                                                        |                                                               |                 |                          |
|---------------------------|-------------------------------------------------------------------|-----------------------------------------------------------------------------------|----------------------------------------|------------|--------------------------------|--------------------|------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------|-----------------|--------------------------|
| E.1 AMR  budget  planning | E.1.1  Budget for  each  activity of  the plan has  been  studied | E.1.1  Budget for  every sub- activity is  put in the  NAP                        | E.1.1  Budget for  every sub- activity | E.1.1  One | E.1.1  Ready   at  'time zero' | E.1.1  WHO         | E.1.1  -Private  sector,  WHO  consultant,  former  LSIDCM  president  (Dr. R  Moghnieh)  -WHO- National  Professiona l Officer  (Dr. A  Rady) | E.1.1  Included in  NAP  preparation  budget  (already  paid) | E.1.1  AMR Plan | E.1.1  Budget  finalized |
| E.1 AMR  budget  planning | E.1.2  Overall  budget of  the plan has  been  assessed           | E.1.2  Meeting  between  Dr. A Rady  and Dr. R  Moghnieh  to finalize  the budget | E.1.2  Meeting                         | E.1.2 One  | E.1.2  20 th December  2018    | E.1.2  WHO  Beirut | E.1.2  -Private  sector,  WHO  consultant,  former  LSIDCM  president                                                                          | E.1.2  Included in  NAP  preparation  budget  (already  paid) | E.1.2  AMR Plan | E.1.2  Budget  finalized |

|                                                |                                                                               |                                                |                                                  |               |                                        |                   | (Dr. R  Moghnieh)  -WHO- National  Professiona l Officer  (Dr. A  Rady)   |             |             |                                            |
|------------------------------------------------|-------------------------------------------------------------------------------|------------------------------------------------|--------------------------------------------------|---------------|----------------------------------------|-------------------|---------------------------------------------------------------------------|-------------|-------------|--------------------------------------------|
| E.2  Looking  for sources  of funding  for NAP | E.2.1  Meeting  with WHO,  MOH,  MOA,  NGOs to  check for  investment  in NAP | E.2.1.1  Financing  from WHO  discussed        | E.2.1.1   Meeting                                | E.2.1.1   one | E.2.1.1 six  months  from 'time  zero' | E.2.1.1  WHO      | E.2.1.1  -Focal  person  -Technical  working  group                       | E.2.1  None | E.2.1  None | E.2.1  Percentage  of budget is  available |
| E.2  Looking  for sources  of funding  for NAP | E.2.1  Meeting  with WHO,  MOH,  MOA,  NGOs to  check for  investment  in NAP | E.2.1.2  Financing  from MOH  discussed        | E.2.1.2   Meeting  with Dr  Ammar                | E.2.1.2  one  | E.2.1.2 six  months  from 'time  zero' | E.2.1.2  MOH      | E.2.1.2  -Focal  person  -Technical  working  group                       | E.2.1  None | E.2.1  None | E.2.1  Percentage  of budget is  available |
| E.2  Looking  for sources  of funding  for NAP | E.2.1  Meeting  with WHO,  MOH,  MOA,  NGOs to  check for  investment  in NAP | E.2.1.3  Financing  from MOA  discussed        | E.2.1.3   Meeting  with   MOA  general  director | E.2.1.3 one   | E.2.1.3   1 st  Jan 2019               | E.2.1.3  MOA      | E.2.1.3   -Focal  person  -Technical  working  group                      | E.2.1  None | E.2.1  None | E.2.1  Percentage  of budget is  available |
| E.2  Looking  for sources  of funding  for NAP | E.2.1  Meeting  with WHO,  MOH,  MOA,  NGOs to  check for  investment  in NAP | E.2.1.4  Financing  from NGO  (FAO,  Fondation | E.2.1.4  Meetings  with  agencies                | E.2.1.4  3-4  | E.2.1.4 six  months  from 'time  zero' | E.2.1.4  Agencies | E.2.1.4   -Focal  person                                                  | E.2.1  None | E.2.1  None | E.2.1  Percentage  of budget is  available |

|                                          | Merieux)  discussed                                                           |                                |                                                                |                                    | -Technical  working  group         |                    |                   |                                                                                   |
|------------------------------------------|-------------------------------------------------------------------------------|--------------------------------|----------------------------------------------------------------|------------------------------------|------------------------------------|--------------------|-------------------|-----------------------------------------------------------------------------------|
|                                          | E.2.2.1  Allocate a  professiona l that will  prepare  proposals  for funding | E.2.2.1  Team  E.2.2.1  One    | E.2.2.1  Three  months  from 'time  zero'  E.2.2.1  -MOH  -WHO | E.2.2.1  Technical  working  group | E.2.2.1  None                      | None               | E.2.2.1           | E.2.2  Number of  proposals  sent to  organizatio ns that are  potential  funders |
| E.2.2  Look for  other  funding  sources | E.2.2.2 The  allocated  professiona l  prepares  the general  proposal        | E.2.2.2  Proposal  E.2.2.2 One | E.2.2.2 Six  months  from 'time  zero'                         | E.2.2.2  -WHO  -MOH  -MOA          | E.2.2.2  Technical  working  group | E.2.2.2  2,000 USD | E.2.2.2  AMR fund | E.2.2  Number of  proposals  sent to  organizatio ns that are  potential  funders |
| (agencies  or bodies or  countries)      | E.2.2.3 Allocate a  specialized  person to  do mapping  of funders            | E.2.2.3  Person  E.2.2.3 One   | E.2.2.3  Three  months  from 'time  zero'                      | E.2.2.3  -WHO  -MOH  -MOA          | E.2.2.3  Technical  working  group | E.2.2.3  None      | E.2.2.3           | E.2.2  Number of  proposals  sent to  organizatio ns that are  potential  funders |
|                                          | Send  proposals  to agencies  or  organizatio ns that are  potential  funders | E.2.2.4  Proposal  E.2.2.4 One | E.2.2.4  Nine  months  from 'time  zero'                       | E.2.2.4  -WHO  -MOH  -MOA          | E.2.2.4  Focal  person             | E.2.2.4  1,000 USD | E.2.2.4  AMR fund | E.2.2  Number of  proposals  sent to  organizatio ns that are  potential  funders |

|                                                                                                                                                      | E.2.3  Include  private  organizatio ns  interested  in AMR  into the                                                                       | E.2.3.1  Mapping of  private  organizatio ns  interested  in AMR                                                            | E.2.3.1  List     | E.2.3.1  One   | E.2.3.1  Three  months  from 'time  zero'   | E.2.3.1  -WHO  -MOH  -MOA   | E.2.3.1  Person in  charge  mapping of  potential  funders   | E.2.3.1  1,000 USD            | E.2.3.1  AMR fund          | E.2.3  Number of  private  organizatio ns that are  collaborati ng with  NAP    |
|------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------|-------------------|----------------|---------------------------------------------|-----------------------------|--------------------------------------------------------------|-------------------------------|----------------------------|---------------------------------------------------------------------------------|
|                                                                                                                                                      | NAP                                                                                                                                         | E.2.3.2  Present  collaboratio n proposals  to these  organizatio ns                                                        | E.2.3.2  Proposal | E.2.3.2 One    | E.2.3.2 Six  months  from 'time  zero'      | E.2.3.2  -WHO  -MOH  -MOA   | E.2.3.2  Proposal  specialist                                | E.2.3.2  Included in  E.2.2.4 | E.2.3.2  Budget for  2.2.4 |                                                                                 |
| E.3  Mapping of  organizatio ns for  potential  collaboratio n in the  investigatio n of natural  sources of  biodiversity  and  bioreposito ries as | E.3.1  Mapping of  internationa l  organizatio ns  /countries  for  potential  collaboratio n in the  investigatio n of natural  sources of | E.3.1.1  Nominate  the person  who will be  in charge of  doing this  mapping  and having  a list of  these  organizatio ns | E.3.1.1  Person   | E.3.1.1 One    | E.3.1.1  3 three  months  from 'time  zero  | E.3.1.1  -WHO  -MOH  -MOA   | E.3.1.1  Person in  charge  mapping of  potential  funders   | E.3.1.1  Included in  E.2.2.4 | E.3.1.1  Budget for  2.2.4 | E.3.1  Number  internation al of  organizatio ns  collaborati ng on this  issue |
| sources of  new  antimicrobi                                                                                                                         | biodiversity  and  bioreposito                                                                                                              | E.3.1.2 Do  the  mapping  plus list                                                                                         | E.3.1.2 List      | E.3.1.2 One    | E.3.1.2  Six months  from 'time  zero'      | E.3.1.2  -WHO  -MOH  -MOA   | E.3.1.2  Person in  charge of  mapping  organizatio          | E.3.1.2  Included in  E.2.2.4 | E.3.1.2  Budget for  2.2.4 | E.3.1  Number  internation al of  organizatio ns  collaborati ng on this  issue |

| al  molecules   | ries as  sources of  new                                                                                                            |                                                                                                                                                                              |                   |                    |                                             |                           | ns and  funds                                  |               |               |                                                                                                                   |
|-----------------|-------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------|--------------------|---------------------------------------------|---------------------------|------------------------------------------------|---------------|---------------|-------------------------------------------------------------------------------------------------------------------|
|                 | antimicrobi al  molecules                                                                                                           | E.3.1.3  Approach  these  organizatio ns through  showing  them the  achieved  research in  Lebanon as  well as  potential  for benefit  sharing  with these  organizatio ns | E.3.1.3  Proposal | E.3.1.3 One        | E.3.1.3  Nine  months  from 'time  zero'    | E.3.1.3  -WHO  -MOH  -MOA | E.3.1.3   Focal  person                        | E.3.1.3  None | E.3.1.3  None |                                                                                                                   |
|                 | E.3.2  Mapping of  existing or  ongoing  local    research  that deals  with  biodiversity  as source of  antimicrobi al  molecules | E.3.2.1  Communic ation with  LAS to  organize a  yearly  meeting  where  researchers  in Lebanon  expose and  discuss  their                                                | E.3.2.1  Meeting  | E.3.2.1  Once/year | E.3.2.1  3 three  months  from 'time  zero' | E.3.2.1  LSIDCM           | E.3.2.1  President  of  LSIDCM  (Dr. Z  Helou) | E.3.2.1  None | E.3.2.1  None | E.3.2  Number of  local  research  bodies that  support  biodiversit y as a  source of  antimicrobi al  molecules |

|                                                                                                 |                                                                              | studies in  the field of  biodiversity  for  alternatives  to ABX                                                              |                                   |              |                                           |                   |                                                                                                                   |                                          |                               |                                                                                                         |
|-------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------|-----------------------------------|--------------|-------------------------------------------|-------------------|-------------------------------------------------------------------------------------------------------------------|------------------------------------------|-------------------------------|---------------------------------------------------------------------------------------------------------|
|                                                                                                 |                                                                              | E.3.2.2  Create a  section of  AMR  Website  where local  studies,  posters,  articles,  projects in  biodiversity  are posted | E.3.2.2  Section on  AMR  website | E.3.2.2  One | E.3.2.2  three  months  from 'time  zero' | E.3.2.2  MOH  WHO | E.3.2.2  IT  specialist  MOH  WHO                                                                                 | E.3.2.2  Included in  budget of  website | E.3.2.2  AMR  Website  Budget |                                                                                                         |
| E.4  Establishin g  communica tion with  public and  private  sector for  collaboratio n to NAP | E.4.1  Establish a  network of  researchers  in public  and private  sectors | E.4.1.1  LSIDCM  to host  yearly  workshop  for  researchers  to discuss  AMR  research                                        | E.4.1.1  Workshop                 | E.4.1.1 One  | E.4.1.1  three  months  from 'time  zero' | E.4.1.1  LSIDCM   | E.4.1  -Private  sector,  WHO  consultant,  former  LSIDCM  president  (Dr. R  Moghnieh)  - President  of  LSIDCM | E.4.1  1,800  USD/year                   | E.4.1  LSIDCM                 | E.4.1  Number of  studies that  are posted  on AMR  website  about  biodiversit y in  research for  ABX |

|                                                                              |                                                                                            |                         |                                         |                                           |                           | (Dr. Z  Helou)  -Private  Sector (Dr.  M Matar)   |                                 |                           |                                                                            |
|------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------|-------------------------|-----------------------------------------|-------------------------------------------|---------------------------|---------------------------------------------------|---------------------------------|---------------------------|----------------------------------------------------------------------------|
| E.4.2  Mapping of  potential  private  partners to  encourage  research      | E.4.2.1  Nominate  the person  who will do  the  mapping                                   | E.4.2.1  Person         | E.4.2.1 One                             | E.4.2.1  Three  months  from 'time  zero' | E.4.2.1 - WHO  -MOH  -MOA | E.4.2  Person in  charge of  NAP                  | E.4.2  Part of  website  budget | E.4.2  AMR fund           | E.4.2  Number of  private  partners  that are  collaborati ng to  research |
| E.4.2  Mapping of  potential  private  partners to  encourage  research      | E.4.2.2  Produce a  list of  potential  partners                                           | E.4.2.2 List            | E.4.2.2 One                             | E.4.2.2  Six months  from 'time  zero'    | E.4.2.2  -WHO  -MOH  -MOA | E.4.2.2  Nominated  person for  mapping           | E.4.2.2  Included in  2.3.1     | E.4.2.2  Budget of  2.3.1 | E.4.2  Number of  private  partners  that are  collaborati ng to  research |
| E.4.3  Establish  communica tion and  collaboratio n with  private  partners | E.4.3.1  Preparation  of specific  proposals  for  collaboratio n with  specific  partners | E.4.3.1  Proposal       | E.4.3.1 One                             | E.4.3.1  Nine  months  from 'time  zero'  | E.4.3.1  -WHO  -MOH  -MOA | E.4.3.1  Proposal  specialist                     | E.4.3.1  Focal  person          | E.4.3.1  None             | E.4.3  Number of  private  partners  that are  collaborati ng to AMR       |
| E.4.3  Establish  communica tion and  collaboratio n with  private  partners | E.4.3.2  Establish  communica tion and  collaboratio n with                                | E.4.3.2  Communic ation | E.4.3.2  Number of  potential  partners | E.4.3.2  One year  from 'time  zero'      | E.4.3.2  -WHO  -MOH  -MOA | E.4.3.2  Person in  charge of  NAP                | E.4.3.2  Focal  person          | E.4.3.2  None             | E.4.3  Number of  private  partners  that are  collaborati ng to AMR       |

## Monitoring and evaluation plan

| Objective                                                                     | Activity                                                                                                      | Sub-activity                                                                      | Indicator                                  | Purpose                                                                       | Calculation   | Frequency         | Data source                                                                                  | Method           | Baseline   |
|-------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------|--------------------------------------------|-------------------------------------------------------------------------------|---------------|-------------------|----------------------------------------------------------------------------------------------|------------------|------------|
| E.0  Organization  of the  responsibiliti es for the  execution of  the tasks | E.0.1  Nominate a  focal person  in charge of  following up  the activities  of the  objectives of  this axis |                                                                                   | E.0.1   Focal person  nominated            | E.0  Organization  of the  responsibiliti es for the  execution of  the tasks | E.0 Yes/No    | E.0 Once/5  years | E.0 -MOH  -WHO  -MOA                                                                         | E.0 Letter       | E.0 NA     |
| E.0  Organization  of the  responsibiliti es for the  execution of  the tasks | E.0.2  Nominate  members of  the technical  working  group                                                    |                                                                                   | E.0.2  Technical  working  group  assigned | E.0  Organization  of the  responsibiliti es for the  execution of  the tasks | E.0 Yes/No    | E.0 Once/5  years | E.0 -MOH  -WHO  -MOA                                                                         | E.0 Letter       | E.0 NA     |
| E.1 AMR  budget  planning                                                     | E.1.1  Budget for  each activity  of the plan  has been  studied                                              | E.1.1  Budget for  every sub- activity is  put in the  NAP                        | E.1.1 Budget  finalized                    | E.1  Mandatory                                                                | E.1 Yes/No    | E.1 Once/5  years | E.1   -WHO  -Private  sector, WHO  consultant,  former  LSIDCM  president  (Dr. R  Moghnieh) | E.1  Calculation | E.1 NA     |
| E.1 AMR  budget  planning                                                     | E.1.2  Overall  budget of the  plan has  been  assessed                                                       | E.1.2  Meeting  between Dr.  A Rady and  Dr. R  Moghnieh to  finalize the  budget | E.1.2  Budget  finalized                   | E.1  Mandatory                                                                | E.1 Yes/No    | E.1 Once/5  years | E.1   -WHO  -Private  sector, WHO  consultant,  former  LSIDCM  president  (Dr. R  Moghnieh) | E.1  Calculation | E.1 NA     |

| E.2 Looking  for sources  of funding  for NAP   | E.2.1  Meeting  with WHO,  MOH,  MOA,  NGOs to  check for                     | E.2.1.1  Financing  from WHO  discussed                                       | E.2.1  Percentage  of budget is  available                                        | E.2.1 Vision  of financial  needs   | E.2.1  Yes/No                                                                     | E.2.1 Once/5  years   | E.2.1  -WHO  -MOH  -MOA   | E.2.1  Meetings                                        | E.2.1 NA   |
|-------------------------------------------------|-------------------------------------------------------------------------------|-------------------------------------------------------------------------------|-----------------------------------------------------------------------------------|-------------------------------------|-----------------------------------------------------------------------------------|-----------------------|---------------------------|--------------------------------------------------------|------------|
| E.2 Looking  for sources  of funding  for NAP   | E.2.1  Meeting  with WHO,  MOH,  MOA,  NGOs to  check for                     | E.2.1.2  Financing  from MOH  discussed                                       | E.2.1  Percentage  of budget is  available                                        | E.2.1 Vision  of financial  needs   | E.2.1  Yes/No                                                                     | E.2.1 Once/5  years   | E.2.1  -WHO  -MOH  -MOA   | E.2.1  Meetings                                        | E.2.1 NA   |
| E.2 Looking  for sources  of funding  for NAP   | E.2.1  Meeting  with WHO,  MOH,  MOA,  NGOs to  check for                     | E.2.1.3  Financing  from MOA  discussed                                       | E.2.1  Percentage  of budget is  available                                        | E.2.1 Vision  of financial  needs   | E.2.1  Yes/No                                                                     | E.2.1 Once/5  years   | E.2.1  -WHO  -MOH  -MOA   | E.2.1  Meetings                                        | E.2.1 NA   |
| E.2 Looking  for sources  of funding  for NAP   | E.2.1  Meeting  with WHO,  MOH,  MOA,  NGOs to  check for                     | E.2.1.4  Financing  from NGO  (FAO,  Fondation  Merieux)  discussed           | E.2.1  Percentage  of budget is  available                                        | E.2.1 Vision  of financial  needs   | E.2.1  Yes/No                                                                     | E.2.1 Once/5  years   | E.2.1  -WHO  -MOH  -MOA   | E.2.1  Meetings                                        | E.2.1 NA   |
| E.2 Looking  for sources  of funding  for NAP   | E.2.2  Look for  other  funding  sources  (agencies or  bodies or  countries) | E.2.2.1  Allocate a  professional  that will  prepare  proposals for  funding | E.2.2  Number of  proposals  sent to  organization s that are  potential  funders | E.2.2  Attract  Funds               | E.2.2  Number of  proposals  sent to  organization s that are  potential  funders | E.2.2 Once/5  years   | E.2.2   -WHO  -MOH  -MOA  | E.2.2  Mapping  organization s  and  sending  proposal | E.2.2 NA   |
| E.2 Looking  for sources  of funding  for NAP   | E.2.2  Look for  other  funding  sources  (agencies or  bodies or  countries) | E.2.2.2 The  allocated  professional  prepares the                            | E.2.2  Number of  proposals  sent to  organization s that are  potential  funders | E.2.2  Attract  Funds               | E.2.2  Number of  proposals  sent to  organization s that are  potential  funders | E.2.2 Once/5  years   | E.2.2   -WHO  -MOH  -MOA  | E.2.2  Mapping  organization s  and  sending  proposal | E.2.2 NA   |

|                                     |                                                                          | general  proposal                                                                    |                                                                             |                                                             |                                                                             |                     |                          |                                                       |          |
|-------------------------------------|--------------------------------------------------------------------------|--------------------------------------------------------------------------------------|-----------------------------------------------------------------------------|-------------------------------------------------------------|-----------------------------------------------------------------------------|---------------------|--------------------------|-------------------------------------------------------|----------|
|                                     |                                                                          | E.2.2.3 Allocate a  specialized  person to do  mapping of  funders                   |                                                                             |                                                             |                                                                             |                     |                          |                                                       |          |
|                                     |                                                                          | E.2.2.4 Send  proposals to  agencies or  organization s that are  potential  funders |                                                                             |                                                             |                                                                             |                     |                          |                                                       |          |
|                                     | E.2.3  Include  private  organization s interested  in AMR into  the NAP | E.2.3.1  Mapping of  private  organization s interested  in AMR                      | E.2.3  Number of  private  organization s that are  collaborating  with NAP | E.2.3 Pool  money into  the plan to  be able to  execute it | E.2.3  Number of  private  organization s that are  collaborating  with NAP | E.2.3 Once/5  years | E.2.3   -WHO  -MOH  -MOA | E.2.3  Mapping  organization s and  sending  proposal | E.2.3 NA |
|                                     | E.2.3  Include  private  organization s interested  in AMR into  the NAP | E.2.3.2  Present  collaboration  proposals to  these  organization                   | E.2.3  Number of  private  organization s that are  collaborating  with NAP | E.2.3 Pool  money into  the plan to  be able to  execute it | E.2.3  Number of  private  organization s that are  collaborating  with NAP | E.2.3 Once/5  years | E.2.3   -WHO  -MOH  -MOA | E.2.3  Mapping  organization s and  sending  proposal | E.2.3 NA |
| E.3 Mapping  of  organization s for | E.3.1  Mapping of  international  organization                           | s  E.3.1.1  Nominate  the person  who will be                                        | E.3.1  Number  international  of                                            | E.3.1 This  field needs  multinational  collaboration       | E.3.1  Number  international  of                                            | E.3.1 Once/5  years | E.3.1   -WHO  -MOH  -MOA | E.3.1  Mapping  organization s and                    | E.3.1 NA |

| potential  collaboration  in the  investigation  of natural  sources of  biodiversity  and  biorepositori es as sources  of new  antimicrobial  molecules   | s /countries  for potential  collaboration  in the  investigation  of natural  sources of  biodiversity  and   | in charge of  doing this  mapping and  having a list  of these  organization s                                                                                               | organization s  collaborating  on this issue   | . This is to  have win- win  collaboration            | organization s  collaborating  on this issue   |                     |                             | sending  proposal      |            |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------|-------------------------------------------------------|------------------------------------------------|---------------------|-----------------------------|------------------------|------------|
| potential  collaboration  in the  investigation  of natural  sources of  biodiversity  and  biorepositori es as sources  of new  antimicrobial  molecules   | biorepositori                                                                                                  | E.3.1.2 Do  the mapping  plus list                                                                                                                                           | organization s  collaborating  on this issue   | . This is to  have win- win  collaboration            | organization s  collaborating  on this issue   |                     |                             | sending  proposal      |            |
| potential  collaboration  in the  investigation  of natural  sources of  biodiversity  and  biorepositori es as sources  of new  antimicrobial  molecules   | es as sources  of new  antimicrobial  molecules                                                                | E.3.1.3  Approach  these  organization s through  showing  them the  achieved  research in  Lebanon as  well as  potential for  benefit  sharing with  these  organization s | organization s  collaborating  on this issue   | . This is to  have win- win  collaboration            | organization s  collaborating  on this issue   |                     |                             | sending  proposal      |            |
| potential  collaboration  in the  investigation  of natural  sources of  biodiversity  and  biorepositori es as sources  of new  antimicrobial  molecules   | E.3.2  Mapping of  existing or  ongoing  local                                                                 | E.3.2.1  Communicat ion with  LAS to  organize a                                                                                                                             | E.3.2  Number of  local  research  bodies that | E.3.2  Establish  continuity of  the work  nationwide | E.3.2  Number of  local  research  bodies that | E.3.2 Once/5  years | E.3.2   -WHO  -MOH  -LSIDCM | E.3.2   Communicat ion | E.3.2   NA |

|                                                                         | research that  deals with  biodiversity  as source of  antimicrobial  molecules   | yearly  meeting  where  researchers  in Lebanon  expose and  discuss their  studies in the  field of  biodiversity  for  alternatives  to ABX   | support  biodiversity  as a source  of  antimicrobial  molecules   | and  communicati on among  researchers                                  | support  biodiversity  as a source  of  antimicrobial  molecules   |                     |                 |                       |          |
|-------------------------------------------------------------------------|-----------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------|-------------------------------------------------------------------------|--------------------------------------------------------------------|---------------------|-----------------|-----------------------|----------|
|                                                                         | research that  deals with  biodiversity  as source of  antimicrobial  molecules   | E.3.2.2  Create a  section of  AMR  Website  where local  studies,  posters,  articles,  projects in  biodiversity  are posted                  | support  biodiversity  as a source  of  antimicrobial  molecules   | and  communicati on among  researchers                                  | support  biodiversity  as a source  of  antimicrobial  molecules   |                     |                 |                       |          |
| E.4  Establishing  communicati on with  public and  private  sector for | E.4.1  Establish a  network of  researchers  in public and  private  sectors      | E.4.1.1  LSIDCM to  host yearly  workshop  for  researchers  to discuss                                                                         | E.4.1  Number of  studies that  are posted on  AMR  website  about | E.4.1  Establish  continuity of  the work  nationwide  and  communicati | E.4.1  Number of  studies that  are posted on  AMR  website  about | E.4.1 Once/5  years | E.4.1   -LSIDCM | E.4.1  Communicat ion | E.4.1 NA |

| collaboration  to NAP   |                                                                             | AMR  research                                                                            | biodiversity  in research  for ABX                                        | on among  researchers.                   | biodiversity  in research  for ABX                                        |                     |                             |                        |            |
|-------------------------|-----------------------------------------------------------------------------|------------------------------------------------------------------------------------------|---------------------------------------------------------------------------|------------------------------------------|---------------------------------------------------------------------------|---------------------|-----------------------------|------------------------|------------|
| collaboration  to NAP   | E.4.2  Mapping of  potential  private  partners to  encourage  research     | E.4.2.1  Nominate  the person  who will do  the mapping                                  | E.4.2  Number of  private  partners that  are  collaborating  to research | E.4.2 Bring  funds from  private  sector | E.4.2  Number of  private  partners that  are  collaborating  to research | E.4.2 Once/5  years | E.4.2   -WHO  -MOH  -LSIDCM | E.4.2   Mapping        | E.4.2   NA |
| collaboration  to NAP   | E.4.2  Mapping of  potential  private  partners to  encourage  research     | E.4.2.2  Produce a  list of  potential  partners                                         | E.4.2  Number of  private  partners that  are  collaborating  to research | E.4.2 Bring  funds from  private  sector | E.4.2  Number of  private  partners that  are  collaborating  to research | E.4.2 Once/5  years | E.4.2   -WHO  -MOH  -LSIDCM | E.4.2   Mapping        | E.4.2   NA |
| collaboration  to NAP   | E.4.3  Establish  communicati on and  collaboration  with private  partners | E.4.3.1  Preparation  of specific  proposals for  collaboration  with specific  partners | E.4.3  Number of  private  partners that  are  collaborating  to AMR      | E.4.3 Bring  funds from  private  sector | E.4.3  Number of  private  partners that  are  collaborating  to AMR      | E.4.3 Once/5  years | E.4.3   -WHO  -MOH  -LSIDCM | E.4.3   Communicat ion | E.4.3  NA  |
| collaboration  to NAP   | E.4.3  Establish  communicati on and  collaboration  with private  partners | E.4.3.2  Establish  communicati on and  collaboration  with these  private  partners     | E.4.3  Number of  private  partners that  are  collaborating  to AMR      | E.4.3 Bring  funds from  private  sector | E.4.3  Number of  private  partners that  are  collaborating  to AMR      | E.4.3 Once/5  years | E.4.3   -WHO  -MOH  -LSIDCM | E.4.3   Communicat ion | E.4.3  NA  |

## References

- 1. Tackling a global health crisis: Initial steps. The Review on Antimicrobial Resistance. Chaired by Jim O'Neill. February 2015. https://amrreview.org/sites/default/files/Report-52.15.pdf
- 2. National Risk Register of Civil Emergencies 2015 edition. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/at tachment\_data/file/419549/20150331\_2015-NRR-WA\_Final.pdf
- 3. El Kary N, El Rassy E, Azar N, Choucair J. Ciprofloxacin and imipenem resistance and cross-resistance in Pseudomonas aeruginosa: A single institution experience. Am J Infect Control. 2016;44(12):1736-7.
- 4. Moghnieh R, Siblani L, Ghadban D, El Mchad H, Zeineddine R, Abdallah D, et al. Extensively drug-resistant Acinetobacter baumannii in a Lebanese intensive care unit: risk factors for acquisition and determination of a colonization score. J Hosp Infect. 2016;92(1):47-53.
- 5. Dandachi I, Sokhn ES, Najem E, Azar E, Daoud Z. Carriage of betalactamase-producing Enterobacteriaceae among nursing home residents in north Lebanon. . Int J Infect Dis. 2016;45:24-31.
- 6. Kanafani ZA, Kmeid J, Nawar T, Assaf SM, Zahreddine N, Kanj SS. Retrospective case series of infections caused by carbapenem-resistant Enterobacteriaceae at a tertiary care centre in Lebanon. Int J Antimicrob Agents. 2016;47(5):415-6.
- 7. Abdallah, Dania; El Mchad, Habiba; and Moghnieh, Rima. 'Pandrug-resistant Acinetobacter baumannii infections: Case series, contributing factors, outcomes and available treatment options'. Clinical Cases in Microbiology and Infectious Diseases.Ed. Ghassan Matar, Ed. New York: Elsevier, 2017. 47-57. Print
- 8. Araj GF Avedissian AZ, Itani LY, Jowana A Obeid JA.  Active antimicrobial agents against carbapenem-resistant E coli . and K pneumoniae . in Lebanon. Journal of Infection in Developing  Countries 2018; 12:164-170.
- 9. Araj GF, Avedissian Az, Ayyash NS, Bey HA, El Asmar RG, Hammoud RZ, Itani LY, Mallak MR, Sabai SA. A Reflection on Bacterial Resistance to Antimicrobial Agents at a  Major tertiary  Care Center in Lebanon Over a Decade. Lebanese Medical Journal 2012; 60 (3): 125-135.
- 10. Chamoun K, Farah M, Araj G, Daoud Z, Moghnieh R, Salameh P, et al. Surveillance of antimicrobial resistance in Lebanese hospitals: retrospective nationwide compiled data. Int J Infect Dis. 2016;46:64-70.
- 11. Moghnieh R, Soboh R, Abdallah D, El-Helou M, Al Hassan S, Ajjour L, Tamim H, Al Tabbah S, Nasreddine W, Mugharbil A. Healthcare Workers' Compliance to the 'Five Moments for Hand Hygiene': Comparison of Two

Interventional Methods. American Journal of Infection Control 2017, 45(1): 89-91.

- 12. Moghnieh R, Kanafani ZA, Abi Hanna P, Matar MJ, Mokhbat J, Jradeh M, Yared N, Husni R, Abdallah D, Atoui R, Choucair J, Al-Awar G, Dakdouki G, Farra A, El Helou G, Hammoud J, Aoun N, Kanj SS. 2016 Lebanese Society of Infectious Diseases and Clinical Microbiology Guidelines on the management of febrile neutropenia in adult cancer patients in the era of growing antimicrobial resistance. J Med Liban 2017; 65 (2): 63-82.
- 13. Awad L, Abdallah D, Mugharbil A, Jisr T, Droubi N, El-Rajab N and Moghnieh R. An Antibiotic Stewardship Exercise in the ICU: Building a Treatment Algorithm for the Management of VAP Based on Local Epidemiology and the 2016 IDSA/ATS Guidelines. Infection and Drug Resistance 2018: 11: 17-28.
- 14. WHO. Antimicrobial Resistance Global Report on Surveillance. http://who.int/iris/bitstream/10665/112642/1/9789241564748\_eng.pdf. Accessed March 24, 2017
- 15. Awad L, Tamim H, Abdallah D, Salameh M, Mugharbil A, Jisr T, Zahran K, Droubi N, Ibrahim A, Moghnieh R. Correlation between antifungal consumption and the distribution of Candida species in different hospital departments of a Lebanese medical Centre. BMC infectious diseases. 2018 Dec;18(1):589.
- 16. Schwarz S, Chaslus-Dancla E. Use of antimicrobials in veterinary medicine and mechanisms of resistance. Veterinary research. 2001 May 1;32(3-4):20125.
- 17. Chang Q, Wang W, Regev -Yochay G, Lipsitch M, Hanage WP. Antibiotics in agriculture and the risk to human health: how worried should we be?. Evolutionary applications. 2015 Mar;8(3):240-7.
- 18. Freeman MH, McIntyre CR. Copper-based wood preservatives. Forest products journal. 2008 Nov 6;58(11):7.
- 19. World Population Prospects: The 2017 Revision. ESA.UN.org (custom data acquired via website). United Nations Department of Economic and Social Affairs, Population Division. Retrieved 20 December 2018 .
- 20. UNHCR Syria Regional Refugee Response -Lebanon. UNHCR Syria Regional Refugee Response . Retrieved 20 December 2018 .
- 21. Knoema, World Data Atlas: Lebanon - Adult (15+) literacy rate. https://knoema.com/atlas/Lebanon/topics/Education/Literacy/Adult-literacyrate. Retrieved 20 December 2018 .

## Acknowledgement

We would like to acknowledge the following persons for attending the consultative workshops and participating in the discussion:

-  Dr. Adla Jammal (Ministry of Agriculture- Lebanese Agricultural Research Institute-Head of Antibiotic Residue Department)
-  Dr. Alissar Rady (World Health Organization-National Professional Officer)
-  Dr. Bassel Bazzal (Ministry of Agriculture-Head of Animal Health Service)
-  Dr. Ghassan Matar (American University of Beirut-Professor)
-  Dr. Jacques Mokhbat (Lebanese American University-Microbiologist and Infectious Diseases Specialist)
-  Dr. Marianne Msallem (Ministry of Health-Primary Health Care DepartmentDental Coordinator)
-  Dr. Mary Deeb (Lebanese American University-School of Medicine-Professor of Epidemiology)
-  Dr. Mohamad Farran (American University of Beirut-Department of Agricultural Engineering-Professor)
-  Dr. Monzer Hamze (Lebanese University-Professor)
-  Dr. Nada El Darra (Beirut Arab University-Coordinator of Masters degree in Food Safety and Analysis)
-  Dr. Oussayma Droubi (Rafik Hariri University Hospital- Infectious Diseases Specialist)
-  Dr. Pascale Salameh (Lebanese University-Professor of Epidemiology)
-  Dr. Rajaa Fakhoury (Beirut Arab University-Dean of the Faculty of Sciences)
-  Dr. Rida El Mays (General Cooperative Union-Chairman)
-  Dr. Rola Husni Samaha (Lebanese American University Medical Center Rizk Hospital-Head of Infectious Diseases Division and Infection Control Program)
-  Dr. Samir Hadjiabduli (International Organization for Migration-Chief Medical Officer)
-  Dr. Souha Kanj (American University of Beirut Medical Center-Head of Division of Infectious Diseases)
-  Dr. Ziad Daoud (University of Balamand- Professor and Head of Laboratory)
-  Eng. Abir Sirawan (Ministry of Agriculture-Head of Poultry Husbandry Department)
-  Eng. Salma Al Asmar (Libanvet-Agricultural Engineer)
-  Eng. Sizar Akkoum (Ministry of Health-Project Coordinator)
-  Mr. Nacif Rihani (Food and Agriculture Organization-Senior Livestock Officer)
-  Ms. Erwina Zoghbi (World Health Organization-Public Health Officer)
-  Ms. Hajar Semaha (Ministry of Health-Public Health Officer)
-  Ms. Josette Najjar (Fondation Mérieux-Representative)
-  Ms. Loubna Al-Batlouni (World Health Organization- Public Health Officer)

## Appendix

## Technical Committee on IHR

## Suggested members:

## 1- Core group

-Head of prevention MOH

Dr. Assaad Khoury, president

-Head of Communicable Diseases division MOH

Dr. Nabil Salam

-Head of surveillance unit MOH

Dr. Nada Ghosn

- Head of Preventive Medicine Department

Dr. Atika Berry

-Quality control officer at Central Public Health Laboratory

to be determined

-WHO focal point for IHR

Dr. Alissar Rady

-FAO focal point for IHR

to be determined

## 2- Technical support group

- Head of quarantine unit at Airports

Dr. Nasser Chahine

- Head of quarantine unit at Beirut port

Dr. Mohammad Sreij

- Representative of Society of Infectious Diseases to be determined

- Representative of Ministry of Interior Security /Municipalities

to be determined

- Head of medical department at Internal Security Forces

to be determined

- Head of medical department at General Security Forces

to be determined

- Representative of syndicate of laboratories

to be determined

- Representative of syndicate of hospitals

to be determined

- Head of veterinary department MOA

Dr. Ghazi Hakim

- Head of agriculture lab at MOA

to be determined

- Environmental hazards specialist at Ministry of Environment

to be determined

- Representative of the Higher Commission for relief to be determined

- Representative of the Order of pharmacists to be determined

## National Committee on AMR containment

-  President :
- Dr. Atika Berry (Ministry of Public Health, Head of Preventive Medicine Department)
-  Vice President :
- Dr. Jacques Mokhbat (Lebanese American University, Microbiologist and Infectious Diseases Specialist)
-  Members ( by alphabetical order of family names ):
- Dr. Georges Araj (American University of Beirut Medical Center, Head of Laboratory Medicine)
- Dr. Ghada Asmar (Lebanese University, School of Dentistry)

Dr. Bassel Bazzal (Ministry of Agriculture, Head of Animal Health Services)

- Dr. Nada Ghosn (Ministry of Public Health, Head of Epidemiology Surveillance Unit)

Dr. Rasha Hamra (Ministry of Public Health, Director of Public Relations and Health Education Departments)

Dr. Rola Husni Samaha (Lebanese American University Medical Center- Rizk

Hospital, Head of Infectious Diseases Division and Infection Control Program)

Dr. Rima Moghnieh (Makassed General Hospital, Head of Antimicrobial Stewardship Program)

- Dr. Alissar Rady (World Health Organization-National Professional Officer)
- Dr. Georges Salem (Lebanese Pediatric Society)
- Dr. Dolla Sarkis (Saint Joseph University, Vice President for Research)
- Eng. Abir Sirawan (Ministry of Agriculture, Head of Poultry Husbandry

Department)

- Dr. Rony Zeinni (Lebanese Order of Pharmacists)